activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1735030	CHEMBL854490	Activity against DYRK2 at 10 uM in the presence of 100 uM ATP relative to control	B	COc1cc(/C=C2\C(=O)NN(c3ccc(Cl)c(Cl)c3)C2=O)ccc1O		CHEMBL380093	=	Activity	%	59.0	CHEMBL4376	Homo sapiens	Activity	%	59.0
	1735030	CHEMBL854490	Activity against DYRK2 at 10 uM in the presence of 100 uM ATP relative to control	B	COc1cc(/C=C2\C(=O)NN(c3ccc(Cl)c(Cl)c3)C2=O)ccc1O		CHEMBL380093	=	Activity	%	59.0	CHEMBL4376	Homo sapiens	Activity	%	59.0
	1735048	CHEMBL854490	Activity against DYRK2 at 10 uM in the presence of 100 uM ATP relative to control	B	COc1cccc(NC(=O)Nc2nnc(-c3ccncc3)s2)c1		CHEMBL377430	=	Activity	%	77.0	CHEMBL4376	Homo sapiens	Activity	%	77.0
	2147239	CHEMBL922814	Activity of human DYRK2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	98.0	CHEMBL4376	Homo sapiens	Activity	%	98.0
Not Active	2302197	CHEMBL950866	Inhibition of human DYRK2 at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
	2417659	CHEMBL954302	Inhibition of human DYRK2 at 10 uM	B	O=C1NN(c2ccc(Cl)c(Cl)c2)C(=O)/C1=C/c1ccc(O)c([N+](=O)[O-])c1		CHEMBL511636	=	Activity	%	17.0	CHEMBL4376	Homo sapiens	Activity	%	17.0
	2417660	CHEMBL954302	Inhibition of human DYRK2 at 10 uM	B	COc1cc(/C=C2\C(=O)NN(c3ccc(C#N)cc3)C2=O)ccc1O		CHEMBL498718	=	Activity	%	78.0	CHEMBL4376	Homo sapiens	Activity	%	78.0
	2567236	CHEMBL973719	Inhibition of human DYRK2 kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	107.0	CHEMBL4376	Homo sapiens	Activity	%	107.0
	2635906	CHEMBL1003336	Inhibition of DYRK2 at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	100.0	CHEMBL4376	Homo sapiens	Residual_activity	%	100.0
	2635974	CHEMBL1003336	Inhibition of DYRK2 at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	100.0	CHEMBL4376	Homo sapiens	Residual_activity	%	100.0
	2636042	CHEMBL1003336	Inhibition of DYRK2 at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	100.0	CHEMBL4376	Homo sapiens	Residual_activity	%	100.0
	2721590	CHEMBL1061748	Inhibition of DYRK2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4376	Homo sapiens	INH	%	50.0
Antagonist	2897292	CHEMBL1062881	Inhibition of DYRK2 in the presence of 50uM ATP	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	IC50	nM	950.0	CHEMBL4376	Homo sapiens	IC50	uM	0.95
Antagonist	2897293	CHEMBL1062881	Inhibition of DYRK2 in the presence of 50uM ATP	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	IC50	nM	300.0	CHEMBL4376	Homo sapiens	IC50	uM	0.3
Antagonist	2897294	CHEMBL1062881	Inhibition of DYRK2 in the presence of 50uM ATP	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	IC50	nM	900.0	CHEMBL4376	Homo sapiens	IC50	uM	0.9
	2900917	CHEMBL1052073	Percentage DYRK2 activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	105.0	CHEMBL4376	Homo sapiens	Activity	%	105.0
	2900918	CHEMBL1052073	Percentage DYRK2 activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	79.0	CHEMBL4376	Homo sapiens	Activity	%	79.0
	2900919	CHEMBL1052073	Percentage DYRK2 activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	92.0	CHEMBL4376	Homo sapiens	Activity	%	92.0
	2900920	CHEMBL1061955	Percentage DYRK2 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	91.0	CHEMBL4376	Homo sapiens	Activity	%	91.0
	2900921	CHEMBL1061955	Percentage DYRK2 activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	76.0	CHEMBL4376	Homo sapiens	Activity	%	76.0
Antagonist	2900922	CHEMBL1061955	Percentage DYRK2 activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	26.0	CHEMBL4376	Homo sapiens	Activity	%	26.0
	2900923	CHEMBL1061955	Percentage DYRK2 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	91.0	CHEMBL4376	Homo sapiens	Activity	%	91.0
	2900924	CHEMBL1061955	Percentage DYRK2 activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	90.0	CHEMBL4376	Homo sapiens	Activity	%	90.0
Antagonist	2900925	CHEMBL1061955	Percentage DYRK2 activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	49.0	CHEMBL4376	Homo sapiens	Activity	%	49.0
	2900926	CHEMBL1061955	Percentage DYRK2 activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	85.0	CHEMBL4376	Homo sapiens	Activity	%	85.0
	2900927	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	76.0	CHEMBL4376	Homo sapiens	Activity	%	76.0
	2900928	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	99.0	CHEMBL4376	Homo sapiens	Activity	%	99.0
	2900929	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	81.0	CHEMBL4376	Homo sapiens	Activity	%	81.0
	2900930	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	71.0	CHEMBL4376	Homo sapiens	Activity	%	71.0
	2900931	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	93.0	CHEMBL4376	Homo sapiens	Activity	%	93.0
	2900932	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	78.0	CHEMBL4376	Homo sapiens	Activity	%	78.0
	2900933	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	94.0	CHEMBL4376	Homo sapiens	Activity	%	94.0
Antagonist	2900934	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	4.0	CHEMBL4376	Homo sapiens	Activity	%	4.0
	2900935	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	87.0	CHEMBL4376	Homo sapiens	Activity	%	87.0
	2900936	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	102.0	CHEMBL4376	Homo sapiens	Activity	%	102.0
	2900937	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	83.0	CHEMBL4376	Homo sapiens	Activity	%	83.0
	2900938	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	98.0	CHEMBL4376	Homo sapiens	Activity	%	98.0
	2900939	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	91.0	CHEMBL4376	Homo sapiens	Activity	%	91.0
	2900940	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	86.0	CHEMBL4376	Homo sapiens	Activity	%	86.0
	2900941	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	66.0	CHEMBL4376	Homo sapiens	Activity	%	66.0
	2900942	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	97.0	CHEMBL4376	Homo sapiens	Activity	%	97.0
	2900943	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	112.0	CHEMBL4376	Homo sapiens	Activity	%	112.0
	2900944	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	92.0	CHEMBL4376	Homo sapiens	Activity	%	92.0
	2900945	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	81.0	CHEMBL4376	Homo sapiens	Activity	%	81.0
	2900946	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	89.0	CHEMBL4376	Homo sapiens	Activity	%	89.0
	2900947	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	89.0	CHEMBL4376	Homo sapiens	Activity	%	89.0
	2900948	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	110.0	CHEMBL4376	Homo sapiens	Activity	%	110.0
	2900949	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	84.0	CHEMBL4376	Homo sapiens	Activity	%	84.0
	2900950	CHEMBL1062007	Percentage DYRK2 activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	118.0	CHEMBL4376	Homo sapiens	Activity	%	118.0
	2900951	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	82.0	CHEMBL4376	Homo sapiens	Activity	%	82.0
	2900952	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	87.0	CHEMBL4376	Homo sapiens	Activity	%	87.0
	2900953	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	81.0	CHEMBL4376	Homo sapiens	Activity	%	81.0
	2900954	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	93.0	CHEMBL4376	Homo sapiens	Activity	%	93.0
	2900955	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	83.0	CHEMBL4376	Homo sapiens	Activity	%	83.0
	2900956	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	96.0	CHEMBL4376	Homo sapiens	Activity	%	96.0
	2900957	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	77.0	CHEMBL4376	Homo sapiens	Activity	%	77.0
	2900958	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	97.0	CHEMBL4376	Homo sapiens	Activity	%	97.0
	2900959	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	102.0	CHEMBL4376	Homo sapiens	Activity	%	102.0
	2900960	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	98.0	CHEMBL4376	Homo sapiens	Activity	%	98.0
	2900961	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	90.0	CHEMBL4376	Homo sapiens	Activity	%	90.0
	2900962	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	87.0	CHEMBL4376	Homo sapiens	Activity	%	87.0
	2900963	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	73.0	CHEMBL4376	Homo sapiens	Activity	%	73.0
Antagonist	2900964	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	34.0	CHEMBL4376	Homo sapiens	Activity	%	34.0
Antagonist	2900965	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	19.0	CHEMBL4376	Homo sapiens	Activity	%	19.0
Antagonist	2900966	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	12.0	CHEMBL4376	Homo sapiens	Activity	%	12.0
Antagonist	2900967	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	15.0	CHEMBL4376	Homo sapiens	Activity	%	15.0
	2900968	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	86.0	CHEMBL4376	Homo sapiens	Activity	%	86.0
	2900969	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	83.0	CHEMBL4376	Homo sapiens	Activity	%	83.0
	2900970	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	73.0	CHEMBL4376	Homo sapiens	Activity	%	73.0
	2900971	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	84.0	CHEMBL4376	Homo sapiens	Activity	%	84.0
	2900972	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	105.0	CHEMBL4376	Homo sapiens	Activity	%	105.0
	2900973	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	95.0	CHEMBL4376	Homo sapiens	Activity	%	95.0
Antagonist	2900974	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	24.0	CHEMBL4376	Homo sapiens	Activity	%	24.0
	2900975	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	95.0	CHEMBL4376	Homo sapiens	Activity	%	95.0
	2900976	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	101.0	CHEMBL4376	Homo sapiens	Activity	%	101.0
	2900977	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	94.0	CHEMBL4376	Homo sapiens	Activity	%	94.0
	2900978	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	84.0	CHEMBL4376	Homo sapiens	Activity	%	84.0
	2900979	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	85.0	CHEMBL4376	Homo sapiens	Activity	%	85.0
	2900980	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	76.0	CHEMBL4376	Homo sapiens	Activity	%	76.0
	2900981	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	100.0	CHEMBL4376	Homo sapiens	Activity	%	100.0
	2900982	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	113.0	CHEMBL4376	Homo sapiens	Activity	%	113.0
	2900983	CHEMBL1062802	Percentage DYRK2 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	85.0	CHEMBL4376	Homo sapiens	Activity	%	85.0
	2900984	CHEMBL1062803	Percentage DYRK2 activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	99.0	CHEMBL4376	Homo sapiens	Activity	%	99.0
	2900985	CHEMBL1062803	Percentage DYRK2 activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	76.0	CHEMBL4376	Homo sapiens	Activity	%	76.0
	2900986	CHEMBL1052086	Percentage DYRK2 activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	92.0	CHEMBL4376	Homo sapiens	Activity	%	92.0
	2900987	CHEMBL1062008	Percentage DYRK2 activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	91.0	CHEMBL4376	Homo sapiens	Activity	%	91.0
	2926232	CHEMBL1054472	Inhibition of DYRK2 assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	94.0	CHEMBL4376	Homo sapiens	Activity	%	94.0
	2928418	CHEMBL1055329	Inhibition of DYRK2 assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	86.0	CHEMBL4376	Homo sapiens	Activity	%	86.0
	2938512	CHEMBL1041353	Inhibition of DYRK2 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	3.0	CHEMBL4376	Homo sapiens	INH	%	3.0
	2999028	CHEMBL1043731	Inhibition of DYRK2 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	101.0	CHEMBL4376	Homo sapiens	Activity	%	101.0
	2999818	CHEMBL1043731	Inhibition of DYRK2 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	104.0	CHEMBL4376	Homo sapiens	Activity	%	104.0
	2999891	CHEMBL1049893	Inhibition of DYRK2 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	82.0	CHEMBL4376	Homo sapiens	Activity	%	82.0
	2999967	CHEMBL1049893	Inhibition of DYRK2 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	101.0	CHEMBL4376	Homo sapiens	Activity	%	101.0
	3213919	CHEMBL1114875	Inhibition of DYRK2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	1.0	CHEMBL4376	Homo sapiens	INH	%	1.0
	3260082	CHEMBL1116007	Inhibition of DYRK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	52.0	CHEMBL4376	Homo sapiens	Activity	%	52.0
	3261391	CHEMBL1116007	Inhibition of DYRK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	51.0	CHEMBL4376	Homo sapiens	Activity	%	51.0
	3294732	CHEMBL1106600	Inhibition of DYRK2	B	COc1ccc(/C=C/c2ccc3ccc(C(=O)O)c(O)c3n2)cc1O		CHEMBL37139	=	IC50	nM	1100.0	CHEMBL4376	Homo sapiens	IC50	uM	1.1
	3294740	CHEMBL1106600	Inhibition of DYRK2	B	O=C(NCc1ccc(O)cc1O)c1ccc2ccc(C(=O)O)c(O)c2n1		CHEMBL81714	=	IC50	nM	6300.0	CHEMBL4376	Homo sapiens	IC50	uM	6.3
	3331903	CHEMBL1168862	Inhibition of DYRK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4376	Homo sapiens	INH	%	50.0
	3333318	CHEMBL1168862	Inhibition of DYRK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4376	Homo sapiens	INH	%	50.0
	3334723	CHEMBL1168862	Inhibition of DYRK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4376	Homo sapiens	INH	%	50.0
	3336143	CHEMBL1168862	Inhibition of DYRK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4376	Homo sapiens	INH	%	50.0
	3340671	CHEMBL1168862	Inhibition of DYRK2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4376	Homo sapiens	INH	%	50.0
	3342087	CHEMBL1168862	Inhibition of DYRK2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4376	Homo sapiens	INH	%	50.0
	3358536	CHEMBL1174324	Inhibition of DYRK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	48.0	CHEMBL4376	Homo sapiens	INH	%	48.0
	3358978	CHEMBL1174324	Inhibition of DYRK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	51.0	CHEMBL4376	Homo sapiens	INH	%	51.0
	3445089	CHEMBL1244800	Binding affinity to DYRK2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	22.0	CHEMBL4376	Homo sapiens	Kd	nM	22.0
	3448407	CHEMBL1244800	Binding affinity to DYRK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	uM	10.0
	3448733	CHEMBL1244800	Binding affinity to DYRK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	uM	10.0
	3449156	CHEMBL1244800	Binding affinity to DYRK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	680.0	CHEMBL4376	Homo sapiens	Kd	nM	680.0
	3449633	CHEMBL1244800	Binding affinity to DYRK2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	uM	10.0
	3450056	CHEMBL1244800	Binding affinity to DYRK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	uM	10.0
	3450975	CHEMBL1244800	Binding affinity to DYRK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	uM	10.0
	5133714	CHEMBL1648528	Inhibition of DYRK2 assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	68.0	CHEMBL4376	Homo sapiens	Activity	%	68.0
	5133809	CHEMBL1648528	Inhibition of DYRK2 assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	70.0	CHEMBL4376	Homo sapiens	Activity	%	70.0
	5133862	CHEMBL1648528	Inhibition of DYRK2 assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	83.0	CHEMBL4376	Homo sapiens	Activity	%	83.0
	5191417	CHEMBL1664065	Inhibition of DYRK2 at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	-4.0	CHEMBL4376	Homo sapiens	INH	%	-4.0
	5191418	CHEMBL1664065	Inhibition of DYRK2 at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	20.0	CHEMBL4376	Homo sapiens	INH	%	20.0
	6183811	CHEMBL1772043	Binding affinity to human Dyrk2 	B	Cc1nc(CN(C)c2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)cs1		CHEMBL1474834	=	Kd	nM	480.0	CHEMBL4376	Homo sapiens	Kd	nM	480.0
	6268751	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CCCNC1=N/C(=C\c2cc(OC)c(OC)c(OC)c2)C(=O)N1C		CHEMBL1803075	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	6268752	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CCCNC1=N/C(=C\c2ccccc2O)C(=O)N1C		CHEMBL1803076	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	6268753	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CCCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1		CHEMBL1803079	=	IC50	nM	120.0	CHEMBL4376	Homo sapiens	IC50	uM	0.12
	6268754	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CCCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1CCC		CHEMBL1803080	=	IC50	nM	2100.0	CHEMBL4376	Homo sapiens	IC50	uM	2.1
	6268755	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CCCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1c1ccccc1		CHEMBL1803081	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	6268756	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1		CHEMBL1803082	=	IC50	nM	160.0	CHEMBL4376	Homo sapiens	IC50	uM	0.16
	6268757	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	O=C1NC(NCC2CC2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1803083	=	IC50	nM	47.0	CHEMBL4376	Homo sapiens	IC50	uM	0.047
	6268758	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	Cc1ccc(NC2=N/C(=C\c3ccc4c(c3)OCO4)C(=O)N2)cc1		CHEMBL1803084	=	IC50	nM	61.0	CHEMBL4376	Homo sapiens	IC50	uM	0.061
	6268759	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	O=C1NC(Nc2ccc(O)cc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1803085	=	IC50	nM	60.0	CHEMBL4376	Homo sapiens	IC50	uM	0.06
	6268760	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	COc1ccc(NC2=N/C(=C\c3ccc4c(c3)OCO4)C(=O)N2)cc1		CHEMBL1802355	=	IC50	nM	80.0	CHEMBL4376	Homo sapiens	IC50	uM	0.08
	6268761	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	O=C1NC(Nc2ccc3c(c2)OCO3)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802356	=	IC50	nM	40.0	CHEMBL4376	Homo sapiens	IC50	uM	0.04
	6268762	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	O=C1NC(Nc2ccc3c(c2)OCCO3)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802357	=	IC50	nM	110.0	CHEMBL4376	Homo sapiens	IC50	uM	0.11
	6268763	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802358	=	IC50	nM	35.0	CHEMBL4376	Homo sapiens	IC50	uM	0.035
Not Active	6268816	CHEMBL1805108	Inhibition of human recombinant GST-tagged DYRK2 using KISGRLSPIMTEQ as substrate and [gamma32]-ATP at 10 uM after 30 mins by scintillation counting	B	CCCNC1=N/C(=C\c2ccccc2)C(=O)N1C		CHEMBL1803074		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
Not Active	6268817	CHEMBL1805108	Inhibition of human recombinant GST-tagged DYRK2 using KISGRLSPIMTEQ as substrate and [gamma32]-ATP at 10 uM after 30 mins by scintillation counting	B	CCCNC1=N/C(=C\c2ccc3c(c2)OC(F)(F)O3)C(=O)N1C		CHEMBL1803077		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
Not Active	6268818	CHEMBL1805108	Inhibition of human recombinant GST-tagged DYRK2 using KISGRLSPIMTEQ as substrate and [gamma32]-ATP at 10 uM after 30 mins by scintillation counting	B	CCCNC1=N/C(=C\c2ccc(Br)cc2)C(=O)N1C		CHEMBL1803078		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
Active	6268867	CHEMBL1805116	Inhibition of recombinant DYRK2-mediated SR 9G8 protein phosphorylation at 10 uM after 30 mins by SDS-PAGE followed by autoradiography	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802358		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
	6268884	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1N		CHEMBL485053	=	IC50	nM	1500.0	CHEMBL4376	Homo sapiens	IC50	uM	1.5
	6273812	CHEMBL1806166	Inhibition of DYRK2 assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	75.0	CHEMBL4376	Homo sapiens	Activity	%	75.0
	6281729	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C		CHEMBL1802841	=	IC50	nM	2200.0	CHEMBL4376	Homo sapiens	IC50	uM	2.2
	6281730	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C		CHEMBL1802842	=	IC50	nM	640.0	CHEMBL4376	Homo sapiens	IC50	uM	0.64
	6281731	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CCCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C		CHEMBL1802843	=	IC50	nM	550.0	CHEMBL4376	Homo sapiens	IC50	uM	0.55
	6281732	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CC(C)NC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C		CHEMBL1802844	=	IC50	nM	530.0	CHEMBL4376	Homo sapiens	IC50	uM	0.53
	6281733	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CCCCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C		CHEMBL1802845	=	IC50	nM	610.0	CHEMBL4376	Homo sapiens	IC50	uM	0.61
	6281734	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CC(C)CNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C		CHEMBL1802846	=	IC50	nM	210.0	CHEMBL4376	Homo sapiens	IC50	uM	0.21
	6281735	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CC(C)CCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C		CHEMBL1802847	=	IC50	nM	560.0	CHEMBL4376	Homo sapiens	IC50	uM	0.56
	6281736	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	C=CCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C		CHEMBL1802848	=	IC50	nM	620.0	CHEMBL4376	Homo sapiens	IC50	uM	0.62
	6281737	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCC1CC1		CHEMBL1802849	=	IC50	nM	340.0	CHEMBL4376	Homo sapiens	IC50	uM	0.34
	6281738	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NC1CCCC1		CHEMBL1802850	=	IC50	nM	6000.0	CHEMBL4376	Homo sapiens	IC50	uM	6.0
	6281739	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCO		CHEMBL1802851	=	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	6281740	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	COCCNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C		CHEMBL1802852	=	IC50	nM	770.0	CHEMBL4376	Homo sapiens	IC50	uM	0.77
	6281741	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCCO		CHEMBL1802853	=	IC50	nM	470.0	CHEMBL4376	Homo sapiens	IC50	uM	0.47
	6281742	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCCCCO		CHEMBL1802854	=	IC50	nM	2000.0	CHEMBL4376	Homo sapiens	IC50	uM	2.0
	6281743	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCN1CCOCC1		CHEMBL1802855	=	IC50	nM	1600.0	CHEMBL4376	Homo sapiens	IC50	uM	1.6
	6281744	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCN		CHEMBL1179821	=	IC50	nM	710.0	CHEMBL4376	Homo sapiens	IC50	uM	0.71
	6281745	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CC(=O)NC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C		CHEMBL1802856	=	IC50	nM	5100.0	CHEMBL4376	Homo sapiens	IC50	uM	5.1
	6281746	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CCOC(=O)C(=O)NC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1C		CHEMBL1802857	=	IC50	nM	6500.0	CHEMBL4376	Homo sapiens	IC50	uM	6.5
	6281747	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCc1ccccc1		CHEMBL1803067	=	IC50	nM	560.0	CHEMBL4376	Homo sapiens	IC50	uM	0.56
	6281748	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCc1ccc2c(c1)OCO2		CHEMBL1803068	=	IC50	nM	3300.0	CHEMBL4376	Homo sapiens	IC50	uM	3.3
	6281749	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1Nc1ccccc1		CHEMBL1803069	=	IC50	nM	460.0	CHEMBL4376	Homo sapiens	IC50	uM	0.46
	6281750	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1Nc1ccc(O)cc1		CHEMBL1803070	=	IC50	nM	1100.0	CHEMBL4376	Homo sapiens	IC50	uM	1.1
	6281751	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	COc1ccc(NC2=N/C(=C\c3ccc4c(c3)OCO4)C(=O)N2C)cc1		CHEMBL1803071	=	IC50	nM	510.0	CHEMBL4376	Homo sapiens	IC50	uM	0.51
	6281752	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1Nc1ccc2c(c1)OCO2		CHEMBL1803072	=	IC50	nM	100.0	CHEMBL4376	Homo sapiens	IC50	uM	0.1
	6281753	CHEMBL1805100	Inhibition of human recombinant GST-tagged DYRK2 using KKISGRLSPIMTEQ as substrate and [gamma32]-ATP after 30 mins by scintillation counting	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1Nc1ccc2c(c1)OCCO2		CHEMBL1803073	=	IC50	nM	120.0	CHEMBL4376	Homo sapiens	IC50	uM	0.12
	6339995	CHEMBL1827233	Activity of DYRK2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	86.0	CHEMBL4376	Homo sapiens	Activity	%	86.0
	7567313	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7567772	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7568269	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7568701	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1300.0	CHEMBL4376	Homo sapiens	Kd	nM	1300.0
	7569286	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7569746	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	4000.0	CHEMBL4376	Homo sapiens	Kd	nM	4000.0
	7569776	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7570239	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7570666	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	680.0	CHEMBL4376	Homo sapiens	Kd	nM	680.0
	7571262	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7571753	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	3700.0	CHEMBL4376	Homo sapiens	Kd	nM	3700.0
	7572216	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Kd	nM	4100.0	CHEMBL4376	Homo sapiens	Kd	nM	4100.0
	7572632	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7573258	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7573734	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7574203	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7574611	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	5600.0	CHEMBL4376	Homo sapiens	Kd	nM	5600.0
	7574779	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7575240	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1300.0	CHEMBL4376	Homo sapiens	Kd	nM	1300.0
	7575711	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7576176	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	2700.0	CHEMBL4376	Homo sapiens	Kd	nM	2700.0
	7576584	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7576753	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	1800.0	CHEMBL4376	Homo sapiens	Kd	nM	1800.0
	7577212	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	2000.0	CHEMBL4376	Homo sapiens	Kd	nM	2000.0
	7577690	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	390.0	CHEMBL4376	Homo sapiens	Kd	nM	390.0
	7578160	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	59.0	CHEMBL4376	Homo sapiens	Kd	nM	59.0
	7578565	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7578761	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	63.0	CHEMBL4376	Homo sapiens	Kd	nM	63.0
	7579135	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7579585	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7580059	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7580528	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7581119	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7581504	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Kd	nM	2100.0	CHEMBL4376	Homo sapiens	Kd	nM	2100.0
	7581949	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7582420	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7582842	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7583465	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7583862	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	1700.0	CHEMBL4376	Homo sapiens	Kd	nM	1700.0
	7584307	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	Kd	nM	7600.0	CHEMBL4376	Homo sapiens	Kd	nM	7600.0
	7584798	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	470.0	CHEMBL4376	Homo sapiens	Kd	nM	470.0
	7585202	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7585795	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7586203	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7586678	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7587132	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7587756	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7588175	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	22.0	CHEMBL4376	Homo sapiens	Kd	nM	22.0
	7588186	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7588657	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7589108	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7590170	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7590644	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7591095	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7591252	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7591674	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	6000.0	CHEMBL4376	Homo sapiens	Kd	nM	6000.0
	7592146	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7592619	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7593072	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7593219	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	210.0	CHEMBL4376	Homo sapiens	Kd	nM	210.0
	7593654	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7594126	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7594599	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7595051	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7595187	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	5400.0	CHEMBL4376	Homo sapiens	Kd	nM	5400.0
	7595631	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	6700.0	CHEMBL4376	Homo sapiens	Kd	nM	6700.0
	7596105	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7596576	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7597159	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7597612	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7598085	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4376	Homo sapiens	Kd	nM	10000.0
	7598555	CHEMBL1908615	Binding constant for DYRK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	250.0	CHEMBL4376	Homo sapiens	Kd	nM	250.0
	7922636	CHEMBL1919012	Inhibition of human recombinant DYRK2 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	104.0	CHEMBL4376	Homo sapiens	INH	%	104.0
	7939634	CHEMBL1919594	Inhibition of human DYRK2	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	7969710	CHEMBL1930966	Inhibition of DYRK2 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	101.0	CHEMBL4376	Homo sapiens	Activity	%	101.0
	8012906	CHEMBL1947277	Binding affinity to DYRK2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CCN1CCC2(CC1)NC(=O)c1c(c3ccc(Cl)c(Cl)c3n1C)C2C#N		CHEMBL1945557	=	Delta Tm	degrees C	0.9	CHEMBL4376	Homo sapiens	deltaTm	degrees C	0.9
	8012931	CHEMBL1947277	Binding affinity to DYRK2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCN(C(=O)OC(C)(C)C)CC1)NC2=O		CHEMBL1945558	=	Delta Tm	degrees C	0.3	CHEMBL4376	Homo sapiens	deltaTm	degrees C	0.3
	8012955	CHEMBL1947277	Binding affinity to DYRK2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	=	Delta Tm	degrees C	3.6	CHEMBL4376	Homo sapiens	deltaTm	degrees C	3.6
	8012979	CHEMBL1947277	Binding affinity to DYRK2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	N#CC1c2c([nH]c3c(Cl)c(Cl)ccc23)C(=O)NC12CCCCC2		CHEMBL1945560	=	Delta Tm	degrees C	1.4	CHEMBL4376	Homo sapiens	deltaTm	degrees C	1.4
	8013003	CHEMBL1947277	Binding affinity to DYRK2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(CN)C(C)(C)NC2=O		CHEMBL1945561	=	Delta Tm	degrees C	0.2	CHEMBL4376	Homo sapiens	deltaTm	degrees C	0.2
	8013028	CHEMBL1947277	Binding affinity to DYRK2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CC(=O)NCC1c2c(n(C)c3c(Cl)c(Cl)ccc23)C(=O)NC1(C)C		CHEMBL1945562	=	Delta Tm	degrees C	0.9	CHEMBL4376	Homo sapiens	deltaTm	degrees C	0.9
	8026920	CHEMBL1947277	Binding affinity to DYRK2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cc[nH]c(=O)c21		CHEMBL474872	=	Delta Tm	degrees C	4.1	CHEMBL4376	Homo sapiens	deltaTm	degrees C	4.1
	8027532	CHEMBL1947277	Binding affinity to DYRK2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cc(N)[nH]c(=O)c21		CHEMBL1945336	=	Delta Tm	degrees C	2.4	CHEMBL4376	Homo sapiens	deltaTm	degrees C	2.4
	8027557	CHEMBL1947277	Binding affinity to DYRK2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C(C)(C)NC2=O		CHEMBL1945337	=	Delta Tm	degrees C	2.0	CHEMBL4376	Homo sapiens	deltaTm	degrees C	2.0
	8027582	CHEMBL1947277	Binding affinity to DYRK2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CC1(C)NC(=O)c2[nH]c3c(Cl)c(Cl)ccc3c2C1C#N		CHEMBL1945338	=	Delta Tm	degrees C	1.3	CHEMBL4376	Homo sapiens	deltaTm	degrees C	1.3
	8027607	CHEMBL1947277	Binding affinity to DYRK2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CCC1(CC)NC(=O)c2c(c3ccc(Cl)c(Cl)c3n2C)C1C#N		CHEMBL1945339	=	Delta Tm	degrees C	0.6	CHEMBL4376	Homo sapiens	deltaTm	degrees C	0.6
	8027632	CHEMBL1947277	Binding affinity to DYRK2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccccc31)C(C#N)C(C)(C)NC2=O		CHEMBL1945340	=	Delta Tm	degrees C	0.5	CHEMBL4376	Homo sapiens	deltaTm	degrees C	0.5
	8027668	CHEMBL1947277	Binding affinity to DYRK2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCCC1)NC2=O		CHEMBL1945554	=	Delta Tm	degrees C	0.7	CHEMBL4376	Homo sapiens	deltaTm	degrees C	0.7
	8027693	CHEMBL1947277	Binding affinity to DYRK2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCOCC1)NC2=O		CHEMBL1945335	=	Delta Tm	degrees C	1.0	CHEMBL4376	Homo sapiens	deltaTm	degrees C	1.0
	8027718	CHEMBL1947277	Binding affinity to DYRK2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cn[nH]c(=O)c21		CHEMBL1945555	=	Delta Tm	degrees C	1.6	CHEMBL4376	Homo sapiens	deltaTm	degrees C	1.6
	8027743	CHEMBL1947277	Binding affinity to DYRK2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CN1CCC2(CC1)NC(=O)c1c(c3ccc(Cl)c(Cl)c3n1C)C2C#N		CHEMBL1945556	=	Delta Tm	degrees C	1.3	CHEMBL4376	Homo sapiens	deltaTm	degrees C	1.3
	8061301	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.33	CHEMBL4376	Homo sapiens	Inhibition	%	0.33
	8061478	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-1.79	CHEMBL4376	Homo sapiens	Inhibition	%	-1.79
	8061809	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.27	CHEMBL4376	Homo sapiens	Inhibition	%	3.27
	8062000	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.52	CHEMBL4376	Homo sapiens	Inhibition	%	2.52
	8062340	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.37	CHEMBL4376	Homo sapiens	Inhibition	%	2.37
	8062502	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	33.74	CHEMBL4376	Homo sapiens	Inhibition	%	33.74
	8062726	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	3.46	CHEMBL4376	Homo sapiens	Inhibition	%	3.46
	8062824	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.17	CHEMBL4376	Homo sapiens	Inhibition	%	2.17
	8063180	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.81	CHEMBL4376	Homo sapiens	Inhibition	%	0.81
	8063347	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.06	CHEMBL4376	Homo sapiens	Inhibition	%	1.06
	8063571	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.84	CHEMBL4376	Homo sapiens	Inhibition	%	1.84
	8063679	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.43	CHEMBL4376	Homo sapiens	Inhibition	%	1.43
	8063861	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	4.08	CHEMBL4376	Homo sapiens	Inhibition	%	4.08
	8064085	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.54	CHEMBL4376	Homo sapiens	Inhibition	%	2.54
	8064200	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	10.13	CHEMBL4376	Homo sapiens	Inhibition	%	10.13
	8064410	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.19	CHEMBL4376	Homo sapiens	Inhibition	%	-0.19
	8064634	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.32	CHEMBL4376	Homo sapiens	Inhibition	%	-0.32
	8064772	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.67	CHEMBL4376	Homo sapiens	Inhibition	%	0.67
	8065162	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.19	CHEMBL4376	Homo sapiens	Inhibition	%	1.19
	8065278	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.31	CHEMBL4376	Homo sapiens	Inhibition	%	1.31
	8065677	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.26	CHEMBL4376	Homo sapiens	Inhibition	%	3.26
	8065792	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.0	CHEMBL4376	Homo sapiens	Inhibition	%	1.0
	8066016	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.79	CHEMBL4376	Homo sapiens	Inhibition	%	2.79
	8066226	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.4	CHEMBL4376	Homo sapiens	Inhibition	%	-0.4
	8066362	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.48	CHEMBL4376	Homo sapiens	Inhibition	%	2.48
	8066752	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.63	CHEMBL4376	Homo sapiens	Inhibition	%	2.63
	8066876	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.11	CHEMBL4376	Homo sapiens	Inhibition	%	3.11
	8067100	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.59	CHEMBL4376	Homo sapiens	Inhibition	%	3.59
	8067275	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.74	CHEMBL4376	Homo sapiens	Inhibition	%	2.74
	8067620	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.76	CHEMBL4376	Homo sapiens	Inhibition	%	0.76
	8067830	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	3.18	CHEMBL4376	Homo sapiens	Inhibition	%	3.18
	8067965	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	5.46	CHEMBL4376	Homo sapiens	Inhibition	%	5.46
	8068189	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	30.22	CHEMBL4376	Homo sapiens	Inhibition	%	30.22
	8068353	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.71	CHEMBL4376	Homo sapiens	Inhibition	%	0.71
	8068702	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.13	CHEMBL4376	Homo sapiens	Inhibition	%	-0.13
	8068876	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.12	CHEMBL4376	Homo sapiens	Inhibition	%	3.12
	8069225	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.76	CHEMBL4376	Homo sapiens	Inhibition	%	1.76
	8069520	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	9.07	CHEMBL4376	Homo sapiens	Inhibition	%	9.07
	8069681	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.45	CHEMBL4376	Homo sapiens	Inhibition	%	2.45
	8070031	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.26	CHEMBL4376	Homo sapiens	Inhibition	%	0.26
	8070203	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.31	CHEMBL4376	Homo sapiens	Inhibition	%	3.31
	8070427	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.71	CHEMBL4376	Homo sapiens	Inhibition	%	1.71
	8070552	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.98	CHEMBL4376	Homo sapiens	Inhibition	%	0.98
	8070850	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	44.97	CHEMBL4376	Homo sapiens	Inhibition	%	44.97
	8071007	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.8	CHEMBL4376	Homo sapiens	Inhibition	%	0.8
	8071231	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.04	CHEMBL4376	Homo sapiens	Inhibition	%	2.04
	8071357	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.1	CHEMBL4376	Homo sapiens	Inhibition	%	0.1
	8071754	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.03	CHEMBL4376	Homo sapiens	Inhibition	%	3.03
	8071879	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.3	CHEMBL4376	Homo sapiens	Inhibition	%	0.3
	8072193	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.32	CHEMBL4376	Homo sapiens	Inhibition	%	-0.32
	8072574	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	0.59	CHEMBL4376	Homo sapiens	Inhibition	%	0.59
	8072699	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	4.03	CHEMBL4376	Homo sapiens	Inhibition	%	4.03
	8072923	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.27	CHEMBL4376	Homo sapiens	Inhibition	%	-0.27
	8073090	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.31	CHEMBL4376	Homo sapiens	Inhibition	%	4.31
	8073215	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.29	CHEMBL4376	Homo sapiens	Inhibition	%	-0.29
	8073439	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.21	CHEMBL4376	Homo sapiens	Inhibition	%	0.21
	8073558	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.43	CHEMBL4376	Homo sapiens	Inhibition	%	0.43
	8073791	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.02	CHEMBL4376	Homo sapiens	Inhibition	%	-0.02
	8074015	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-1.68	CHEMBL4376	Homo sapiens	Inhibition	%	-1.68
	8074167	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	0.89	CHEMBL4376	Homo sapiens	Inhibition	%	0.89
	8074521	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	2.19	CHEMBL4376	Homo sapiens	Inhibition	%	2.19
	8074678	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.28	CHEMBL4376	Homo sapiens	Inhibition	%	2.28
	8075029	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-1.54	CHEMBL4376	Homo sapiens	Inhibition	%	-1.54
	8075140	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.62	CHEMBL4376	Homo sapiens	Inhibition	%	-0.62
	8075364	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.03	CHEMBL4376	Homo sapiens	Inhibition	%	-0.03
	8075601	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.64	CHEMBL4376	Homo sapiens	Inhibition	%	0.64
	8075742	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.93	CHEMBL4376	Homo sapiens	Inhibition	%	1.93
	8076108	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.29	CHEMBL4376	Homo sapiens	Inhibition	%	-0.29
	8076256	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.74	CHEMBL4376	Homo sapiens	Inhibition	%	3.74
	8076480	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	-0.08	CHEMBL4376	Homo sapiens	Inhibition	%	-0.08
	8076614	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-1.74	CHEMBL4376	Homo sapiens	Inhibition	%	-1.74
	8076940	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.55	CHEMBL4376	Homo sapiens	Inhibition	%	0.55
	8077187	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-1.27	CHEMBL4376	Homo sapiens	Inhibition	%	-1.27
	8077315	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.84	CHEMBL4376	Homo sapiens	Inhibition	%	2.84
	8077539	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.13	CHEMBL4376	Homo sapiens	Inhibition	%	1.13
	8077690	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.33	CHEMBL4376	Homo sapiens	Inhibition	%	1.33
	8078057	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	4.14	CHEMBL4376	Homo sapiens	Inhibition	%	4.14
	8078196	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-2.19	CHEMBL4376	Homo sapiens	Inhibition	%	-2.19
	8078522	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.01	CHEMBL4376	Homo sapiens	Inhibition	%	-0.01
	8078772	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	0.08	CHEMBL4376	Homo sapiens	Inhibition	%	0.08
	8079112	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.2	CHEMBL4376	Homo sapiens	Inhibition	%	1.2
	8079270	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-1.33	CHEMBL4376	Homo sapiens	Inhibition	%	-1.33
	8079636	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.63	CHEMBL4376	Homo sapiens	Inhibition	%	1.63
	8079775	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	3.75	CHEMBL4376	Homo sapiens	Inhibition	%	3.75
	8079999	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	10.3	CHEMBL4376	Homo sapiens	Inhibition	%	10.3
	8080104	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.2	CHEMBL4376	Homo sapiens	Inhibition	%	1.2
	8080356	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	1.28	CHEMBL4376	Homo sapiens	Inhibition	%	1.28
	8080695	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.27	CHEMBL4376	Homo sapiens	Inhibition	%	1.27
	8080859	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	1.61	CHEMBL4376	Homo sapiens	Inhibition	%	1.61
	8081083	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-3.5	CHEMBL4376	Homo sapiens	Inhibition	%	-3.5
	8081218	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.4	CHEMBL4376	Homo sapiens	Inhibition	%	3.4
	8081586	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	49.04	CHEMBL4376	Homo sapiens	Inhibition	%	49.04
	8081689	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.0	CHEMBL4376	Homo sapiens	Inhibition	%	1.0
	8081941	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	22.35	CHEMBL4376	Homo sapiens	Inhibition	%	22.35
	8082165	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-2.75	CHEMBL4376	Homo sapiens	Inhibition	%	-2.75
	8082278	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.65	CHEMBL4376	Homo sapiens	Inhibition	%	2.65
	8082675	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.66	CHEMBL4376	Homo sapiens	Inhibition	%	1.66
	8082798	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.22	CHEMBL4376	Homo sapiens	Inhibition	%	2.22
	8083178	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	4.62	CHEMBL4376	Homo sapiens	Inhibition	%	4.62
	8083277	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.69	CHEMBL4376	Homo sapiens	Inhibition	%	0.69
	8083501	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.73	CHEMBL4376	Homo sapiens	Inhibition	%	1.73
	8083755	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-0.12	CHEMBL4376	Homo sapiens	Inhibition	%	-0.12
	8083865	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.29	CHEMBL4376	Homo sapiens	Inhibition	%	2.29
	8084089	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	12.5	CHEMBL4376	Homo sapiens	Inhibition	%	12.5
	8084274	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	6.76	CHEMBL4376	Homo sapiens	Inhibition	%	6.76
	8084392	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.3	CHEMBL4376	Homo sapiens	Inhibition	%	3.3
	8084616	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.42	CHEMBL4376	Homo sapiens	Inhibition	%	2.42
	8084777	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	16.2	CHEMBL4376	Homo sapiens	Inhibition	%	16.2
	8085099	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.58	CHEMBL4376	Homo sapiens	Inhibition	%	0.58
	8085355	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-4.67	CHEMBL4376	Homo sapiens	Inhibition	%	-4.67
	8085687	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.36	CHEMBL4376	Homo sapiens	Inhibition	%	1.36
	8085876	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	35.68	CHEMBL4376	Homo sapiens	Inhibition	%	35.68
	8086215	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.63	CHEMBL4376	Homo sapiens	Inhibition	%	2.63
	8086377	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	6.68	CHEMBL4376	Homo sapiens	Inhibition	%	6.68
	8086700	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.94	CHEMBL4376	Homo sapiens	Inhibition	%	1.94
	8086911	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.17	CHEMBL4376	Homo sapiens	Inhibition	%	3.17
	8087293	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.11	CHEMBL4376	Homo sapiens	Inhibition	%	3.11
	8087407	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.34	CHEMBL4376	Homo sapiens	Inhibition	%	2.34
	8087631	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.18	CHEMBL4376	Homo sapiens	Inhibition	%	4.18
	8087769	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.22	CHEMBL4376	Homo sapiens	Inhibition	%	1.22
	8088135	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	7.99	CHEMBL4376	Homo sapiens	Inhibition	%	7.99
	8088283	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.61	CHEMBL4376	Homo sapiens	Inhibition	%	0.61
	8088635	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	2.62	CHEMBL4376	Homo sapiens	Inhibition	%	2.62
	8088952	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	5.28	CHEMBL4376	Homo sapiens	Inhibition	%	5.28
	8089080	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.2	CHEMBL4376	Homo sapiens	Inhibition	%	-0.2
	8089304	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.67	CHEMBL4376	Homo sapiens	Inhibition	%	0.67
	8089452	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.58	CHEMBL4376	Homo sapiens	Inhibition	%	0.58
	8089796	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.98	CHEMBL4376	Homo sapiens	Inhibition	%	1.98
	8089976	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.97	CHEMBL4376	Homo sapiens	Inhibition	%	-1.97
	8090141	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.66	CHEMBL4376	Homo sapiens	Inhibition	%	2.66
	8090365	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	5.93	CHEMBL4376	Homo sapiens	Inhibition	%	5.93
	8090532	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.55	CHEMBL4376	Homo sapiens	Inhibition	%	1.55
	8090895	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	2.23	CHEMBL4376	Homo sapiens	Inhibition	%	2.23
	8091100	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	5.3	CHEMBL4376	Homo sapiens	Inhibition	%	5.3
	8091237	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	6.98	CHEMBL4376	Homo sapiens	Inhibition	%	6.98
	8091461	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	8.53	CHEMBL4376	Homo sapiens	Inhibition	%	8.53
	8091616	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.91	CHEMBL4376	Homo sapiens	Inhibition	%	2.91
	8091956	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.04	CHEMBL4376	Homo sapiens	Inhibition	%	3.04
	8092093	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.43	CHEMBL4376	Homo sapiens	Inhibition	%	1.43
	8092317	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.78	CHEMBL4376	Homo sapiens	Inhibition	%	0.78
	8092468	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.75	CHEMBL4376	Homo sapiens	Inhibition	%	3.75
	8092616	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	2.18	CHEMBL4376	Homo sapiens	Inhibition	%	2.18
	8092840	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-1.01	CHEMBL4376	Homo sapiens	Inhibition	%	-1.01
	8092969	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.36	CHEMBL4376	Homo sapiens	Inhibition	%	3.36
	8093281	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.33	CHEMBL4376	Homo sapiens	Inhibition	%	2.33
	8093645	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-1.52	CHEMBL4376	Homo sapiens	Inhibition	%	-1.52
	8093784	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.29	CHEMBL4376	Homo sapiens	Inhibition	%	2.29
	8094128	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	11.79	CHEMBL4376	Homo sapiens	Inhibition	%	11.79
	8094308	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.1	CHEMBL4376	Homo sapiens	Inhibition	%	-0.1
	8094707	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	5.36	CHEMBL4376	Homo sapiens	Inhibition	%	5.36
	8094863	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	5.9	CHEMBL4376	Homo sapiens	Inhibition	%	5.9
	8095227	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	3.14	CHEMBL4376	Homo sapiens	Inhibition	%	3.14
	8095430	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.62	CHEMBL4376	Homo sapiens	Inhibition	%	2.62
	8095795	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	44.22	CHEMBL4376	Homo sapiens	Inhibition	%	44.22
	8095943	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.37	CHEMBL4376	Homo sapiens	Inhibition	%	2.37
	8096284	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.43	CHEMBL4376	Homo sapiens	Inhibition	%	4.43
	8096647	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.29	CHEMBL4376	Homo sapiens	Inhibition	%	1.29
	8096803	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	8.37	CHEMBL4376	Homo sapiens	Inhibition	%	8.37
	8097174	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.17	CHEMBL4376	Homo sapiens	Inhibition	%	1.17
	8097481	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.97	CHEMBL4376	Homo sapiens	Inhibition	%	3.97
	8097855	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.54	CHEMBL4376	Homo sapiens	Inhibition	%	-0.54
	8097988	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.41	CHEMBL4376	Homo sapiens	Inhibition	%	0.41
	8098212	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.17	CHEMBL4376	Homo sapiens	Inhibition	%	-0.17
	8098332	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.21	CHEMBL4376	Homo sapiens	Inhibition	%	-0.21
	8098512	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-1.43	CHEMBL4376	Homo sapiens	Inhibition	%	-1.43
	8098736	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.31	CHEMBL4376	Homo sapiens	Inhibition	%	0.31
	8098921	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	36.43	CHEMBL4376	Homo sapiens	Inhibition	%	36.43
	8099065	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.02	CHEMBL4376	Homo sapiens	Inhibition	%	3.02
	8099289	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	4.76	CHEMBL4376	Homo sapiens	Inhibition	%	4.76
	8099431	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.35	CHEMBL4376	Homo sapiens	Inhibition	%	1.35
	8099625	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.64	CHEMBL4376	Homo sapiens	Inhibition	%	0.64
	8099849	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.6	CHEMBL4376	Homo sapiens	Inhibition	%	-0.6
	8099996	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.76	CHEMBL4376	Homo sapiens	Inhibition	%	5.76
	8100142	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.95	CHEMBL4376	Homo sapiens	Inhibition	%	2.95
	8100366	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	9.21	CHEMBL4376	Homo sapiens	Inhibition	%	9.21
	8100482	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.66	CHEMBL4376	Homo sapiens	Inhibition	%	2.66
	8100846	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.17	CHEMBL4376	Homo sapiens	Inhibition	%	0.17
	8101006	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.8	CHEMBL4376	Homo sapiens	Inhibition	%	3.8
	8101230	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	9.87	CHEMBL4376	Homo sapiens	Inhibition	%	9.87
	8101372	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-2.15	CHEMBL4376	Homo sapiens	Inhibition	%	-2.15
	8101557	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.27	CHEMBL4376	Homo sapiens	Inhibition	%	2.27
	8101781	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.75	CHEMBL4376	Homo sapiens	Inhibition	%	2.75
	8101810	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	11.72	CHEMBL4376	Homo sapiens	Inhibition	%	11.72
	8102034	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	57.8	CHEMBL4376	Homo sapiens	Inhibition	%	57.8
	8102189	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-1.74	CHEMBL4376	Homo sapiens	Inhibition	%	-1.74
	8102544	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.64	CHEMBL4376	Homo sapiens	Inhibition	%	1.64
	8102664	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-2.08	CHEMBL4376	Homo sapiens	Inhibition	%	-2.08
	8103066	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-1.53	CHEMBL4376	Homo sapiens	Inhibition	%	-1.53
	8103262	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	3.62	CHEMBL4376	Homo sapiens	Inhibition	%	3.62
	8103624	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.36	CHEMBL4376	Homo sapiens	Inhibition	%	1.36
	8103774	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.43	CHEMBL4376	Homo sapiens	Inhibition	%	1.43
	8104183	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.12	CHEMBL4376	Homo sapiens	Inhibition	%	1.12
	8104331	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	13.61	CHEMBL4376	Homo sapiens	Inhibition	%	13.61
	8104701	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	52.03	CHEMBL4376	Homo sapiens	Inhibition	%	52.03
	8104815	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.92	CHEMBL4376	Homo sapiens	Inhibition	%	2.92
	8105039	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.24	CHEMBL4376	Homo sapiens	Inhibition	%	2.24
	8105179	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.08	CHEMBL4376	Homo sapiens	Inhibition	%	-0.08
	8105569	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.47	CHEMBL4376	Homo sapiens	Inhibition	%	2.47
	8105707	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-1.69	CHEMBL4376	Homo sapiens	Inhibition	%	-1.69
	8105987	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	3.61	CHEMBL4376	Homo sapiens	Inhibition	%	3.61
	8106376	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.01	CHEMBL4376	Homo sapiens	Inhibition	%	1.01
	8106532	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	7.45	CHEMBL4376	Homo sapiens	Inhibition	%	7.45
	8106885	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	6.15	CHEMBL4376	Homo sapiens	Inhibition	%	6.15
	8107006	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.82	CHEMBL4376	Homo sapiens	Inhibition	%	-0.82
	8107230	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-4.73	CHEMBL4376	Homo sapiens	Inhibition	%	-4.73
	8107402	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.75	CHEMBL4376	Homo sapiens	Inhibition	%	1.75
	8107603	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.79	CHEMBL4376	Homo sapiens	Inhibition	%	4.79
	8107962	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.82	CHEMBL4376	Homo sapiens	Inhibition	%	1.82
	8108120	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.15	CHEMBL4376	Homo sapiens	Inhibition	%	2.15
	8108344	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.34	CHEMBL4376	Homo sapiens	Inhibition	%	1.34
	8108519	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-2.41	CHEMBL4376	Homo sapiens	Inhibition	%	-2.41
	8108666	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	4.66	CHEMBL4376	Homo sapiens	Inhibition	%	4.66
	8108890	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	9.72	CHEMBL4376	Homo sapiens	Inhibition	%	9.72
	8109032	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.96	CHEMBL4376	Homo sapiens	Inhibition	%	0.96
	8109370	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.91	CHEMBL4376	Homo sapiens	Inhibition	%	2.91
	8109500	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.96	CHEMBL4376	Homo sapiens	Inhibition	%	0.96
	8109724	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.57	CHEMBL4376	Homo sapiens	Inhibition	%	-0.57
	8109895	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	7.45	CHEMBL4376	Homo sapiens	Inhibition	%	7.45
	8110027	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.09	CHEMBL4376	Homo sapiens	Inhibition	%	2.09
	8110251	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.69	CHEMBL4376	Homo sapiens	Inhibition	%	1.69
	8110306	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.41	CHEMBL4376	Homo sapiens	Inhibition	%	1.41
	8110530	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.77	CHEMBL4376	Homo sapiens	Inhibition	%	1.77
	8110696	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	2.09	CHEMBL4376	Homo sapiens	Inhibition	%	2.09
	8110854	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.75	CHEMBL4376	Homo sapiens	Inhibition	%	-2.75
	8111078	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.66	CHEMBL4376	Homo sapiens	Inhibition	%	-1.66
	8111201	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.73	CHEMBL4376	Homo sapiens	Inhibition	%	0.73
	8111552	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.4	CHEMBL4376	Homo sapiens	Inhibition	%	0.4
	8111718	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.34	CHEMBL4376	Homo sapiens	Inhibition	%	0.34
	8111923	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.21	CHEMBL4376	Homo sapiens	Inhibition	%	3.21
	8112147	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	5.94	CHEMBL4376	Homo sapiens	Inhibition	%	5.94
	8112284	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.5	CHEMBL4376	Homo sapiens	Inhibition	%	0.5
	8112676	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.42	CHEMBL4376	Homo sapiens	Inhibition	%	3.42
	8112848	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.79	CHEMBL4376	Homo sapiens	Inhibition	%	0.79
	8113224	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	5.86	CHEMBL4376	Homo sapiens	Inhibition	%	5.86
	8113360	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.34	CHEMBL4376	Homo sapiens	Inhibition	%	2.34
	8113708	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.81	CHEMBL4376	Homo sapiens	Inhibition	%	1.81
	8114048	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.39	CHEMBL4376	Homo sapiens	Inhibition	%	-1.39
	8114224	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.45	CHEMBL4376	Homo sapiens	Inhibition	%	3.45
	8114580	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.21	CHEMBL4376	Homo sapiens	Inhibition	%	3.21
	8114856	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.81	CHEMBL4376	Homo sapiens	Inhibition	%	1.81
	8115022	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.49	CHEMBL4376	Homo sapiens	Inhibition	%	2.49
	8115411	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.79	CHEMBL4376	Homo sapiens	Inhibition	%	-0.79
	8115531	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.13	CHEMBL4376	Homo sapiens	Inhibition	%	1.13
	8115888	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-2.07	CHEMBL4376	Homo sapiens	Inhibition	%	-2.07
	8116047	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.82	CHEMBL4376	Homo sapiens	Inhibition	%	0.82
	8116271	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	9.64	CHEMBL4376	Homo sapiens	Inhibition	%	9.64
	8116474	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.3	CHEMBL4376	Homo sapiens	Inhibition	%	2.3
	8116608	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	4.22	CHEMBL4376	Homo sapiens	Inhibition	%	4.22
	8116832	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.96	CHEMBL4376	Homo sapiens	Inhibition	%	0.96
	8117004	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.46	CHEMBL4376	Homo sapiens	Inhibition	%	2.46
	8117175	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-1.66	CHEMBL4376	Homo sapiens	Inhibition	%	-1.66
	8117557	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	5.26	CHEMBL4376	Homo sapiens	Inhibition	%	5.26
	8117687	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.23	CHEMBL4376	Homo sapiens	Inhibition	%	-0.23
	8117911	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.41	CHEMBL4376	Homo sapiens	Inhibition	%	1.41
	8118049	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.98	CHEMBL4376	Homo sapiens	Inhibition	%	1.98
	8118389	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.75	CHEMBL4376	Homo sapiens	Inhibition	%	3.75
	8118561	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	6.22	CHEMBL4376	Homo sapiens	Inhibition	%	6.22
	8118921	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	0.35	CHEMBL4376	Homo sapiens	Inhibition	%	0.35
	8119192	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	2.4	CHEMBL4376	Homo sapiens	Inhibition	%	2.4
	8119351	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	3.45	CHEMBL4376	Homo sapiens	Inhibition	%	3.45
	8119575	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	5.08	CHEMBL4376	Homo sapiens	Inhibition	%	5.08
	8119742	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.95	CHEMBL4376	Homo sapiens	Inhibition	%	-0.95
	8119861	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.37	CHEMBL4376	Homo sapiens	Inhibition	%	0.37
	8120085	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.12	CHEMBL4376	Homo sapiens	Inhibition	%	2.12
	8120224	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.27	CHEMBL4376	Homo sapiens	Inhibition	%	-0.27
	8120608	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.74	CHEMBL4376	Homo sapiens	Inhibition	%	-0.74
	8120809	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.89	CHEMBL4376	Homo sapiens	Inhibition	%	3.89
	8121161	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.44	CHEMBL4376	Homo sapiens	Inhibition	%	-0.44
	8121333	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.26	CHEMBL4376	Homo sapiens	Inhibition	%	2.26
	8121500	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.67	CHEMBL4376	Homo sapiens	Inhibition	%	-0.67
	8121724	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-1.25	CHEMBL4376	Homo sapiens	Inhibition	%	-1.25
	8121887	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	3.45	CHEMBL4376	Homo sapiens	Inhibition	%	3.45
	8122232	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.01	CHEMBL4376	Homo sapiens	Inhibition	%	-1.01
	8122370	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.31	CHEMBL4376	Homo sapiens	Inhibition	%	2.31
	8122714	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	8.4	CHEMBL4376	Homo sapiens	Inhibition	%	8.4
	8122881	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.84	CHEMBL4376	Homo sapiens	Inhibition	%	3.84
	8123105	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	6.27	CHEMBL4376	Homo sapiens	Inhibition	%	6.27
	8123247	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	1.73	CHEMBL4376	Homo sapiens	Inhibition	%	1.73
	8123525	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	5.3	CHEMBL4376	Homo sapiens	Inhibition	%	5.3
	8123899	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	23.68	CHEMBL4376	Homo sapiens	Inhibition	%	23.68
	8124066	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.79	CHEMBL4376	Homo sapiens	Inhibition	%	0.79
	8124409	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	5.88	CHEMBL4376	Homo sapiens	Inhibition	%	5.88
	8124548	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-1.15	CHEMBL4376	Homo sapiens	Inhibition	%	-1.15
	8124772	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-0.18	CHEMBL4376	Homo sapiens	Inhibition	%	-0.18
	8124937	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-3.59	CHEMBL4376	Homo sapiens	Inhibition	%	-3.59
	8125138	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.87	CHEMBL4376	Homo sapiens	Inhibition	%	4.87
	8125492	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	20.63	CHEMBL4376	Homo sapiens	Inhibition	%	20.63
	8125660	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.33	CHEMBL4376	Homo sapiens	Inhibition	%	0.33
	8126048	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.03	CHEMBL4376	Homo sapiens	Inhibition	%	-0.03
	8126212	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.8	CHEMBL4376	Homo sapiens	Inhibition	%	5.8
	8126551	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.47	CHEMBL4376	Homo sapiens	Inhibition	%	-1.47
	8126687	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	6.51	CHEMBL4376	Homo sapiens	Inhibition	%	6.51
	8126911	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	29.04	CHEMBL4376	Homo sapiens	Inhibition	%	29.04
	8127033	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.61	CHEMBL4376	Homo sapiens	Inhibition	%	4.61
	8127424	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	5.21	CHEMBL4376	Homo sapiens	Inhibition	%	5.21
	8127566	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	3.25	CHEMBL4376	Homo sapiens	Inhibition	%	3.25
	8127854	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.11	CHEMBL4376	Homo sapiens	Inhibition	%	2.11
	8128230	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.94	CHEMBL4376	Homo sapiens	Inhibition	%	2.94
	8128397	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	2.96	CHEMBL4376	Homo sapiens	Inhibition	%	2.96
	8128740	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	37.64	CHEMBL4376	Homo sapiens	Inhibition	%	37.64
	8129101	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-1.6	CHEMBL4376	Homo sapiens	Inhibition	%	-1.6
	8129272	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.36	CHEMBL4376	Homo sapiens	Inhibition	%	-1.36
	8129461	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.71	CHEMBL4376	Homo sapiens	Inhibition	%	4.71
	8129685	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.14	CHEMBL4376	Homo sapiens	Inhibition	%	2.14
	8129824	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	74.98	CHEMBL4376	Homo sapiens	Inhibition	%	74.98
	8129985	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.04	CHEMBL4376	Homo sapiens	Inhibition	%	2.04
	8130209	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	14.27	CHEMBL4376	Homo sapiens	Inhibition	%	14.27
	8130381	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	2.26	CHEMBL4376	Homo sapiens	Inhibition	%	2.26
	8130541	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	5.06	CHEMBL4376	Homo sapiens	Inhibition	%	5.06
	8130765	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	25.66	CHEMBL4376	Homo sapiens	Inhibition	%	25.66
	8130881	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.98	CHEMBL4376	Homo sapiens	Inhibition	%	1.98
	8131244	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.68	CHEMBL4376	Homo sapiens	Inhibition	%	3.68
	8131364	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	7.67	CHEMBL4376	Homo sapiens	Inhibition	%	7.67
	8131588	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.37	CHEMBL4376	Homo sapiens	Inhibition	%	3.37
	8131755	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	13.67	CHEMBL4376	Homo sapiens	Inhibition	%	13.67
	8131896	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	3.2	CHEMBL4376	Homo sapiens	Inhibition	%	3.2
	8132120	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	2.85	CHEMBL4376	Homo sapiens	Inhibition	%	2.85
	8132182	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.95	CHEMBL4376	Homo sapiens	Inhibition	%	1.95
	8132406	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	2.31	CHEMBL4376	Homo sapiens	Inhibition	%	2.31
	8132553	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.72	CHEMBL4376	Homo sapiens	Inhibition	%	3.72
	8132721	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.32	CHEMBL4376	Homo sapiens	Inhibition	%	1.32
	8132945	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.49	CHEMBL4376	Homo sapiens	Inhibition	%	1.49
	8133066	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.77	CHEMBL4376	Homo sapiens	Inhibition	%	0.77
	8133428	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.7	CHEMBL4376	Homo sapiens	Inhibition	%	1.7
	8133600	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-2.61	CHEMBL4376	Homo sapiens	Inhibition	%	-2.61
	8134004	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	4.06	CHEMBL4376	Homo sapiens	Inhibition	%	4.06
	8134152	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.06	CHEMBL4376	Homo sapiens	Inhibition	%	0.06
	8134536	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.99	CHEMBL4376	Homo sapiens	Inhibition	%	1.99
	8134720	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-1.66	CHEMBL4376	Homo sapiens	Inhibition	%	-1.66
	8135104	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	3.69	CHEMBL4376	Homo sapiens	Inhibition	%	3.69
	8135219	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.49	CHEMBL4376	Homo sapiens	Inhibition	%	2.49
	8135443	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.17	CHEMBL4376	Homo sapiens	Inhibition	%	3.17
	8135584	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.17	CHEMBL4376	Homo sapiens	Inhibition	%	3.17
	8135929	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	7.29	CHEMBL4376	Homo sapiens	Inhibition	%	7.29
	8136097	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.19	CHEMBL4376	Homo sapiens	Inhibition	%	2.19
	8136465	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.24	CHEMBL4376	Homo sapiens	Inhibition	%	3.24
	8136755	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.64	CHEMBL4376	Homo sapiens	Inhibition	%	1.64
	8136890	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.35	CHEMBL4376	Homo sapiens	Inhibition	%	1.35
	8137277	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	2.85	CHEMBL4376	Homo sapiens	Inhibition	%	2.85
	8137397	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	7.51	CHEMBL4376	Homo sapiens	Inhibition	%	7.51
	8137621	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.14	CHEMBL4376	Homo sapiens	Inhibition	%	-0.14
	8137769	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	5.64	CHEMBL4376	Homo sapiens	Inhibition	%	5.64
	8137935	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.0	CHEMBL4376	Homo sapiens	Inhibition	%	-2.0
	8138159	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.88	CHEMBL4376	Homo sapiens	Inhibition	%	-2.88
	8138338	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.36	CHEMBL4376	Homo sapiens	Inhibition	%	1.36
	8138486	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	18.49	CHEMBL4376	Homo sapiens	Inhibition	%	18.49
	8138710	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.49	CHEMBL4376	Homo sapiens	Inhibition	%	-2.49
	8138868	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.34	CHEMBL4376	Homo sapiens	Inhibition	%	0.34
	8139053	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.97	CHEMBL4376	Homo sapiens	Inhibition	%	-0.97
	8139277	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.72	CHEMBL4376	Homo sapiens	Inhibition	%	4.72
	8139436	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.85	CHEMBL4376	Homo sapiens	Inhibition	%	4.85
	8139774	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.91	CHEMBL4376	Homo sapiens	Inhibition	%	0.91
	8139915	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.92	CHEMBL4376	Homo sapiens	Inhibition	%	4.92
	8140262	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.17	CHEMBL4376	Homo sapiens	Inhibition	%	4.17
	8140421	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	6.04	CHEMBL4376	Homo sapiens	Inhibition	%	6.04
	8140645	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.23	CHEMBL4376	Homo sapiens	Inhibition	%	2.23
	8140788	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.38	CHEMBL4376	Homo sapiens	Inhibition	%	3.38
	8141090	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.22	CHEMBL4376	Homo sapiens	Inhibition	%	2.22
	8141220	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.88	CHEMBL4376	Homo sapiens	Inhibition	%	2.88
	8141444	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.49	CHEMBL4376	Homo sapiens	Inhibition	%	1.49
	8141604	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	14.23	CHEMBL4376	Homo sapiens	Inhibition	%	14.23
	8141947	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.61	CHEMBL4376	Homo sapiens	Inhibition	%	-0.61
	8142108	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.08	CHEMBL4376	Homo sapiens	Inhibition	%	0.08
	8142500	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-2.57	CHEMBL4376	Homo sapiens	Inhibition	%	-2.57
	8142676	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.03	CHEMBL4376	Homo sapiens	Inhibition	%	1.03
	8143049	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-3.21	CHEMBL4376	Homo sapiens	Inhibition	%	-3.21
	8143204	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.74	CHEMBL4376	Homo sapiens	Inhibition	%	1.74
	8143615	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	8.06	CHEMBL4376	Homo sapiens	Inhibition	%	8.06
	8143774	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	4.31	CHEMBL4376	Homo sapiens	Inhibition	%	4.31
	8144112	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.81	CHEMBL4376	Homo sapiens	Inhibition	%	2.81
	8144251	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.13	CHEMBL4376	Homo sapiens	Inhibition	%	4.13
	8144475	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.34	CHEMBL4376	Homo sapiens	Inhibition	%	2.34
	8144605	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	8.56	CHEMBL4376	Homo sapiens	Inhibition	%	8.56
	8144982	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.03	CHEMBL4376	Homo sapiens	Inhibition	%	2.03
	8145119	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.86	CHEMBL4376	Homo sapiens	Inhibition	%	3.86
	8145432	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.02	CHEMBL4376	Homo sapiens	Inhibition	%	2.02
	8145780	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.64	CHEMBL4376	Homo sapiens	Inhibition	%	1.64
	8145941	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.28	CHEMBL4376	Homo sapiens	Inhibition	%	2.28
	8146285	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.2	CHEMBL4376	Homo sapiens	Inhibition	%	0.2
	8146445	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-3.08	CHEMBL4376	Homo sapiens	Inhibition	%	-3.08
	8146669	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.67	CHEMBL4376	Homo sapiens	Inhibition	%	-0.67
	8146836	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-2.94	CHEMBL4376	Homo sapiens	Inhibition	%	-2.94
	8147005	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	6.28	CHEMBL4376	Homo sapiens	Inhibition	%	6.28
	8147371	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.14	CHEMBL4376	Homo sapiens	Inhibition	%	1.14
	8147524	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.41	CHEMBL4376	Homo sapiens	Inhibition	%	0.41
	8147748	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.77	CHEMBL4376	Homo sapiens	Inhibition	%	1.77
	8147935	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	5.68	CHEMBL4376	Homo sapiens	Inhibition	%	5.68
	8148093	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	5.83	CHEMBL4376	Homo sapiens	Inhibition	%	5.83
	8148317	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.52	CHEMBL4376	Homo sapiens	Inhibition	%	4.52
	8148431	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.15	CHEMBL4376	Homo sapiens	Inhibition	%	1.15
	8148794	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	1.38	CHEMBL4376	Homo sapiens	Inhibition	%	1.38
	8148932	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.43	CHEMBL4376	Homo sapiens	Inhibition	%	4.43
	8149315	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.54	CHEMBL4376	Homo sapiens	Inhibition	%	0.54
	8149449	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.88	CHEMBL4376	Homo sapiens	Inhibition	%	2.88
	8149673	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	7.99	CHEMBL4376	Homo sapiens	Inhibition	%	7.99
	8149771	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.64	CHEMBL4376	Homo sapiens	Inhibition	%	2.64
	8150120	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.62	CHEMBL4376	Homo sapiens	Inhibition	%	0.62
	8150280	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.29	CHEMBL4376	Homo sapiens	Inhibition	%	1.29
	8150504	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.97	CHEMBL4376	Homo sapiens	Inhibition	%	0.97
	8150624	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.89	CHEMBL4376	Homo sapiens	Inhibition	%	0.89
	8151013	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-2.75	CHEMBL4376	Homo sapiens	Inhibition	%	-2.75
	8151176	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.32	CHEMBL4376	Homo sapiens	Inhibition	%	-3.32
	8151353	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	34.0	CHEMBL4376	Homo sapiens	Inhibition	%	34.0
	8151577	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.81	CHEMBL4376	Homo sapiens	Inhibition	%	1.81
	8151715	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.09	CHEMBL4376	Homo sapiens	Inhibition	%	0.09
	8152093	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.78	CHEMBL4376	Homo sapiens	Inhibition	%	0.78
	8152281	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	18.81	CHEMBL4376	Homo sapiens	Inhibition	%	18.81
	8152663	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	5.66	CHEMBL4376	Homo sapiens	Inhibition	%	5.66
	8152777	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.84	CHEMBL4376	Homo sapiens	Inhibition	%	2.84
	8153140	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.17	CHEMBL4376	Homo sapiens	Inhibition	%	2.17
	8153277	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	9.4	CHEMBL4376	Homo sapiens	Inhibition	%	9.4
	8153501	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.35	CHEMBL4376	Homo sapiens	Inhibition	%	4.35
	8153658	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.76	CHEMBL4376	Homo sapiens	Inhibition	%	0.76
	8154015	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	37.16	CHEMBL4376	Homo sapiens	Inhibition	%	37.16
	8154112	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.73	CHEMBL4376	Homo sapiens	Inhibition	%	2.73
	8154336	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.66	CHEMBL4376	Homo sapiens	Inhibition	%	2.66
	8154462	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.74	CHEMBL4376	Homo sapiens	Inhibition	%	0.74
	8154845	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.82	CHEMBL4376	Homo sapiens	Inhibition	%	1.82
	8154965	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.72	CHEMBL4376	Homo sapiens	Inhibition	%	0.72
	8155189	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.41	CHEMBL4376	Homo sapiens	Inhibition	%	-0.41
	8155365	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.12	CHEMBL4376	Homo sapiens	Inhibition	%	0.12
	8155526	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.69	CHEMBL4376	Homo sapiens	Inhibition	%	-3.69
	8155928	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	10.93	CHEMBL4376	Homo sapiens	Inhibition	%	10.93
	8156066	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.79	CHEMBL4376	Homo sapiens	Inhibition	%	1.79
	8156290	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.78	CHEMBL4376	Homo sapiens	Inhibition	%	0.78
	8156502	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.48	CHEMBL4376	Homo sapiens	Inhibition	%	2.48
	8156652	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	5.6	CHEMBL4376	Homo sapiens	Inhibition	%	5.6
	8157019	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	8.68	CHEMBL4376	Homo sapiens	Inhibition	%	8.68
	8157139	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.28	CHEMBL4376	Homo sapiens	Inhibition	%	2.28
	8157363	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.97	CHEMBL4376	Homo sapiens	Inhibition	%	3.97
	8157504	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.73	CHEMBL4376	Homo sapiens	Inhibition	%	2.73
	8157858	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.64	CHEMBL4376	Homo sapiens	Inhibition	%	2.64
	8158019	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.42	CHEMBL4376	Homo sapiens	Inhibition	%	0.42
	8158269	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.35	CHEMBL4376	Homo sapiens	Inhibition	%	4.35
	8158493	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	15.04	CHEMBL4376	Homo sapiens	Inhibition	%	15.04
	8158651	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	3.11	CHEMBL4376	Homo sapiens	Inhibition	%	3.11
	8158820	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.2	CHEMBL4376	Homo sapiens	Inhibition	%	2.2
	8159044	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.59	CHEMBL4376	Homo sapiens	Inhibition	%	3.59
	8159179	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.84	CHEMBL4376	Homo sapiens	Inhibition	%	3.84
	8159523	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.26	CHEMBL4376	Homo sapiens	Inhibition	%	1.26
	8159654	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	4.65	CHEMBL4376	Homo sapiens	Inhibition	%	4.65
	8160019	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.95	CHEMBL4376	Homo sapiens	Inhibition	%	1.95
	8160156	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.96	CHEMBL4376	Homo sapiens	Inhibition	%	1.96
	8160380	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.75	CHEMBL4376	Homo sapiens	Inhibition	%	4.75
	8160530	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-1.97	CHEMBL4376	Homo sapiens	Inhibition	%	-1.97
	8160824	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	8.21	CHEMBL4376	Homo sapiens	Inhibition	%	8.21
	8160974	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	1.44	CHEMBL4376	Homo sapiens	Inhibition	%	1.44
	8161198	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.05	CHEMBL4376	Homo sapiens	Inhibition	%	3.05
	8161341	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	10.7	CHEMBL4376	Homo sapiens	Inhibition	%	10.7
	8161690	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.09	CHEMBL4376	Homo sapiens	Inhibition	%	3.09
	8161828	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	3.63	CHEMBL4376	Homo sapiens	Inhibition	%	3.63
	8162182	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.03	CHEMBL4376	Homo sapiens	Inhibition	%	3.03
	8162342	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.8	CHEMBL4376	Homo sapiens	Inhibition	%	0.8
	8162566	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.19	CHEMBL4376	Homo sapiens	Inhibition	%	-0.19
	8162819	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	59.49	CHEMBL4376	Homo sapiens	Inhibition	%	59.49
	8162967	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	10.88	CHEMBL4376	Homo sapiens	Inhibition	%	10.88
	8163360	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.86	CHEMBL4376	Homo sapiens	Inhibition	%	1.86
	8163494	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.68	CHEMBL4376	Homo sapiens	Inhibition	%	3.68
	8163841	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.86	CHEMBL4376	Homo sapiens	Inhibition	%	1.86
	8163975	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	36.31	CHEMBL4376	Homo sapiens	Inhibition	%	36.31
	8164199	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	82.33	CHEMBL4376	Homo sapiens	Inhibition	%	82.33
	8164339	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.23	CHEMBL4376	Homo sapiens	Inhibition	%	0.23
	8164718	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	20.28	CHEMBL4376	Homo sapiens	Inhibition	%	20.28
	8164862	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-2.78	CHEMBL4376	Homo sapiens	Inhibition	%	-2.78
	8165156	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.42	CHEMBL4376	Homo sapiens	Inhibition	%	3.42
	8165521	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.54	CHEMBL4376	Homo sapiens	Inhibition	%	2.54
	8165664	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	50.79	CHEMBL4376	Homo sapiens	Inhibition	%	50.79
	8166014	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.96	CHEMBL4376	Homo sapiens	Inhibition	%	2.96
	8166152	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.93	CHEMBL4376	Homo sapiens	Inhibition	%	1.93
	8166376	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.01	CHEMBL4376	Homo sapiens	Inhibition	%	4.01
	8166506	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.63	CHEMBL4376	Homo sapiens	Inhibition	%	2.63
	8166831	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	4.25	CHEMBL4376	Homo sapiens	Inhibition	%	4.25
	8167143	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.68	CHEMBL4376	Homo sapiens	Inhibition	%	3.68
	8167284	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	46.24	CHEMBL4376	Homo sapiens	Inhibition	%	46.24
	8167672	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.69	CHEMBL4376	Homo sapiens	Inhibition	%	2.69
	8167805	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.17	CHEMBL4376	Homo sapiens	Inhibition	%	4.17
	8168029	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.15	CHEMBL4376	Homo sapiens	Inhibition	%	4.15
	8168153	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.94	CHEMBL4376	Homo sapiens	Inhibition	%	0.94
	8168518	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	3.28	CHEMBL4376	Homo sapiens	Inhibition	%	3.28
	8168654	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.37	CHEMBL4376	Homo sapiens	Inhibition	%	-0.37
	8168878	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.18	CHEMBL4376	Homo sapiens	Inhibition	%	-1.18
	8169042	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	71.52	CHEMBL4376	Homo sapiens	Inhibition	%	71.52
	8169184	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.37	CHEMBL4376	Homo sapiens	Inhibition	%	2.37
	8169408	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.73	CHEMBL4376	Homo sapiens	Inhibition	%	2.73
	8169488	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	8.03	CHEMBL4376	Homo sapiens	Inhibition	%	8.03
	8169846	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.84	CHEMBL4376	Homo sapiens	Inhibition	%	2.84
	8169991	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.71	CHEMBL4376	Homo sapiens	Inhibition	%	1.71
	8170215	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	2.18	CHEMBL4376	Homo sapiens	Inhibition	%	2.18
	8170340	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.62	CHEMBL4376	Homo sapiens	Inhibition	%	2.62
	8170704	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	1.35	CHEMBL4376	Homo sapiens	Inhibition	%	1.35
	8170839	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	5.4	CHEMBL4376	Homo sapiens	Inhibition	%	5.4
	8171063	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.73	CHEMBL4376	Homo sapiens	Inhibition	%	2.73
	8171260	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.95	CHEMBL4376	Homo sapiens	Inhibition	%	1.95
	8171477	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	5.39	CHEMBL4376	Homo sapiens	Inhibition	%	5.39
	8171618	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.55	CHEMBL4376	Homo sapiens	Inhibition	%	4.55
	8171842	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	6.57	CHEMBL4376	Homo sapiens	Inhibition	%	6.57
	8171995	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	4.29	CHEMBL4376	Homo sapiens	Inhibition	%	4.29
	8172351	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	4.31	CHEMBL4376	Homo sapiens	Inhibition	%	4.31
	8172479	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.08	CHEMBL4376	Homo sapiens	Inhibition	%	2.08
	8172703	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.06	CHEMBL4376	Homo sapiens	Inhibition	%	-0.06
	8172845	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	5.26	CHEMBL4376	Homo sapiens	Inhibition	%	5.26
	8173205	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.6	CHEMBL4376	Homo sapiens	Inhibition	%	-0.6
	8173370	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	14.23	CHEMBL4376	Homo sapiens	Inhibition	%	14.23
	8173735	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.53	CHEMBL4376	Homo sapiens	Inhibition	%	3.53
	8173822	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	6.85	CHEMBL4376	Homo sapiens	Inhibition	%	6.85
	8174046	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	33.39	CHEMBL4376	Homo sapiens	Inhibition	%	33.39
	8174178	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.09	CHEMBL4376	Homo sapiens	Inhibition	%	3.09
	8174550	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.27	CHEMBL4376	Homo sapiens	Inhibition	%	2.27
	8174672	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.24	CHEMBL4376	Homo sapiens	Inhibition	%	3.24
	8174896	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.13	CHEMBL4376	Homo sapiens	Inhibition	%	3.13
	8175039	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	1.98	CHEMBL4376	Homo sapiens	Inhibition	%	1.98
	8175399	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	14.02	CHEMBL4376	Homo sapiens	Inhibition	%	14.02
	8175655	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	6.8	CHEMBL4376	Homo sapiens	Inhibition	%	6.8
	8175818	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.83	CHEMBL4376	Homo sapiens	Inhibition	%	2.83
	8176195	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	3.41	CHEMBL4376	Homo sapiens	Inhibition	%	3.41
	8176344	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	16.77	CHEMBL4376	Homo sapiens	Inhibition	%	16.77
	8176700	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	11.11	CHEMBL4376	Homo sapiens	Inhibition	%	11.11
	8177054	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.1	CHEMBL4376	Homo sapiens	Inhibition	%	0.1
	8177196	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.24	CHEMBL4376	Homo sapiens	Inhibition	%	2.24
	8177558	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	6.81	CHEMBL4376	Homo sapiens	Inhibition	%	6.81
	8177722	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	58.94	CHEMBL4376	Homo sapiens	Inhibition	%	58.94
	8178086	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	15.5	CHEMBL4376	Homo sapiens	Inhibition	%	15.5
	8178398	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.0	CHEMBL4376	Homo sapiens	Inhibition	%	2.0
	8178525	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.0	CHEMBL4376	Homo sapiens	Inhibition	%	4.0
	8178749	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	5.25	CHEMBL4376	Homo sapiens	Inhibition	%	5.25
	8178898	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.38	CHEMBL4376	Homo sapiens	Inhibition	%	3.38
	8179245	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	5.14	CHEMBL4376	Homo sapiens	Inhibition	%	5.14
	8179389	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	2.69	CHEMBL4376	Homo sapiens	Inhibition	%	2.69
	8179750	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.93	CHEMBL4376	Homo sapiens	Inhibition	%	1.93
	8180007	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.83	CHEMBL4376	Homo sapiens	Inhibition	%	4.83
	8180161	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.82	CHEMBL4376	Homo sapiens	Inhibition	%	2.82
	8180385	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.57	CHEMBL4376	Homo sapiens	Inhibition	%	1.57
	8180541	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	4.54	CHEMBL4376	Homo sapiens	Inhibition	%	4.54
	8180689	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.54	CHEMBL4376	Homo sapiens	Inhibition	%	1.54
	8180913	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	4.74	CHEMBL4376	Homo sapiens	Inhibition	%	4.74
	8181046	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	3.03	CHEMBL4376	Homo sapiens	Inhibition	%	3.03
	8181401	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-1.67	CHEMBL4376	Homo sapiens	Inhibition	%	-1.67
	8181541	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.95	CHEMBL4376	Homo sapiens	Inhibition	%	3.95
	8181765	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.82	CHEMBL4376	Homo sapiens	Inhibition	%	2.82
	8181904	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	28.96	CHEMBL4376	Homo sapiens	Inhibition	%	28.96
	8182067	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.22	CHEMBL4376	Homo sapiens	Inhibition	%	3.22
	8182291	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	5.03	CHEMBL4376	Homo sapiens	Inhibition	%	5.03
	8182431	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.31	CHEMBL4376	Homo sapiens	Inhibition	%	2.31
	8182747	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.24	CHEMBL4376	Homo sapiens	Inhibition	%	2.24
	8183093	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	18.79	CHEMBL4376	Homo sapiens	Inhibition	%	18.79
	8183242	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.86	CHEMBL4376	Homo sapiens	Inhibition	%	3.86
	8183595	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-0.81	CHEMBL4376	Homo sapiens	Inhibition	%	-0.81
	8183737	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	8.09	CHEMBL4376	Homo sapiens	Inhibition	%	8.09
	8183961	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.3	CHEMBL4376	Homo sapiens	Inhibition	%	2.3
	8184097	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.03	CHEMBL4376	Homo sapiens	Inhibition	%	2.03
	8184363	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	9.37	CHEMBL4376	Homo sapiens	Inhibition	%	9.37
	8184734	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.07	CHEMBL4376	Homo sapiens	Inhibition	%	1.07
	8184891	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	3.56	CHEMBL4376	Homo sapiens	Inhibition	%	3.56
	8185264	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.17	CHEMBL4376	Homo sapiens	Inhibition	%	1.17
	8185395	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	4.88	CHEMBL4376	Homo sapiens	Inhibition	%	4.88
	8185619	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	2.91	CHEMBL4376	Homo sapiens	Inhibition	%	2.91
	8185750	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	3.79	CHEMBL4376	Homo sapiens	Inhibition	%	3.79
	8186113	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.68	CHEMBL4376	Homo sapiens	Inhibition	%	4.68
	8186254	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	2.83	CHEMBL4376	Homo sapiens	Inhibition	%	2.83
	8186642	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.77	CHEMBL4376	Homo sapiens	Inhibition	%	3.77
	8186781	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.44	CHEMBL4376	Homo sapiens	Inhibition	%	3.44
	8187005	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.66	CHEMBL4376	Homo sapiens	Inhibition	%	2.66
	8187103	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.62	CHEMBL4376	Homo sapiens	Inhibition	%	1.62
	8187451	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	4.32	CHEMBL4376	Homo sapiens	Inhibition	%	4.32
	8187599	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	18.39	CHEMBL4376	Homo sapiens	Inhibition	%	18.39
	8187823	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.13	CHEMBL4376	Homo sapiens	Inhibition	%	2.13
	8187952	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	0.53	CHEMBL4376	Homo sapiens	Inhibition	%	0.53
	8188319	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.44	CHEMBL4376	Homo sapiens	Inhibition	%	3.44
	8188454	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	14.49	CHEMBL4376	Homo sapiens	Inhibition	%	14.49
	8188728	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.19	CHEMBL4376	Homo sapiens	Inhibition	%	3.19
	8189100	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.46	CHEMBL4376	Homo sapiens	Inhibition	%	1.46
	8189256	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	4.44	CHEMBL4376	Homo sapiens	Inhibition	%	4.44
	8189480	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.56	CHEMBL4376	Homo sapiens	Inhibition	%	3.56
	8189629	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.66	CHEMBL4376	Homo sapiens	Inhibition	%	-0.66
	8189985	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	7.08	CHEMBL4376	Homo sapiens	Inhibition	%	7.08
	8190117	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.68	CHEMBL4376	Homo sapiens	Inhibition	%	3.68
	8190481	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.61	CHEMBL4376	Homo sapiens	Inhibition	%	3.61
	8190618	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.6	CHEMBL4376	Homo sapiens	Inhibition	%	3.6
	8190842	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.57	CHEMBL4376	Homo sapiens	Inhibition	%	2.57
	8191006	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.13	CHEMBL4376	Homo sapiens	Inhibition	%	5.13
	8191368	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.33	CHEMBL4376	Homo sapiens	Inhibition	%	4.33
	8191464	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	3.99	CHEMBL4376	Homo sapiens	Inhibition	%	3.99
	8191688	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.37	CHEMBL4376	Homo sapiens	Inhibition	%	1.37
	8191810	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	16.02	CHEMBL4376	Homo sapiens	Inhibition	%	16.02
	8192183	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.5	CHEMBL4376	Homo sapiens	Inhibition	%	2.5
	8192312	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.27	CHEMBL4376	Homo sapiens	Inhibition	%	0.27
	8192680	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	1.99	CHEMBL4376	Homo sapiens	Inhibition	%	1.99
	8192816	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	24.95	CHEMBL4376	Homo sapiens	Inhibition	%	24.95
	8193040	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.12	CHEMBL4376	Homo sapiens	Inhibition	%	1.12
	8193088	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.53	CHEMBL4376	Homo sapiens	Inhibition	%	4.53
	8193312	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.58	CHEMBL4376	Homo sapiens	Inhibition	%	3.58
	8193457	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	5.67	CHEMBL4376	Homo sapiens	Inhibition	%	5.67
	8193838	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	9.5	CHEMBL4376	Homo sapiens	Inhibition	%	9.5
	8193987	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.18	CHEMBL4376	Homo sapiens	Inhibition	%	-1.18
	8194342	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	2.96	CHEMBL4376	Homo sapiens	Inhibition	%	2.96
	8194473	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.79	CHEMBL4376	Homo sapiens	Inhibition	%	4.79
	8194697	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.3	CHEMBL4376	Homo sapiens	Inhibition	%	3.3
	8194840	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	4.25	CHEMBL4376	Homo sapiens	Inhibition	%	4.25
	8195197	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.9	CHEMBL4376	Homo sapiens	Inhibition	%	3.9
	8195361	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.34	CHEMBL4376	Homo sapiens	Inhibition	%	3.34
	8195724	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.62	CHEMBL4376	Homo sapiens	Inhibition	%	2.62
	8196046	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.27	CHEMBL4376	Homo sapiens	Inhibition	%	1.27
	8196163	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.99	CHEMBL4376	Homo sapiens	Inhibition	%	1.99
	8196537	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	3.2	CHEMBL4376	Homo sapiens	Inhibition	%	3.2
	8196665	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	1.42	CHEMBL4376	Homo sapiens	Inhibition	%	1.42
	8196889	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	0.17	CHEMBL4376	Homo sapiens	Inhibition	%	0.17
	8197030	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.1	CHEMBL4376	Homo sapiens	Inhibition	%	3.1
	8197391	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	5.62	CHEMBL4376	Homo sapiens	Inhibition	%	5.62
	8197666	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.04	CHEMBL4376	Homo sapiens	Inhibition	%	5.04
	8197806	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.19	CHEMBL4376	Homo sapiens	Inhibition	%	0.19
	8198030	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.53	CHEMBL4376	Homo sapiens	Inhibition	%	2.53
	8198187	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.91	CHEMBL4376	Homo sapiens	Inhibition	%	2.91
	8198325	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.63	CHEMBL4376	Homo sapiens	Inhibition	%	-1.63
	8198549	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.36	CHEMBL4376	Homo sapiens	Inhibition	%	3.36
	8198679	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.5	CHEMBL4376	Homo sapiens	Inhibition	%	4.5
	8199034	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.36	CHEMBL4376	Homo sapiens	Inhibition	%	3.36
	8199182	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.79	CHEMBL4376	Homo sapiens	Inhibition	%	3.79
	8199540	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	3.74	CHEMBL4376	Homo sapiens	Inhibition	%	3.74
	8199703	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	13.43	CHEMBL4376	Homo sapiens	Inhibition	%	13.43
	8199927	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.52	CHEMBL4376	Homo sapiens	Inhibition	%	1.52
	8200065	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.63	CHEMBL4376	Homo sapiens	Inhibition	%	3.63
	8200393	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.34	CHEMBL4376	Homo sapiens	Inhibition	%	1.34
	8200508	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	3.84	CHEMBL4376	Homo sapiens	Inhibition	%	3.84
	8200732	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	7.46	CHEMBL4376	Homo sapiens	Inhibition	%	7.46
	8200882	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.94	CHEMBL4376	Homo sapiens	Inhibition	%	2.94
	8201236	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	4.35	CHEMBL4376	Homo sapiens	Inhibition	%	4.35
	8201371	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.46	CHEMBL4376	Homo sapiens	Inhibition	%	2.46
	8201595	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.11	CHEMBL4376	Homo sapiens	Inhibition	%	3.11
	8201728	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.45	CHEMBL4376	Homo sapiens	Inhibition	%	-0.45
	8202007	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.83	CHEMBL4376	Homo sapiens	Inhibition	%	2.83
	8202371	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-2.46	CHEMBL4376	Homo sapiens	Inhibition	%	-2.46
	8202538	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.31	CHEMBL4376	Homo sapiens	Inhibition	%	2.31
	8202887	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.06	CHEMBL4376	Homo sapiens	Inhibition	%	4.06
	8203017	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.42	CHEMBL4376	Homo sapiens	Inhibition	%	3.42
	8203372	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	2.38	CHEMBL4376	Homo sapiens	Inhibition	%	2.38
	8203518	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.25	CHEMBL4376	Homo sapiens	Inhibition	%	5.25
	8203742	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.99	CHEMBL4376	Homo sapiens	Inhibition	%	1.99
	8203876	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.05	CHEMBL4376	Homo sapiens	Inhibition	%	4.05
	8204266	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.56	CHEMBL4376	Homo sapiens	Inhibition	%	3.56
	8204403	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	3.35	CHEMBL4376	Homo sapiens	Inhibition	%	3.35
	8204732	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.66	CHEMBL4376	Homo sapiens	Inhibition	%	0.66
	8205071	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	44.8	CHEMBL4376	Homo sapiens	Inhibition	%	44.8
	8205220	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	5.57	CHEMBL4376	Homo sapiens	Inhibition	%	5.57
	8205444	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	32.77	CHEMBL4376	Homo sapiens	Inhibition	%	32.77
	8205580	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.54	CHEMBL4376	Homo sapiens	Inhibition	%	1.54
	8205943	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.06	CHEMBL4376	Homo sapiens	Inhibition	%	2.06
	8206075	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.0	CHEMBL4376	Homo sapiens	Inhibition	%	0.0
	8206351	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.42	CHEMBL4376	Homo sapiens	Inhibition	%	3.42
	8206718	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.96	CHEMBL4376	Homo sapiens	Inhibition	%	-0.96
	8206898	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.75	CHEMBL4376	Homo sapiens	Inhibition	%	2.75
	8207248	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.16	CHEMBL4376	Homo sapiens	Inhibition	%	3.16
	8207378	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.62	CHEMBL4376	Homo sapiens	Inhibition	%	3.62
	8207602	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	12.36	CHEMBL4376	Homo sapiens	Inhibition	%	12.36
	8207734	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	2.71	CHEMBL4376	Homo sapiens	Inhibition	%	2.71
	8208103	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.39	CHEMBL4376	Homo sapiens	Inhibition	%	5.39
	8208235	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.14	CHEMBL4376	Homo sapiens	Inhibition	%	4.14
	8208459	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.1	CHEMBL4376	Homo sapiens	Inhibition	%	3.1
	8208625	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.96	CHEMBL4376	Homo sapiens	Inhibition	%	0.96
	8208758	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	5.79	CHEMBL4376	Homo sapiens	Inhibition	%	5.79
	8208982	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.16	CHEMBL4376	Homo sapiens	Inhibition	%	4.16
	8209087	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.46	CHEMBL4376	Homo sapiens	Inhibition	%	1.46
	8209427	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.04	CHEMBL4376	Homo sapiens	Inhibition	%	2.04
	8209801	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.63	CHEMBL4376	Homo sapiens	Inhibition	%	1.63
	8209937	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.84	CHEMBL4376	Homo sapiens	Inhibition	%	2.84
	8210302	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.68	CHEMBL4376	Homo sapiens	Inhibition	%	2.68
	8210438	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.64	CHEMBL4376	Homo sapiens	Inhibition	%	-0.64
	8210662	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	14.0	CHEMBL4376	Homo sapiens	Inhibition	%	14.0
	8210697	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.1	CHEMBL4376	Homo sapiens	Inhibition	%	2.1
	8210921	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	3.03	CHEMBL4376	Homo sapiens	Inhibition	%	3.03
	8211065	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.48	CHEMBL4376	Homo sapiens	Inhibition	%	3.48
	8211235	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.79	CHEMBL4376	Homo sapiens	Inhibition	%	3.79
	8211459	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.27	CHEMBL4376	Homo sapiens	Inhibition	%	3.27
	8211582	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.31	CHEMBL4376	Homo sapiens	Inhibition	%	5.31
	8211935	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	53.33	CHEMBL4376	Homo sapiens	Inhibition	%	53.33
	8212067	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.59	CHEMBL4376	Homo sapiens	Inhibition	%	3.59
	8212291	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.57	CHEMBL4376	Homo sapiens	Inhibition	%	3.57
	8212432	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.57	CHEMBL4376	Homo sapiens	Inhibition	%	2.57
	8212789	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.15	CHEMBL4376	Homo sapiens	Inhibition	%	3.15
	8212959	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.61	CHEMBL4376	Homo sapiens	Inhibition	%	1.61
	8213312	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	19.62	CHEMBL4376	Homo sapiens	Inhibition	%	19.62
	8213416	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	10.27	CHEMBL4376	Homo sapiens	Inhibition	%	10.27
	8213640	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-2.12	CHEMBL4376	Homo sapiens	Inhibition	%	-2.12
	8213753	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	4.58	CHEMBL4376	Homo sapiens	Inhibition	%	4.58
	8214124	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.47	CHEMBL4376	Homo sapiens	Inhibition	%	3.47
	8214261	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	2.5	CHEMBL4376	Homo sapiens	Inhibition	%	2.5
	8214485	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	5.55	CHEMBL4376	Homo sapiens	Inhibition	%	5.55
	8214619	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	2.25	CHEMBL4376	Homo sapiens	Inhibition	%	2.25
	8214995	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-0.9	CHEMBL4376	Homo sapiens	Inhibition	%	-0.9
	8215246	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.1	CHEMBL4376	Homo sapiens	Inhibition	%	3.1
	8215399	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.12	CHEMBL4376	Homo sapiens	Inhibition	%	4.12
	8215787	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.77	CHEMBL4376	Homo sapiens	Inhibition	%	2.77
	8215906	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	3.04	CHEMBL4376	Homo sapiens	Inhibition	%	3.04
	8216249	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.93	CHEMBL4376	Homo sapiens	Inhibition	%	2.93
	8216609	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	5.9	CHEMBL4376	Homo sapiens	Inhibition	%	5.9
	8216747	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.75	CHEMBL4376	Homo sapiens	Inhibition	%	2.75
	8217105	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.04	CHEMBL4376	Homo sapiens	Inhibition	%	5.04
	8217279	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.4	CHEMBL4376	Homo sapiens	Inhibition	%	0.4
	8217503	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.21	CHEMBL4376	Homo sapiens	Inhibition	%	0.21
	8217634	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	2.4	CHEMBL4376	Homo sapiens	Inhibition	%	2.4
	8217959	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.19	CHEMBL4376	Homo sapiens	Inhibition	%	-1.19
	8218074	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.04	CHEMBL4376	Homo sapiens	Inhibition	%	2.04
	8218298	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.1	CHEMBL4376	Homo sapiens	Inhibition	%	4.1
	8218425	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	20.93	CHEMBL4376	Homo sapiens	Inhibition	%	20.93
	8218792	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	1.92	CHEMBL4376	Homo sapiens	Inhibition	%	1.92
	8218923	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	7.18	CHEMBL4376	Homo sapiens	Inhibition	%	7.18
	8219307	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-1.36	CHEMBL4376	Homo sapiens	Inhibition	%	-1.36
	8219557	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.1	CHEMBL4376	Homo sapiens	Inhibition	%	4.1
	8219718	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.83	CHEMBL4376	Homo sapiens	Inhibition	%	3.83
	8219942	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	4.61	CHEMBL4376	Homo sapiens	Inhibition	%	4.61
	8220111	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.85	CHEMBL4376	Homo sapiens	Inhibition	%	3.85
	8220240	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	5.79	CHEMBL4376	Homo sapiens	Inhibition	%	5.79
	8220464	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.66	CHEMBL4376	Homo sapiens	Inhibition	%	3.66
	8220578	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.03	CHEMBL4376	Homo sapiens	Inhibition	%	4.03
	8220940	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	24.68	CHEMBL4376	Homo sapiens	Inhibition	%	24.68
	8221076	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.22	CHEMBL4376	Homo sapiens	Inhibition	%	3.22
	8221300	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	19.66	CHEMBL4376	Homo sapiens	Inhibition	%	19.66
	8221433	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.88	CHEMBL4376	Homo sapiens	Inhibition	%	2.88
	8221822	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.2	CHEMBL4376	Homo sapiens	Inhibition	%	-0.2
	8221953	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	4.87	CHEMBL4376	Homo sapiens	Inhibition	%	4.87
	8222275	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.2	CHEMBL4376	Homo sapiens	Inhibition	%	2.2
	8222633	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.13	CHEMBL4376	Homo sapiens	Inhibition	%	2.13
	8222751	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	66.32	CHEMBL4376	Homo sapiens	Inhibition	%	66.32
	8223119	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	5.52	CHEMBL4376	Homo sapiens	Inhibition	%	5.52
	8223248	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.36	CHEMBL4376	Homo sapiens	Inhibition	%	2.36
	8223472	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	3.65	CHEMBL4376	Homo sapiens	Inhibition	%	3.65
	8223633	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.01	CHEMBL4376	Homo sapiens	Inhibition	%	-0.01
	8223883	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.55	CHEMBL4376	Homo sapiens	Inhibition	%	3.55
	8224269	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.77	CHEMBL4376	Homo sapiens	Inhibition	%	2.77
	8224439	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.53	CHEMBL4376	Homo sapiens	Inhibition	%	4.53
	8224798	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.05	CHEMBL4376	Homo sapiens	Inhibition	%	4.05
	8224912	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.57	CHEMBL4376	Homo sapiens	Inhibition	%	2.57
	8225136	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.68	CHEMBL4376	Homo sapiens	Inhibition	%	2.68
	8225270	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.82	CHEMBL4376	Homo sapiens	Inhibition	%	3.82
	8225632	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.61	CHEMBL4376	Homo sapiens	Inhibition	%	1.61
	8225767	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.2	CHEMBL4376	Homo sapiens	Inhibition	%	4.2
	8226149	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.95	CHEMBL4376	Homo sapiens	Inhibition	%	-0.95
	8226274	CHEMBL1962040	GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.08	CHEMBL4376	Homo sapiens	Inhibition	%	3.08
	8226498	CHEMBL1962041	GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.89	CHEMBL4376	Homo sapiens	Inhibition	%	4.89
	10838524	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	COc1ccc2c3ccnc(C)c3n(CCCN)c2c1		CHEMBL2012558	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	10838525	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	COc1ccc2c3ccnc(C)c3n(CCCCN)c2c1		CHEMBL2012559	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	10838526	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	COc1ccc2c3ccncc3n(CCCCN)c2c1		CHEMBL2012560	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	10838527	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	COc1ccc2c3ccnc(C(C)C)c3n(CCCCN)c2c1		CHEMBL2012561	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	10838528	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	CCc1nccc2c3ccc(OC)cc3n(CCCCN)c12		CHEMBL2012562	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	10838529	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	Cc1nccc2c3ccc(O)cc3n(CCCCN)c12		CHEMBL2012563	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	10838530	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	Cc1nccc2c3ccc(F)cc3n(CCCCN)c12		CHEMBL2012564	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	10838531	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	Cc1nccc2c3ccc(NS(C)(=O)=O)cc3n(CCCCN)c12		CHEMBL2012565	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	10838532	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	Cc1nccc2c3ccc(OC(C)(C)C)cc3n(CCCCN)c12		CHEMBL2012566	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	10838533	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	COc1cccc2c1c1ccnc(C)c1n2CCCCN		CHEMBL2012567	=	IC50	nM	7000.0	CHEMBL4376	Homo sapiens	IC50	uM	7.0
	10838534	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	COc1ccc2c(c1)c1ccnc(C)c1n2CCCCN		CHEMBL2012568	=	IC50	nM	4900.0	CHEMBL4376	Homo sapiens	IC50	uM	4.9
	10838535	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	COc1cccc2c3ccnc(C)c3n(CCCCN)c12		CHEMBL2012569	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	10838536	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	Cc1nccc2c3cc4c(cc3n(CCCCN)c12)OCO4		CHEMBL2012570	=	IC50	nM	4800.0	CHEMBL4376	Homo sapiens	IC50	uM	4.8
	10838537	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	COc1ccc2c3ccnc(C)c3n(CCCCN)c2c1Cl		CHEMBL2012571	=	IC50	nM	8000.0	CHEMBL4376	Homo sapiens	IC50	uM	8.0
	10838538	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	CNCCCCn1c2cc(OC)ccc2c2ccnc(C)c21		CHEMBL2012572	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	10838539	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	COc1ccc2c3ccnc(C)c3n(CCCCN(C)C)c2c1		CHEMBL2012573	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	10838540	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	IC50	nM	15000.0	CHEMBL4376	Homo sapiens	IC50	uM	15.0
	10838541	CHEMBL2014114	Inhibition of human N-terminal GST-tagged DYRK2 expressed in baculovirus using DYRKtide-F as substrate assessed as inhibition of [33P] incorporation into substrate using [gamma33P]ATP after 10 mins by liquid scintillation counting	B	NCCCCn1c2cc(O)ccc2c2ccnc(C(F)(F)F)c21		CHEMBL2012575	=	IC50	nM	8500.0	CHEMBL4376	Homo sapiens	IC50	uM	8.5
	10838694	CHEMBL2014920	Inhibition of DYRK2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	86.0	CHEMBL4376	Homo sapiens	INH	%	86.0
	10839507	CHEMBL2015537	Inhibition of DYRK2	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	IC50	nM	690.0	CHEMBL4376	Homo sapiens	IC50	uM	0.69
	10839508	CHEMBL2015537	Inhibition of DYRK2	B	Cc1[nH]ccc2c1[nH]c1cc(=O)ccc12		CHEMBL486817	=	IC50	nM	1500.0	CHEMBL4376	Homo sapiens	IC50	uM	1.5
	10839667	CHEMBL2015004	Inhibition of DYRK2 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	106.0	CHEMBL4376	Homo sapiens	Activity	%	106.0
	10840428	CHEMBL2015848	Inhibition of DYRK2 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	105.0	CHEMBL4376	Homo sapiens	Activity	%	105.0
Active	12140051	CHEMBL2186709	Binding affinity to DYRK2	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1N		CHEMBL485053		Activity			CHEMBL4376	Homo sapiens	Activity		
Active	12140054	CHEMBL2186709	Binding affinity to DYRK2	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538		Activity			CHEMBL4376	Homo sapiens	Activity		
Not Active	12141707	CHEMBL2182309	Inhibition of human recombinant GST-tagged DYRK2 expressed in Escherichia coli using GRSRSRSRSRSR as substrate and [gamma33P]ATP at 10 uM after 30 mins by scintillation counting	B	Nc1c2c(nc3ccccc13)CCCC2		CHEMBL95		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
Not Active	12141711	CHEMBL2182309	Inhibition of human recombinant GST-tagged DYRK2 expressed in Escherichia coli using GRSRSRSRSRSR as substrate and [gamma33P]ATP at 10 uM after 30 mins by scintillation counting	B	CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1		CHEMBL636		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
Not Active	12141715	CHEMBL2182309	Inhibition of human recombinant GST-tagged DYRK2 expressed in Escherichia coli using GRSRSRSRSRSR as substrate and [gamma33P]ATP at 10 uM after 30 mins by scintillation counting	B	CC12CC3CC(C)(C1)CC(N)(C3)C2		CHEMBL807		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
	12141733	CHEMBL2186709	Binding affinity to DYRK2	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802358	=	Kd	nM	450.0	CHEMBL4376	Homo sapiens	Kd	nM	450.0
Active	12141745	CHEMBL2186721	Inhibition of human recombinant GST-tagged DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate at 1 uM after 30 mins	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802358		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
Active	12141746	CHEMBL2186720	Inhibition of human recombinant GST-tagged DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate at 10 uM after 30 mins	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802358		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
	12141758	CHEMBL2187132	Inhibition of human recombinant GST-tagged DYRK2 expressed in Escherichia coli using GRSRSRSRSRSR as substrate and [gamma33P]ATP after 30 mins by scintillation counting	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802358	=	IC50	nM	73.0	CHEMBL4376	Homo sapiens	IC50	uM	0.073
	12141784	CHEMBL2187132	Inhibition of human recombinant GST-tagged DYRK2 expressed in Escherichia coli using GRSRSRSRSRSR as substrate and [gamma33P]ATP after 30 mins by scintillation counting	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1N		CHEMBL485053	=	IC50	nM	2000.0	CHEMBL4376	Homo sapiens	IC50	uM	2.0
	12141810	CHEMBL2187132	Inhibition of human recombinant GST-tagged DYRK2 expressed in Escherichia coli using GRSRSRSRSRSR as substrate and [gamma33P]ATP after 30 mins by scintillation counting	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	IC50	nM	120.0	CHEMBL4376	Homo sapiens	IC50	uM	0.12
Not Active	12141829	CHEMBL2182309	Inhibition of human recombinant GST-tagged DYRK2 expressed in Escherichia coli using GRSRSRSRSRSR as substrate and [gamma33P]ATP at 10 uM after 30 mins by scintillation counting	B	COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2		CHEMBL659		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
Not Active	12141833	CHEMBL2182309	Inhibition of human recombinant GST-tagged DYRK2 expressed in Escherichia coli using GRSRSRSRSRSR as substrate and [gamma33P]ATP at 10 uM after 30 mins by scintillation counting	B	COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2		CHEMBL502		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
	12170822	CHEMBL2212690	Inhibition of DYRK2 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	90.0	CHEMBL4376	Homo sapiens	Activity	%	90.0
	12172123	CHEMBL2213949	Inhibition of DYRK2 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	92.0	CHEMBL4376	Homo sapiens	Activity	%	92.0
	12173654	CHEMBL2216433	Inhibition of DYRK2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL4376	Homo sapiens	Activity	%	100.0
	12230628	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	107.0	CHEMBL4376	Homo sapiens	Residual Activity	%	107.0
	12230629	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	101.0	CHEMBL4376	Homo sapiens	Residual Activity	%	101.0
	12230630	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	97.0	CHEMBL4376	Homo sapiens	Residual Activity	%	97.0
	12230631	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	101.0	CHEMBL4376	Homo sapiens	Residual Activity	%	101.0
	12230632	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	90.0	CHEMBL4376	Homo sapiens	Residual Activity	%	90.0
	12230633	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	85.0	CHEMBL4376	Homo sapiens	Residual Activity	%	85.0
	12230634	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	102.0	CHEMBL4376	Homo sapiens	Residual Activity	%	102.0
	12230635	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	92.0	CHEMBL4376	Homo sapiens	Residual Activity	%	92.0
	12230636	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	108.0	CHEMBL4376	Homo sapiens	Residual Activity	%	108.0
	12230637	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	98.0	CHEMBL4376	Homo sapiens	Residual Activity	%	98.0
	12230638	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	102.0	CHEMBL4376	Homo sapiens	Residual Activity	%	102.0
	12230639	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	102.0	CHEMBL4376	Homo sapiens	Residual Activity	%	102.0
	12230640	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	99.0	CHEMBL4376	Homo sapiens	Residual Activity	%	99.0
	12230641	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	109.0	CHEMBL4376	Homo sapiens	Residual Activity	%	109.0
	12230642	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	104.0	CHEMBL4376	Homo sapiens	Residual Activity	%	104.0
	12230643	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	104.0	CHEMBL4376	Homo sapiens	Residual Activity	%	104.0
	12230644	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	99.0	CHEMBL4376	Homo sapiens	Residual Activity	%	99.0
	12230645	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	107.0	CHEMBL4376	Homo sapiens	Residual Activity	%	107.0
	12230646	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	98.0	CHEMBL4376	Homo sapiens	Residual Activity	%	98.0
	12230647	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	76.0	CHEMBL4376	Homo sapiens	Residual Activity	%	76.0
	12230648	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	112.0	CHEMBL4376	Homo sapiens	Residual Activity	%	112.0
	12230649	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	105.0	CHEMBL4376	Homo sapiens	Residual Activity	%	105.0
	12230650	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	101.0	CHEMBL4376	Homo sapiens	Residual Activity	%	101.0
	12230651	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	105.0	CHEMBL4376	Homo sapiens	Residual Activity	%	105.0
	12230652	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	99.0	CHEMBL4376	Homo sapiens	Residual Activity	%	99.0
	12230653	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	92.0	CHEMBL4376	Homo sapiens	Residual Activity	%	92.0
	12230654	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	81.0	CHEMBL4376	Homo sapiens	Residual Activity	%	81.0
	12230655	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	48.0	CHEMBL4376	Homo sapiens	Residual Activity	%	48.0
	12230656	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	92.0	CHEMBL4376	Homo sapiens	Residual Activity	%	92.0
	12230657	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	98.0	CHEMBL4376	Homo sapiens	Residual Activity	%	98.0
	12230658	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	89.0	CHEMBL4376	Homo sapiens	Residual Activity	%	89.0
	12230659	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	92.0	CHEMBL4376	Homo sapiens	Residual Activity	%	92.0
	12230660	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	111.0	CHEMBL4376	Homo sapiens	Residual Activity	%	111.0
	12230661	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	97.0	CHEMBL4376	Homo sapiens	Residual Activity	%	97.0
	12230662	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	97.0	CHEMBL4376	Homo sapiens	Residual Activity	%	97.0
	12230663	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	90.0	CHEMBL4376	Homo sapiens	Residual Activity	%	90.0
	12230664	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	96.0	CHEMBL4376	Homo sapiens	Residual Activity	%	96.0
	12230665	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	99.0	CHEMBL4376	Homo sapiens	Residual Activity	%	99.0
	12230666	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	94.0	CHEMBL4376	Homo sapiens	Residual Activity	%	94.0
	12230667	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	97.0	CHEMBL4376	Homo sapiens	Residual Activity	%	97.0
	12230668	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	105.0	CHEMBL4376	Homo sapiens	Residual Activity	%	105.0
	12230669	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	108.0	CHEMBL4376	Homo sapiens	Residual Activity	%	108.0
	12230670	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	76.0	CHEMBL4376	Homo sapiens	Residual Activity	%	76.0
	12230671	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	-5.0	CHEMBL4376	Homo sapiens	Residual Activity	%	-5.0
	12230672	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	106.0	CHEMBL4376	Homo sapiens	Residual Activity	%	106.0
	12230673	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	77.0	CHEMBL4376	Homo sapiens	Residual Activity	%	77.0
	12230674	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	96.0	CHEMBL4376	Homo sapiens	Residual Activity	%	96.0
	12230675	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	91.0	CHEMBL4376	Homo sapiens	Residual Activity	%	91.0
	12230676	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	101.0	CHEMBL4376	Homo sapiens	Residual Activity	%	101.0
	12230677	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	94.0	CHEMBL4376	Homo sapiens	Residual Activity	%	94.0
	12230678	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	94.0	CHEMBL4376	Homo sapiens	Residual Activity	%	94.0
	12230679	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	91.0	CHEMBL4376	Homo sapiens	Residual Activity	%	91.0
	12230680	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	1.0	CHEMBL4376	Homo sapiens	Residual Activity	%	1.0
	12230681	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	91.0	CHEMBL4376	Homo sapiens	Residual Activity	%	91.0
	12230682	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	87.0	CHEMBL4376	Homo sapiens	Residual Activity	%	87.0
	12230683	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	100.0	CHEMBL4376	Homo sapiens	Residual Activity	%	100.0
	12230684	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	98.0	CHEMBL4376	Homo sapiens	Residual Activity	%	98.0
	12230685	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	102.0	CHEMBL4376	Homo sapiens	Residual Activity	%	102.0
	12230686	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	83.0	CHEMBL4376	Homo sapiens	Residual Activity	%	83.0
	12230687	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	93.0	CHEMBL4376	Homo sapiens	Residual Activity	%	93.0
	12230688	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	83.0	CHEMBL4376	Homo sapiens	Residual Activity	%	83.0
	12230689	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	90.0	CHEMBL4376	Homo sapiens	Residual Activity	%	90.0
	12230690	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	85.0	CHEMBL4376	Homo sapiens	Residual Activity	%	85.0
	12230691	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	100.0	CHEMBL4376	Homo sapiens	Residual Activity	%	100.0
	12230692	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	102.0	CHEMBL4376	Homo sapiens	Residual Activity	%	102.0
	12230693	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	98.0	CHEMBL4376	Homo sapiens	Residual Activity	%	98.0
	12230694	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	95.0	CHEMBL4376	Homo sapiens	Residual Activity	%	95.0
	12230695	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	87.0	CHEMBL4376	Homo sapiens	Residual Activity	%	87.0
	12230696	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	7.0	CHEMBL4376	Homo sapiens	Residual Activity	%	7.0
	12230697	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	99.0	CHEMBL4376	Homo sapiens	Residual Activity	%	99.0
	12230698	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	85.0	CHEMBL4376	Homo sapiens	Residual Activity	%	85.0
	12230699	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	95.0	CHEMBL4376	Homo sapiens	Residual Activity	%	95.0
	12230700	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	103.0	CHEMBL4376	Homo sapiens	Residual Activity	%	103.0
	12230701	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	102.0	CHEMBL4376	Homo sapiens	Residual Activity	%	102.0
	12230702	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	92.0	CHEMBL4376	Homo sapiens	Residual Activity	%	92.0
	12230703	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	86.0	CHEMBL4376	Homo sapiens	Residual Activity	%	86.0
	12230704	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	86.0	CHEMBL4376	Homo sapiens	Residual Activity	%	86.0
	12230705	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	78.0	CHEMBL4376	Homo sapiens	Residual Activity	%	78.0
	12230706	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	93.0	CHEMBL4376	Homo sapiens	Residual Activity	%	93.0
	12230707	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	65.0	CHEMBL4376	Homo sapiens	Residual Activity	%	65.0
	12230708	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	103.0	CHEMBL4376	Homo sapiens	Residual Activity	%	103.0
	12230709	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	104.0	CHEMBL4376	Homo sapiens	Residual Activity	%	104.0
	12230710	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	100.0	CHEMBL4376	Homo sapiens	Residual Activity	%	100.0
	12230711	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	101.0	CHEMBL4376	Homo sapiens	Residual Activity	%	101.0
	12230712	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	104.0	CHEMBL4376	Homo sapiens	Residual Activity	%	104.0
	12230713	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	105.0	CHEMBL4376	Homo sapiens	Residual Activity	%	105.0
	12230714	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	105.0	CHEMBL4376	Homo sapiens	Residual Activity	%	105.0
	12230715	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	115.0	CHEMBL4376	Homo sapiens	Residual Activity	%	115.0
	12230716	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	101.0	CHEMBL4376	Homo sapiens	Residual Activity	%	101.0
	12230717	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	79.0	CHEMBL4376	Homo sapiens	Residual Activity	%	79.0
	12230718	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	90.0	CHEMBL4376	Homo sapiens	Residual Activity	%	90.0
	12230719	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	94.0	CHEMBL4376	Homo sapiens	Residual Activity	%	94.0
	12230720	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	88.0	CHEMBL4376	Homo sapiens	Residual Activity	%	88.0
	12230721	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	102.0	CHEMBL4376	Homo sapiens	Residual Activity	%	102.0
	12230722	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	106.0	CHEMBL4376	Homo sapiens	Residual Activity	%	106.0
	12230723	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	104.0	CHEMBL4376	Homo sapiens	Residual Activity	%	104.0
	12230724	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	98.0	CHEMBL4376	Homo sapiens	Residual Activity	%	98.0
	12230725	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	96.0	CHEMBL4376	Homo sapiens	Residual Activity	%	96.0
	12230726	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	85.0	CHEMBL4376	Homo sapiens	Residual Activity	%	85.0
	12230727	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	99.0	CHEMBL4376	Homo sapiens	Residual Activity	%	99.0
	12230728	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	68.0	CHEMBL4376	Homo sapiens	Residual Activity	%	68.0
	12230729	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	2.0	CHEMBL4376	Homo sapiens	Residual Activity	%	2.0
	12230730	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	100.0	CHEMBL4376	Homo sapiens	Residual Activity	%	100.0
	12230731	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	91.0	CHEMBL4376	Homo sapiens	Residual Activity	%	91.0
	12230732	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	54.0	CHEMBL4376	Homo sapiens	Residual Activity	%	54.0
	12230733	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	99.0	CHEMBL4376	Homo sapiens	Residual Activity	%	99.0
	12230734	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	5.0	CHEMBL4376	Homo sapiens	Residual Activity	%	5.0
	12230735	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	99.0	CHEMBL4376	Homo sapiens	Residual Activity	%	99.0
	12230736	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	102.0	CHEMBL4376	Homo sapiens	Residual Activity	%	102.0
	12230737	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	92.0	CHEMBL4376	Homo sapiens	Residual Activity	%	92.0
	12230738	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	100.0	CHEMBL4376	Homo sapiens	Residual Activity	%	100.0
	12230739	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	99.0	CHEMBL4376	Homo sapiens	Residual Activity	%	99.0
	12230740	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	28.0	CHEMBL4376	Homo sapiens	Residual Activity	%	28.0
	12230741	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	97.0	CHEMBL4376	Homo sapiens	Residual Activity	%	97.0
	12230742	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	87.0	CHEMBL4376	Homo sapiens	Residual Activity	%	87.0
	12230743	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	96.0	CHEMBL4376	Homo sapiens	Residual Activity	%	96.0
	12230744	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	96.0	CHEMBL4376	Homo sapiens	Residual Activity	%	96.0
	12230745	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	100.0	CHEMBL4376	Homo sapiens	Residual Activity	%	100.0
	12230746	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	83.0	CHEMBL4376	Homo sapiens	Residual Activity	%	83.0
	12230747	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	103.0	CHEMBL4376	Homo sapiens	Residual Activity	%	103.0
	12230748	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	85.0	CHEMBL4376	Homo sapiens	Residual Activity	%	85.0
	12230749	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	103.0	CHEMBL4376	Homo sapiens	Residual Activity	%	103.0
	12230750	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	95.0	CHEMBL4376	Homo sapiens	Residual Activity	%	95.0
	12230751	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	87.0	CHEMBL4376	Homo sapiens	Residual Activity	%	87.0
	12230752	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	70.0	CHEMBL4376	Homo sapiens	Residual Activity	%	70.0
	12230753	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	95.0	CHEMBL4376	Homo sapiens	Residual Activity	%	95.0
	12230754	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	99.0	CHEMBL4376	Homo sapiens	Residual Activity	%	99.0
	12230755	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	104.0	CHEMBL4376	Homo sapiens	Residual Activity	%	104.0
	12230756	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	93.0	CHEMBL4376	Homo sapiens	Residual Activity	%	93.0
	12230757	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	49.0	CHEMBL4376	Homo sapiens	Residual Activity	%	49.0
	12230758	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	87.0	CHEMBL4376	Homo sapiens	Residual Activity	%	87.0
	12230759	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	84.0	CHEMBL4376	Homo sapiens	Residual Activity	%	84.0
	12230760	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	4.0	CHEMBL4376	Homo sapiens	Residual Activity	%	4.0
	12230761	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	100.0	CHEMBL4376	Homo sapiens	Residual Activity	%	100.0
	12230762	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	89.0	CHEMBL4376	Homo sapiens	Residual Activity	%	89.0
	12230763	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	94.0	CHEMBL4376	Homo sapiens	Residual Activity	%	94.0
	12230764	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	92.0	CHEMBL4376	Homo sapiens	Residual Activity	%	92.0
	12230765	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	90.0	CHEMBL4376	Homo sapiens	Residual Activity	%	90.0
	12230766	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	87.0	CHEMBL4376	Homo sapiens	Residual Activity	%	87.0
	12230767	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	91.0	CHEMBL4376	Homo sapiens	Residual Activity	%	91.0
	12230768	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	105.0	CHEMBL4376	Homo sapiens	Residual Activity	%	105.0
	12233381	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	98.0	CHEMBL4376	Homo sapiens	Residual Activity	%	98.0
	12233382	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	54.0	CHEMBL4376	Homo sapiens	Residual Activity	%	54.0
	12233383	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	52.0	CHEMBL4376	Homo sapiens	Residual Activity	%	52.0
	12233384	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	108.0	CHEMBL4376	Homo sapiens	Residual Activity	%	108.0
	12233385	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	96.0	CHEMBL4376	Homo sapiens	Residual Activity	%	96.0
	12233386	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	96.0	CHEMBL4376	Homo sapiens	Residual Activity	%	96.0
	12233387	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	19.0	CHEMBL4376	Homo sapiens	Residual Activity	%	19.0
	12233388	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	79.0	CHEMBL4376	Homo sapiens	Residual Activity	%	79.0
	12233389	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	87.0	CHEMBL4376	Homo sapiens	Residual Activity	%	87.0
	12233390	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	77.0	CHEMBL4376	Homo sapiens	Residual Activity	%	77.0
	12233391	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	92.0	CHEMBL4376	Homo sapiens	Residual Activity	%	92.0
	12233392	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	90.0	CHEMBL4376	Homo sapiens	Residual Activity	%	90.0
	12233393	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	103.0	CHEMBL4376	Homo sapiens	Residual Activity	%	103.0
	12233394	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	102.0	CHEMBL4376	Homo sapiens	Residual Activity	%	102.0
	12233395	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	103.0	CHEMBL4376	Homo sapiens	Residual Activity	%	103.0
	12233396	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	99.0	CHEMBL4376	Homo sapiens	Residual Activity	%	99.0
	12233397	CHEMBL2219032	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	104.0	CHEMBL4376	Homo sapiens	Residual Activity	%	104.0
	12233398	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	101.0	CHEMBL4376	Homo sapiens	Residual Activity	%	101.0
	12233399	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	82.0	CHEMBL4376	Homo sapiens	Residual Activity	%	82.0
	12233400	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	99.0	CHEMBL4376	Homo sapiens	Residual Activity	%	99.0
	12233401	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	102.0	CHEMBL4376	Homo sapiens	Residual Activity	%	102.0
	12233402	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	86.0	CHEMBL4376	Homo sapiens	Residual Activity	%	86.0
	12233403	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	44.0	CHEMBL4376	Homo sapiens	Residual Activity	%	44.0
	12233404	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	99.0	CHEMBL4376	Homo sapiens	Residual Activity	%	99.0
	12233405	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	55.0	CHEMBL4376	Homo sapiens	Residual Activity	%	55.0
	12233406	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	87.0	CHEMBL4376	Homo sapiens	Residual Activity	%	87.0
	12233407	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	79.0	CHEMBL4376	Homo sapiens	Residual Activity	%	79.0
	12233408	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	93.0	CHEMBL4376	Homo sapiens	Residual Activity	%	93.0
	12233409	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	88.0	CHEMBL4376	Homo sapiens	Residual Activity	%	88.0
	12233410	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	82.0	CHEMBL4376	Homo sapiens	Residual Activity	%	82.0
	12233411	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	99.0	CHEMBL4376	Homo sapiens	Residual Activity	%	99.0
	12233412	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	93.0	CHEMBL4376	Homo sapiens	Residual Activity	%	93.0
	12233413	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	101.0	CHEMBL4376	Homo sapiens	Residual Activity	%	101.0
	12233414	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	103.0	CHEMBL4376	Homo sapiens	Residual Activity	%	103.0
	12233415	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	96.0	CHEMBL4376	Homo sapiens	Residual Activity	%	96.0
	12233416	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	90.0	CHEMBL4376	Homo sapiens	Residual Activity	%	90.0
	12233417	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	72.0	CHEMBL4376	Homo sapiens	Residual Activity	%	72.0
	12233418	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	102.0	CHEMBL4376	Homo sapiens	Residual Activity	%	102.0
	12233419	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	101.0	CHEMBL4376	Homo sapiens	Residual Activity	%	101.0
	12233420	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	106.0	CHEMBL4376	Homo sapiens	Residual Activity	%	106.0
	12233421	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	100.0	CHEMBL4376	Homo sapiens	Residual Activity	%	100.0
	12233422	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	71.0	CHEMBL4376	Homo sapiens	Residual Activity	%	71.0
	12233423	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	58.0	CHEMBL4376	Homo sapiens	Residual Activity	%	58.0
	12233424	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	47.0	CHEMBL4376	Homo sapiens	Residual Activity	%	47.0
	12233425	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	10.0	CHEMBL4376	Homo sapiens	Residual Activity	%	10.0
	12233426	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	98.0	CHEMBL4376	Homo sapiens	Residual Activity	%	98.0
	12233427	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	80.0	CHEMBL4376	Homo sapiens	Residual Activity	%	80.0
	12233428	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	104.0	CHEMBL4376	Homo sapiens	Residual Activity	%	104.0
	12233429	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	98.0	CHEMBL4376	Homo sapiens	Residual Activity	%	98.0
	12233430	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	98.0	CHEMBL4376	Homo sapiens	Residual Activity	%	98.0
	12233431	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	65.0	CHEMBL4376	Homo sapiens	Residual Activity	%	65.0
	12233432	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	99.0	CHEMBL4376	Homo sapiens	Residual Activity	%	99.0
	12233433	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	93.0	CHEMBL4376	Homo sapiens	Residual Activity	%	93.0
	12233434	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	93.0	CHEMBL4376	Homo sapiens	Residual Activity	%	93.0
	12233435	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	101.0	CHEMBL4376	Homo sapiens	Residual Activity	%	101.0
	12233436	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	104.0	CHEMBL4376	Homo sapiens	Residual Activity	%	104.0
	12233437	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	99.0	CHEMBL4376	Homo sapiens	Residual Activity	%	99.0
	12233438	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	103.0	CHEMBL4376	Homo sapiens	Residual Activity	%	103.0
	12233439	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	92.0	CHEMBL4376	Homo sapiens	Residual Activity	%	92.0
	12233440	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	66.0	CHEMBL4376	Homo sapiens	Residual Activity	%	66.0
	12233441	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	-6.0	CHEMBL4376	Homo sapiens	Residual Activity	%	-6.0
	12233442	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	91.0	CHEMBL4376	Homo sapiens	Residual Activity	%	91.0
	12233443	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	21.0	CHEMBL4376	Homo sapiens	Residual Activity	%	21.0
	12233444	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	107.0	CHEMBL4376	Homo sapiens	Residual Activity	%	107.0
	12233445	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	94.0	CHEMBL4376	Homo sapiens	Residual Activity	%	94.0
	12233446	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	100.0	CHEMBL4376	Homo sapiens	Residual Activity	%	100.0
	12233447	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	98.0	CHEMBL4376	Homo sapiens	Residual Activity	%	98.0
	12233448	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	92.0	CHEMBL4376	Homo sapiens	Residual Activity	%	92.0
	12233449	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	82.0	CHEMBL4376	Homo sapiens	Residual Activity	%	82.0
	12233450	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	-5.0	CHEMBL4376	Homo sapiens	Residual Activity	%	-5.0
	12233451	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	94.0	CHEMBL4376	Homo sapiens	Residual Activity	%	94.0
	12233452	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	73.0	CHEMBL4376	Homo sapiens	Residual Activity	%	73.0
	12233453	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	94.0	CHEMBL4376	Homo sapiens	Residual Activity	%	94.0
	12233454	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	98.0	CHEMBL4376	Homo sapiens	Residual Activity	%	98.0
	12233455	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	96.0	CHEMBL4376	Homo sapiens	Residual Activity	%	96.0
	12233456	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	71.0	CHEMBL4376	Homo sapiens	Residual Activity	%	71.0
	12233457	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	91.0	CHEMBL4376	Homo sapiens	Residual Activity	%	91.0
	12233458	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	70.0	CHEMBL4376	Homo sapiens	Residual Activity	%	70.0
	12233459	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	88.0	CHEMBL4376	Homo sapiens	Residual Activity	%	88.0
	12233460	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	93.0	CHEMBL4376	Homo sapiens	Residual Activity	%	93.0
	12233461	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	93.0	CHEMBL4376	Homo sapiens	Residual Activity	%	93.0
	12233462	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	91.0	CHEMBL4376	Homo sapiens	Residual Activity	%	91.0
	12233463	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	98.0	CHEMBL4376	Homo sapiens	Residual Activity	%	98.0
	12233464	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	101.0	CHEMBL4376	Homo sapiens	Residual Activity	%	101.0
	12233465	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	94.0	CHEMBL4376	Homo sapiens	Residual Activity	%	94.0
	12233466	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	-4.0	CHEMBL4376	Homo sapiens	Residual Activity	%	-4.0
	12233467	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	95.0	CHEMBL4376	Homo sapiens	Residual Activity	%	95.0
	12233468	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	105.0	CHEMBL4376	Homo sapiens	Residual Activity	%	105.0
	12233469	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	96.0	CHEMBL4376	Homo sapiens	Residual Activity	%	96.0
	12233470	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	97.0	CHEMBL4376	Homo sapiens	Residual Activity	%	97.0
	12233471	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	94.0	CHEMBL4376	Homo sapiens	Residual Activity	%	94.0
	12233472	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	62.0	CHEMBL4376	Homo sapiens	Residual Activity	%	62.0
	12233473	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	98.0	CHEMBL4376	Homo sapiens	Residual Activity	%	98.0
	12233474	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	65.0	CHEMBL4376	Homo sapiens	Residual Activity	%	65.0
	12233475	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	37.0	CHEMBL4376	Homo sapiens	Residual Activity	%	37.0
	12233476	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	99.0	CHEMBL4376	Homo sapiens	Residual Activity	%	99.0
	12233477	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	17.0	CHEMBL4376	Homo sapiens	Residual Activity	%	17.0
	12233478	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	87.0	CHEMBL4376	Homo sapiens	Residual Activity	%	87.0
	12233479	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	84.0	CHEMBL4376	Homo sapiens	Residual Activity	%	84.0
	12233480	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	75.0	CHEMBL4376	Homo sapiens	Residual Activity	%	75.0
	12233481	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	91.0	CHEMBL4376	Homo sapiens	Residual Activity	%	91.0
	12233482	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	91.0	CHEMBL4376	Homo sapiens	Residual Activity	%	91.0
	12233483	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	91.0	CHEMBL4376	Homo sapiens	Residual Activity	%	91.0
	12233484	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	86.0	CHEMBL4376	Homo sapiens	Residual Activity	%	86.0
	12233485	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	98.0	CHEMBL4376	Homo sapiens	Residual Activity	%	98.0
	12233486	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	95.0	CHEMBL4376	Homo sapiens	Residual Activity	%	95.0
	12233487	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	20.0	CHEMBL4376	Homo sapiens	Residual Activity	%	20.0
	12233488	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	66.0	CHEMBL4376	Homo sapiens	Residual Activity	%	66.0
	12233489	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	88.0	CHEMBL4376	Homo sapiens	Residual Activity	%	88.0
	12233490	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	41.0	CHEMBL4376	Homo sapiens	Residual Activity	%	41.0
	12233491	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	95.0	CHEMBL4376	Homo sapiens	Residual Activity	%	95.0
	12233492	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	102.0	CHEMBL4376	Homo sapiens	Residual Activity	%	102.0
	12233493	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	101.0	CHEMBL4376	Homo sapiens	Residual Activity	%	101.0
	12233494	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	100.0	CHEMBL4376	Homo sapiens	Residual Activity	%	100.0
	12233495	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	102.0	CHEMBL4376	Homo sapiens	Residual Activity	%	102.0
	12233496	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	100.0	CHEMBL4376	Homo sapiens	Residual Activity	%	100.0
	12233497	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	95.0	CHEMBL4376	Homo sapiens	Residual Activity	%	95.0
	12233498	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	57.0	CHEMBL4376	Homo sapiens	Residual Activity	%	57.0
	12233499	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	-4.0	CHEMBL4376	Homo sapiens	Residual Activity	%	-4.0
	12233500	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	94.0	CHEMBL4376	Homo sapiens	Residual Activity	%	94.0
	12233501	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	58.0	CHEMBL4376	Homo sapiens	Residual Activity	%	58.0
	12233502	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	71.0	CHEMBL4376	Homo sapiens	Residual Activity	%	71.0
	12233503	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	89.0	CHEMBL4376	Homo sapiens	Residual Activity	%	89.0
	12233504	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	-5.0	CHEMBL4376	Homo sapiens	Residual Activity	%	-5.0
	12233505	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	92.0	CHEMBL4376	Homo sapiens	Residual Activity	%	92.0
	12233506	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	93.0	CHEMBL4376	Homo sapiens	Residual Activity	%	93.0
	12233507	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	45.0	CHEMBL4376	Homo sapiens	Residual Activity	%	45.0
	12233508	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	91.0	CHEMBL4376	Homo sapiens	Residual Activity	%	91.0
	12233509	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	87.0	CHEMBL4376	Homo sapiens	Residual Activity	%	87.0
	12233510	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	12.0	CHEMBL4376	Homo sapiens	Residual Activity	%	12.0
	12233511	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	91.0	CHEMBL4376	Homo sapiens	Residual Activity	%	91.0
	12233512	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	53.0	CHEMBL4376	Homo sapiens	Residual Activity	%	53.0
	12233513	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	82.0	CHEMBL4376	Homo sapiens	Residual Activity	%	82.0
	12233514	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	76.0	CHEMBL4376	Homo sapiens	Residual Activity	%	76.0
	12233515	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	91.0	CHEMBL4376	Homo sapiens	Residual Activity	%	91.0
	12233516	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	40.0	CHEMBL4376	Homo sapiens	Residual Activity	%	40.0
	12233517	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	91.0	CHEMBL4376	Homo sapiens	Residual Activity	%	91.0
	12233518	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	34.0	CHEMBL4376	Homo sapiens	Residual Activity	%	34.0
	12233519	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	85.0	CHEMBL4376	Homo sapiens	Residual Activity	%	85.0
	12233520	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	69.0	CHEMBL4376	Homo sapiens	Residual Activity	%	69.0
	12233521	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	60.0	CHEMBL4376	Homo sapiens	Residual Activity	%	60.0
	12233522	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	52.0	CHEMBL4376	Homo sapiens	Residual Activity	%	52.0
	12233523	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	87.0	CHEMBL4376	Homo sapiens	Residual Activity	%	87.0
	12233524	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	86.0	CHEMBL4376	Homo sapiens	Residual Activity	%	86.0
	12233525	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	93.0	CHEMBL4376	Homo sapiens	Residual Activity	%	93.0
	12233526	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	93.0	CHEMBL4376	Homo sapiens	Residual Activity	%	93.0
	12233527	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-1.0	CHEMBL4376	Homo sapiens	Residual Activity	%	-1.0
	12233528	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	67.0	CHEMBL4376	Homo sapiens	Residual Activity	%	67.0
	12233529	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	85.0	CHEMBL4376	Homo sapiens	Residual Activity	%	85.0
	12233530	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	-5.0	CHEMBL4376	Homo sapiens	Residual Activity	%	-5.0
	12233531	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	92.0	CHEMBL4376	Homo sapiens	Residual Activity	%	92.0
	12233532	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	62.0	CHEMBL4376	Homo sapiens	Residual Activity	%	62.0
	12233533	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	74.0	CHEMBL4376	Homo sapiens	Residual Activity	%	74.0
	12233534	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	41.0	CHEMBL4376	Homo sapiens	Residual Activity	%	41.0
	12233535	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	73.0	CHEMBL4376	Homo sapiens	Residual Activity	%	73.0
	12233536	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	86.0	CHEMBL4376	Homo sapiens	Residual Activity	%	86.0
	12233537	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	75.0	CHEMBL4376	Homo sapiens	Residual Activity	%	75.0
	12233538	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	95.0	CHEMBL4376	Homo sapiens	Residual Activity	%	95.0
	12233539	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	89.0	CHEMBL4376	Homo sapiens	Residual Activity	%	89.0
	12233540	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	11.0	CHEMBL4376	Homo sapiens	Residual Activity	%	11.0
	12233541	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	7.0	CHEMBL4376	Homo sapiens	Residual Activity	%	7.0
	12233542	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	97.0	CHEMBL4376	Homo sapiens	Residual Activity	%	97.0
	12233543	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	106.0	CHEMBL4376	Homo sapiens	Residual Activity	%	106.0
	12233544	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	92.0	CHEMBL4376	Homo sapiens	Residual Activity	%	92.0
	12233545	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	2.0	CHEMBL4376	Homo sapiens	Residual Activity	%	2.0
	12233546	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	30.0	CHEMBL4376	Homo sapiens	Residual Activity	%	30.0
	12233547	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	34.0	CHEMBL4376	Homo sapiens	Residual Activity	%	34.0
	12233548	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	16.0	CHEMBL4376	Homo sapiens	Residual Activity	%	16.0
	12233549	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	38.0	CHEMBL4376	Homo sapiens	Residual Activity	%	38.0
	12233550	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	95.0	CHEMBL4376	Homo sapiens	Residual Activity	%	95.0
	12233551	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	89.0	CHEMBL4376	Homo sapiens	Residual Activity	%	89.0
	12233552	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	95.0	CHEMBL4376	Homo sapiens	Residual Activity	%	95.0
	12233553	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	92.0	CHEMBL4376	Homo sapiens	Residual Activity	%	92.0
	12233554	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	76.0	CHEMBL4376	Homo sapiens	Residual Activity	%	76.0
	12233555	CHEMBL2219033	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	94.0	CHEMBL4376	Homo sapiens	Residual Activity	%	94.0
	12634301	CHEMBL2320042	Inhibition of DYRK2 (unknown origin)	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	IC50	nM	900.0	CHEMBL4376	Homo sapiens	IC50	nM	900.0
Not Determined	12649293	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccc(/C=N\O)cc2/C1=N\O		CHEMBL2321965		IC50			CHEMBL4376	Homo sapiens	IC50		
Not Determined	12649294	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccc(CO)cc2/C1=N\O		CHEMBL2321964		IC50			CHEMBL4376	Homo sapiens	IC50		
Not Determined	12649295	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	COC(=O)c1ccc2c(c1)NC(=C1\C(=O)Nc3c1cccc3C(F)(F)F)/C2=N/O		CHEMBL2321961		IC50			CHEMBL4376	Homo sapiens	IC50		
Not Determined	12649296	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2ccc(C(=O)O)cc2/C1=N\O		CHEMBL2321878		IC50			CHEMBL4376	Homo sapiens	IC50		
Not Determined	12649297	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccc(/C=N/O)cc2C1=O		CHEMBL2321948		IC50			CHEMBL4376	Homo sapiens	IC50		
	12649298	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2cc(C(=O)O)ccc2/C1=N\O		CHEMBL2321963	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649299	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	COC(=O)c1ccc2c(c1)NC(=C1\C(=O)Nc3c(Br)cccc31)/C2=N/O		CHEMBL2321960	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649300	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	COC(=O)c1ccc2c(c1)C(=N\O)/C(=C1/C(=O)N(C)c3c(Br)cccc31)N2		CHEMBL2321957	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649301	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2ccc(-c3nnn[nH]3)cc2/C1=N\O		CHEMBL2321956	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649302	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	N#Cc1ccc2c(c1)C(=N\O)/C(=C1/C(=O)Nc3c1cccc3C(F)(F)F)N2		CHEMBL2321955	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649303	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	COC(=O)c1ccc2c(c1)C(=N\O)/C(=C1/C(=O)Nc3c1cccc3C(F)(F)F)N2		CHEMBL2321954	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649304	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	COC(=O)c1ccc2c(c1)C(=N\O)/C(=C1/C(=O)Nc3c(Br)cccc31)N2		CHEMBL2321953	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649305	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	Cn1c(O)c(-c2[nH]c3ccccc3c2N=O)c2cccc(Br)c21		CHEMBL213454	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649306	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL2321949	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649307	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccc(CO)cc2C1=O		CHEMBL2321947	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649308	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2cc(C(=O)O)ccc2C1=O		CHEMBL2321946	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649309	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	COC(=O)c1ccc2c(c1)N/C(=C1\C(=O)Nc3c1cccc3C(F)(F)F)C2=O		CHEMBL2322019	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649310	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	COC(=O)c1ccc2c(c1)N/C(=C1\C(=O)Nc3c(Br)cccc31)C2=O		CHEMBL2321975	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649311	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	COC(=O)c1ccc2c(c1)C(=O)/C(=C1/C(=O)N(C)c3c(Br)cccc31)N2		CHEMBL2321973	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649312	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2ccc(-c3nnn[nH]3)cc2C1=O		CHEMBL2321972	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649313	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	N#Cc1ccc2c(c1)C(=O)/C(=C1/C(=O)Nc3c1cccc3C(F)(F)F)N2		CHEMBL2321971	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649314	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	COC(=O)c1ccc2c(c1)C(=O)/C(=C1/C(=O)Nc3c1cccc3C(F)(F)F)N2		CHEMBL2321970	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649315	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	COC(=O)c1ccc2c(c1)C(=O)/C(=C1/C(=O)Nc3c(Br)cccc31)N2		CHEMBL2321969	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649316	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	COC(=O)c1ccc2c(c1)C(=O)/C(=C1/C(=O)Nc3ccccc31)N2		CHEMBL2321967	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649317	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	Cn1c(O)c(C2=Nc3ccccc3C2=O)c2cccc(Br)c21		CHEMBL375870	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	12649318	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	COC(=O)c1ccc2c(c1)C(=N\O)/C(=C1/C(=O)Nc3ccccc31)N2		CHEMBL2321951	>	IC50	nM	1000.0	CHEMBL4376	Homo sapiens	IC50	uM	1.0
	12649319	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	IC50	nM	2100.0	CHEMBL4376	Homo sapiens	IC50	uM	2.1
	12649320	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2ccccc2/C1=C1/Nc2cc(C(=O)O)ccc2/C1=N\O		CHEMBL2321959	=	IC50	nM	1900.0	CHEMBL4376	Homo sapiens	IC50	uM	1.9
	12649321	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2ccccc2/C1=C1/Nc2ccc(C(=O)O)cc2C1=O		CHEMBL2321968	=	IC50	nM	1800.0	CHEMBL4376	Homo sapiens	IC50	uM	1.8
	12649322	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2c(Br)cccc2/C1=C1/Nc2cc(C(=O)O)ccc2/C1=N\O		CHEMBL2321962	=	IC50	nM	1700.0	CHEMBL4376	Homo sapiens	IC50	uM	1.7
	12649323	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2c(Br)cccc2/C1=C1/Nc2cc(C(=O)O)ccc2C1=O		CHEMBL2321945	=	IC50	nM	1300.0	CHEMBL4376	Homo sapiens	IC50	uM	1.3
	12649324	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=Nc1c(-c2c(O)[nH]c3c(Br)cccc23)[nH]c2ccccc12		CHEMBL373834	=	IC50	nM	1300.0	CHEMBL4376	Homo sapiens	IC50	uM	1.3
	12649325	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2ccccc2/C1=C1/Nc2cc(C(=O)O)ccc2C1=O		CHEMBL2321974	=	IC50	nM	1100.0	CHEMBL4376	Homo sapiens	IC50	uM	1.1
	12649326	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2ccccc2/C1=C1/Nc2ccc(C(=O)O)cc2/C1=N\O		CHEMBL2321952	=	IC50	nM	350.0	CHEMBL4376	Homo sapiens	IC50	uM	0.35
	12649327	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	CN1C(=O)/C(=C2\Nc3ccc(C(=O)O)cc3\C2=N/O)c2cccc(Br)c21		CHEMBL2321958	=	IC50	nM	220.0	CHEMBL4376	Homo sapiens	IC50	uM	0.22
	12649328	CHEMBL2329082	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP	B	O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccc(C(=O)O)cc2/C1=N\O		CHEMBL1233659	=	IC50	nM	130.0	CHEMBL4376	Homo sapiens	IC50	uM	0.13
	12673067	CHEMBL2345619	Inhibition of recombinant DYRK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	16.0	CHEMBL4376	Homo sapiens	Activity	%	16.0
	12673068	CHEMBL2345619	Inhibition of recombinant DYRK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	27.0	CHEMBL4376	Homo sapiens	Activity	%	27.0
	12693239	CHEMBL2343924	Inhibition of DYRK2 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	nM	10000.0
	12730872	CHEMBL2352472	Inhibition of DYRK2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	99.0	CHEMBL4376	Homo sapiens	Activity	%	99.0
	13342322	CHEMBL2394156	Competitive binding affinity to DYRK2 (unknown origin) assessed as enzyme remaining bound to anchored active-site ligand at 10 uM relative to control	B	Clc1ccc(CNc2nccc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1892019	<	Activity	%	30.0	CHEMBL4376	Homo sapiens	Activity	%	30.0
	13396888	CHEMBL2410940	Inhibition of Dyrk-2 (unknown origin) assessed as residual activity at 0.1 uM/L relative to control	B	CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1C		CHEMBL2409175	=	Activity	%	18.0	CHEMBL4376	Homo sapiens	Activity	%	18.0
	13856164	CHEMBL3097748	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using GRSRSRSRSRSR as substrate	B	NCCOCCOCCOc1ccc(NC2=N/C(=C\c3ccccc3)C(=O)N2)cc1		CHEMBL3092864	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	13856165	CHEMBL3097748	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using GRSRSRSRSRSR as substrate	B	NCCOCCOCCOCCOc1ccc(NC2=N/C(=C\c3ccc4c(c3)OCO4)C(=O)N2)cc1		CHEMBL3092863	=	IC50	nM	130.0	CHEMBL4376	Homo sapiens	IC50	uM	0.13
	13856166	CHEMBL3097748	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using GRSRSRSRSRSR as substrate	B	NCCOCCOCCOc1ccc(NC2=N/C(=C\c3ccc4c(c3)OCO4)C(=O)N2)cc1		CHEMBL3092862	=	IC50	nM	150.0	CHEMBL4376	Homo sapiens	IC50	uM	0.15
	13856167	CHEMBL3097748	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using GRSRSRSRSRSR as substrate	B	NCCOCCOCCO		CHEMBL3092861	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	13856168	CHEMBL3097748	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using GRSRSRSRSRSR as substrate	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccccc1		CHEMBL3092860	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	13856169	CHEMBL3097748	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using GRSRSRSRSRSR as substrate	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802358	=	IC50	nM	220.0	CHEMBL4376	Homo sapiens	IC50	uM	0.22
	13881588	CHEMBL3108557	Inhibition of human DYRK2 at 5 x 10'-8 M relative to control	B	Oc1ccc(-c2c[nH]c3ncc(-c4ccc(O)cc4O)cc23)cc1		CHEMBL3102951	<	Inhibition	%	50.0	CHEMBL4376	Homo sapiens	INH	%	50.0
	13954788	CHEMBL3132499	Inhibition of human DYRK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	30.0	CHEMBL4376	Homo sapiens	Activity	%	30.0
	13954800	CHEMBL3132499	Inhibition of human DYRK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	20.0	CHEMBL4376	Homo sapiens	Activity	%	20.0
	13954806	CHEMBL3132499	Inhibition of human DYRK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	11.0	CHEMBL4376	Homo sapiens	Activity	%	11.0
	14750921	CHEMBL3299313	Inhibition of DYRK2 (unknown origin)	B	COc1c(O)ccc2c(=O)c3c(O)cc4c(c3[nH]c12)C=CC(C)(C)O4		CHEMBL3297832	=	IC50	nM	1700.0	CHEMBL4376	Homo sapiens	IC50	uM	1.7
	15072429	CHEMBL3388064	Inhibition of DYRK2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	96.0	CHEMBL4376	Homo sapiens	Activity	%	96.0
	15095655	CHEMBL3382859	Inhibition of recombinant Dyrk2 (unknown origin) using KKISGRLSPIMTEQ-NH2 peptide substrate at 5 uM	B	O=C(c1cccc(O)c1)c1cc2cc(O)ccc2s1		CHEMBL3335350	=	Inhibition	%	49.0	CHEMBL4376	Homo sapiens	INH	%	49.0
	15095656	CHEMBL3382859	Inhibition of recombinant Dyrk2 (unknown origin) using KKISGRLSPIMTEQ-NH2 peptide substrate at 5 uM	B	O=C(c1cccc(O)c1)c1cc2cc(O)ccc2o1		CHEMBL3335351	=	Inhibition	%	34.0	CHEMBL4376	Homo sapiens	INH	%	34.0
	15095657	CHEMBL3382859	Inhibition of recombinant Dyrk2 (unknown origin) using KKISGRLSPIMTEQ-NH2 peptide substrate at 5 uM	B	O=C(c1cccc(O)c1)c1cc2cc(O)ccc2[nH]1		CHEMBL3335352	=	Inhibition	%	24.0	CHEMBL4376	Homo sapiens	INH	%	24.0
	15095658	CHEMBL3382859	Inhibition of recombinant Dyrk2 (unknown origin) using KKISGRLSPIMTEQ-NH2 peptide substrate at 5 uM	B	Cn1c(C(=O)c2cccc(O)c2)cc2cc(O)ccc21		CHEMBL3335353	=	Inhibition	%	25.0	CHEMBL4376	Homo sapiens	INH	%	25.0
	15095659	CHEMBL3382859	Inhibition of recombinant Dyrk2 (unknown origin) using KKISGRLSPIMTEQ-NH2 peptide substrate at 5 uM	B	O=C(c1ccc(O)cc1)c1cc2cc(O)ccc2s1		CHEMBL3335354	=	Inhibition	%	25.0	CHEMBL4376	Homo sapiens	INH	%	25.0
	15095660	CHEMBL3382859	Inhibition of recombinant Dyrk2 (unknown origin) using KKISGRLSPIMTEQ-NH2 peptide substrate at 5 uM	B	O=C(c1ccc(O)cc1)c1cc2cc(O)ccc2o1		CHEMBL3335355	=	Inhibition	%	38.0	CHEMBL4376	Homo sapiens	INH	%	38.0
	15095661	CHEMBL3382859	Inhibition of recombinant Dyrk2 (unknown origin) using KKISGRLSPIMTEQ-NH2 peptide substrate at 5 uM	B	Cc1ccc(C(=O)c2cc3cc(O)ccc3s2)cc1O		CHEMBL3335356	=	Inhibition	%	50.0	CHEMBL4376	Homo sapiens	INH	%	50.0
	15095662	CHEMBL3382859	Inhibition of recombinant Dyrk2 (unknown origin) using KKISGRLSPIMTEQ-NH2 peptide substrate at 5 uM	B	Cc1cc(C(=O)c2cc3cc(O)ccc3s2)ccc1O		CHEMBL3335357	=	Inhibition	%	8.0	CHEMBL4376	Homo sapiens	INH	%	8.0
	15095663	CHEMBL3382859	Inhibition of recombinant Dyrk2 (unknown origin) using KKISGRLSPIMTEQ-NH2 peptide substrate at 5 uM	B	O=C(c1cc2cc(O)ccc2s1)c1cc(O)ccc1F		CHEMBL3335358	=	Inhibition	%	30.0	CHEMBL4376	Homo sapiens	INH	%	30.0
	15095664	CHEMBL3382859	Inhibition of recombinant Dyrk2 (unknown origin) using KKISGRLSPIMTEQ-NH2 peptide substrate at 5 uM	B	O=C(c1ccc(F)c(O)c1)c1cc2cc(O)ccc2s1		CHEMBL3335359	=	Inhibition	%	27.0	CHEMBL4376	Homo sapiens	INH	%	27.0
	15095665	CHEMBL3382859	Inhibition of recombinant Dyrk2 (unknown origin) using KKISGRLSPIMTEQ-NH2 peptide substrate at 5 uM	B	N#Cc1cccc(C(=O)c2cc3cc(O)ccc3s2)c1		CHEMBL3335360	=	Inhibition	%	6.0	CHEMBL4376	Homo sapiens	INH	%	6.0
	15095666	CHEMBL3382859	Inhibition of recombinant Dyrk2 (unknown origin) using KKISGRLSPIMTEQ-NH2 peptide substrate at 5 uM	B	O=C(c1ccccc1)c1cc2cc(O)ccc2s1		CHEMBL3335361	=	Inhibition	%	37.0	CHEMBL4376	Homo sapiens	INH	%	37.0
	15095667	CHEMBL3382859	Inhibition of recombinant Dyrk2 (unknown origin) using KKISGRLSPIMTEQ-NH2 peptide substrate at 5 uM	B	O=C(c1cccc(O)c1)c1cc2ccccc2s1		CHEMBL3335362	=	Inhibition	%	15.0	CHEMBL4376	Homo sapiens	INH	%	15.0
	15095668	CHEMBL3382859	Inhibition of recombinant Dyrk2 (unknown origin) using KKISGRLSPIMTEQ-NH2 peptide substrate at 5 uM	B	CC(=O)c1cc2cc(O)ccc2s1		CHEMBL3335363	=	Inhibition	%	46.0	CHEMBL4376	Homo sapiens	INH	%	46.0
	15095669	CHEMBL3382859	Inhibition of recombinant Dyrk2 (unknown origin) using KKISGRLSPIMTEQ-NH2 peptide substrate at 5 uM	B	COc1cccc(C(=O)c2cc3cc(OC)ccc3s2)c1		CHEMBL3335364	=	Inhibition	%	-7.0	CHEMBL4376	Homo sapiens	INH	%	-7.0
	15095670	CHEMBL3382859	Inhibition of recombinant Dyrk2 (unknown origin) using KKISGRLSPIMTEQ-NH2 peptide substrate at 5 uM	B	COc1ccc2sc(C(=O)N(C)OC)cc2c1		CHEMBL3335365	=	Inhibition	%	41.0	CHEMBL4376	Homo sapiens	INH	%	41.0
	15104919	CHEMBL3386806	Inhibition of DYRK2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(C(=O)Nc2nc3cc4c(cc3[nH]2)OC(F)(F)O4)c1		CHEMBL3337846	=	Activity	%	8.3	CHEMBL4376	Homo sapiens	Activity	%	8.3
	15104920	CHEMBL3386806	Inhibition of DYRK2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	O=C(Nc1nc2cc3c(cc2[nH]1)OC(F)(F)O3)c1csc(NC(=O)c2ccccc2OC(F)(F)F)n1		CHEMBL3337845	=	Activity	%	27.0	CHEMBL4376	Homo sapiens	Activity	%	27.0
	15137739	CHEMBL3385166	Inhibition of DYRK2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	CO[C@H]1CC[C@H](NC(=O)c2n[nH]cc2NC(=O)c2ccccc2)CC1		CHEMBL3335124	=	Activity	%	3.0	CHEMBL4376	Homo sapiens	Activity	%	3.0
	15137740	CHEMBL3385166	Inhibition of DYRK2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(OC)c1C(=O)Nc1c[nH]nc1C(=O)N[C@H]1CC[C@H](OC)CC1		CHEMBL3335141	=	Activity	%	63.0	CHEMBL4376	Homo sapiens	Activity	%	63.0
	15137741	CHEMBL3385166	Inhibition of DYRK2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	CO[C@H]1CC[C@H](NC(=O)c2n[nH]cc2NC(=O)c2ccc(-c3ccccc3)o2)CC1		CHEMBL3335153	=	Activity	%	1.0	CHEMBL4376	Homo sapiens	Activity	%	1.0
	15137742	CHEMBL3385166	Inhibition of DYRK2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(OC)c1C(=O)Nc1c[nH]nc1C(=O)NCc1ccccc1		CHEMBL3335161	=	Activity	%	28.0	CHEMBL4376	Homo sapiens	Activity	%	28.0
	15235294	CHEMBL3424976	Inhibition of GST-tagged Dyrk2 (unknown origin) expressed in Escherichia coli using [33P]ATP[gammaP]/DYRKtide as substrate after 5 mins by liquid scintillation counting analysis	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	IC50	nM	2000.0	CHEMBL4376	Homo sapiens	IC50	uM	2.0
	15235394	CHEMBL3424987	Inhibition of Dyrk2 (unknown origin) at 1 uM	B	COc1cc(N2CCN(C)CC2)ccc1Nc1nccc(-c2c[nH]c3cnccc23)n1		CHEMBL3421967	=	Inhibition	%	92.0	CHEMBL4376	Homo sapiens	INH	%	92.0
	15235403	CHEMBL3424993	Inhibition of Dyrk2 (unknown origin)	B	COc1cc(N2CCN(C)CC2)ccc1Nc1nccc(-c2cn(C)c3cnccc23)n1	Outside typical range	CHEMBL3421968	=	IC50	nM	190000.0	CHEMBL4376	Homo sapiens	IC50	uM	190.0
	15251803	CHEMBL3430195	Inhibition of DYRK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	9.0	CHEMBL4376	Homo sapiens	Activity	%	9.0
	15251905	CHEMBL3430195	Inhibition of DYRK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	4.0	CHEMBL4376	Homo sapiens	Activity	%	4.0
	15251994	CHEMBL3430195	Inhibition of DYRK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	13.0	CHEMBL4376	Homo sapiens	Activity	%	13.0
	15252639	CHEMBL3430195	Inhibition of DYRK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	14.0	CHEMBL4376	Homo sapiens	Activity	%	14.0
	15252741	CHEMBL3430195	Inhibition of DYRK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	31.0	CHEMBL4376	Homo sapiens	Activity	%	31.0
	15252843	CHEMBL3430195	Inhibition of DYRK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	34.0	CHEMBL4376	Homo sapiens	Activity	%	34.0
	15253517	CHEMBL3430195	Inhibition of DYRK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	15.0	CHEMBL4376	Homo sapiens	Activity	%	15.0
	15253619	CHEMBL3430195	Inhibition of DYRK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	14.0	CHEMBL4376	Homo sapiens	Activity	%	14.0
	15253721	CHEMBL3430195	Inhibition of DYRK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	10.0	CHEMBL4376	Homo sapiens	Activity	%	10.0
	15254387	CHEMBL3430195	Inhibition of DYRK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	3.0	CHEMBL4376	Homo sapiens	Activity	%	3.0
	15254489	CHEMBL3430195	Inhibition of DYRK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	4.0	CHEMBL4376	Homo sapiens	Activity	%	4.0
	15254591	CHEMBL3430195	Inhibition of DYRK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	1.0	CHEMBL4376	Homo sapiens	Activity	%	1.0
	15255282	CHEMBL3430195	Inhibition of DYRK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	4.0	CHEMBL4376	Homo sapiens	Activity	%	4.0
	15255384	CHEMBL3430195	Inhibition of DYRK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	17.0	CHEMBL4376	Homo sapiens	Activity	%	17.0
	15255487	CHEMBL3430195	Inhibition of DYRK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	5.0	CHEMBL4376	Homo sapiens	Activity	%	5.0
	15256218	CHEMBL3430195	Inhibition of DYRK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	27.0	CHEMBL4376	Homo sapiens	Activity	%	27.0
	15643447	CHEMBL3591329	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using RS peptide as substrate	B	O=C(O)c1nc2ccccc2c2[nH]c3c(Cl)cccc3c12		CHEMBL3589660	=	IC50	nM	40.0	CHEMBL4376	Homo sapiens	IC50	uM	0.04
	15643448	CHEMBL3591329	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using RS peptide as substrate	B	O=C(O)c1nc2ccccc2c2[nH]c3c(Br)cccc3c12		CHEMBL3589661	=	IC50	nM	16.0	CHEMBL4376	Homo sapiens	IC50	uM	0.016
	15643449	CHEMBL3591329	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using RS peptide as substrate	B	O=C(O)c1nc2ccccc2c2[nH]c3c(I)cccc3c12		CHEMBL3589662	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	15643450	CHEMBL3591329	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using RS peptide as substrate	B	COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(F)c3[nH]c21		CHEMBL3589664	=	IC50	nM	8000.0	CHEMBL4376	Homo sapiens	IC50	uM	8.0
	15643451	CHEMBL3591329	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using RS peptide as substrate	B	COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(Cl)c3[nH]c21		CHEMBL3589665	=	IC50	nM	33.0	CHEMBL4376	Homo sapiens	IC50	uM	0.033
	15643452	CHEMBL3591329	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using RS peptide as substrate	B	COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(Br)c3[nH]c21		CHEMBL3589666	=	IC50	nM	23.0	CHEMBL4376	Homo sapiens	IC50	uM	0.023
	15643453	CHEMBL3591329	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using RS peptide as substrate	B	COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(I)c3[nH]c21		CHEMBL3589667	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	15643454	CHEMBL3591329	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using RS peptide as substrate	B	CCOc1ccc2c(c1)nc(C(=O)O)c1c3cccc(Cl)c3[nH]c21		CHEMBL3589669	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	15643455	CHEMBL3591329	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using RS peptide as substrate	B	O=C(O)c1nc2ccc(I)cc2c2[nH]c3c(F)cccc3c12		CHEMBL3589670	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	15643456	CHEMBL3591329	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using RS peptide as substrate	B	O=C(O)c1nc2ccc(I)cc2c2[nH]c3c(Cl)cccc3c12		CHEMBL3589671	=	IC50	nM	220.0	CHEMBL4376	Homo sapiens	IC50	uM	0.22
	15643457	CHEMBL3591329	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using RS peptide as substrate	B	O=C(O)c1nc2ccc(I)cc2c2[nH]c3c(Br)cccc3c12		CHEMBL3589672	=	IC50	nM	130.0	CHEMBL4376	Homo sapiens	IC50	uM	0.13
	15643458	CHEMBL3591329	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using RS peptide as substrate	B	COc1cccc(-c2ccc3nc(C(=O)O)c4c5cccc(Cl)c5[nH]c4c3c2)c1		CHEMBL3589674	=	IC50	nM	79.0	CHEMBL4376	Homo sapiens	IC50	uM	0.079
	15643459	CHEMBL3591329	Inhibition of human recombinant DYRK2 expressed in Escherichia coli using RS peptide as substrate	B	O=C(O)c1nc2cccnc2c2[nH]c3c(Br)cccc3c12		CHEMBL3589775	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	15654933	CHEMBL3599515	Inhibition of Dyrk2 (unknown origin) using Woodtide as substrate after 30 mins by P81 membrane assay in presence of [33P]-g-ATP	B	Nc1nccc(-c2cn(C(=O)N3CCOCC3)c3ccc(Br)cc23)n1		CHEMBL3133762	=	IC50	nM	1400.0	CHEMBL4376	Homo sapiens	IC50	uM	1.4
	15654988	CHEMBL3599539	Inhibition of human recombinant GST-fused Dyrk2 expressed in Escherichia coli using Woodtide as substrate after 15 mins by P81 membrane assay in presence of [33P]-g-ATP	B	c1cncc(-c2csc(-c3cncs3)c2)c1		CHEMBL3597991	=	IC50	nM	40.0	CHEMBL4376	Homo sapiens	IC50	uM	0.04
	15756032	CHEMBL3630353	Inhibition of DYRK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	37.4	CHEMBL4376	Homo sapiens	INH	%	37.4
	15757027	CHEMBL3630353	Inhibition of DYRK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	77.8	CHEMBL4376	Homo sapiens	INH	%	77.8
	15758690	CHEMBL3630353	Inhibition of DYRK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	11.52	CHEMBL4376	Homo sapiens	INH	%	11.52
	16381051	CHEMBL3736807	Inhibition of human recombinant DYRK2 by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4cccc(F)c4F)cc23)CC1		CHEMBL3735506	=	IC50	nM	530.0	CHEMBL4376	Homo sapiens	IC50	uM	0.53
	16431807	CHEMBL3749430	Inhibition of human DYRK2 using [RRRFRPASPLRGPPK] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	16495387	CHEMBL3778367	Inhibition of N-terminal His6-tagged recombinant human DYRK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-8.0	CHEMBL4376	Homo sapiens	Activity	%	-8.0
	16506350	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	O=C1NC(=O)/C(=C/c2ccc3nccnc3c2)S1		CHEMBL568150	=	IC50	nM	100.0	CHEMBL4376	Homo sapiens	IC50	uM	0.1
	16506351	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	uM	3.0
	16506352	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	O=C1NC(=S)N/C1=C\c1ccc2ncsc2c1		CHEMBL3775754	=	IC50	nM	1500.0	CHEMBL4376	Homo sapiens	IC50	uM	1.5
	16506353	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1		CHEMBL3774448	=	IC50	nM	60.0	CHEMBL4376	Homo sapiens	IC50	uM	0.06
	16506354	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	O=C1NC(=S)S/C1=C\c1ccc2ncsc2c1		CHEMBL3775393	=	IC50	nM	200.0	CHEMBL4376	Homo sapiens	IC50	uM	0.2
	16506355	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	O=C1NC(=S)S/C1=C\c1ccc2c(c1)CCO2		CHEMBL3774830	=	IC50	nM	1000.0	CHEMBL4376	Homo sapiens	IC50	uM	1.0
	16506356	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	COc1ccc(/C=C2/SC(=S)NC2=O)cc1		CHEMBL3775949	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	16506357	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	COc1ccc(/C=C2\NC(=O)SC2=O)cc1		CHEMBL3774667	=	IC50	nM	9200.0	CHEMBL4376	Homo sapiens	IC50	uM	9.2
Not Active	16506358	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	COc1ccc(/C=C2\NC(=O)NC2=O)cc1		CHEMBL38043		IC50			CHEMBL4376	Homo sapiens	IC50		
Not Determined	16506359	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	COc1ccc(/C=C2\CC(=O)NC2=O)cc1		CHEMBL571292		IC50			CHEMBL4376	Homo sapiens	IC50		
	16506360	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	CC1C/C(=C\c2ccc3ncsc3c2)C(=O)O1		CHEMBL3775538	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	16506361	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	O=C1OCC/C1=C\c1ccc2c(c1)OCO2		CHEMBL3193172	=	IC50	nM	990.0	CHEMBL4376	Homo sapiens	IC50	uM	0.99
	16506362	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	O=C1OCC/C1=C\c1ccc2c(c1)OCCO2		CHEMBL3774696	=	IC50	nM	2040.0	CHEMBL4376	Homo sapiens	IC50	uM	2.04
	16506363	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	O=C1OCC/C1=C\c1ccc2ncsc2c1		CHEMBL3774704	=	IC50	nM	60.0	CHEMBL4376	Homo sapiens	IC50	uM	0.06
	16506364	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	CC1C/C(=C\c2ccc3c(c2)CCO3)C(=O)O1		CHEMBL3775111	=	IC50	nM	430.0	CHEMBL4376	Homo sapiens	IC50	uM	0.43
	16506365	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	O=C1OCC/C1=C\c1ccc2c(c1)CCO2		CHEMBL3775821	=	IC50	nM	820.0	CHEMBL4376	Homo sapiens	IC50	uM	0.82
Not Active	16506366	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	COc1ccc(/C=C2\CC(C)OC2=O)cc1		CHEMBL3775969		IC50			CHEMBL4376	Homo sapiens	IC50		
	16506367	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	COc1ccc(/C=C2\CCCOC2=O)cc1		CHEMBL3774736	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	16506368	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	O=C1OCC/C1=C\c1ccc2c(c1)CCCO2		CHEMBL3775193	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	16506369	CHEMBL3778245	Inhibition of recombinant human N-terminal GST-tagged DYRK2 expressed in Escherichia coli BL21(DE3) cells using KKISGRLSPIMTEQ-NH2 as substrate incubated for 15 mins in presence of [gamma-32P]ATP	B	COc1ccc(/C=C2\CCOC2=O)cc1		CHEMBL1612487	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	16508156	CHEMBL3778367	Inhibition of N-terminal His6-tagged recombinant human DYRK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-3.0	CHEMBL4376	Homo sapiens	Activity	%	-3.0
	16509133	CHEMBL3778367	Inhibition of N-terminal His6-tagged recombinant human DYRK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-7.0	CHEMBL4376	Homo sapiens	Activity	%	-7.0
Not Active	16581012	CHEMBL3802150	Inhibition of human DYRK2 by radiometric assay	B	CC(C)c1nn(C)cc1-c1nc2cc(Br)cnc2[nH]1		CHEMBL3613594		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
	16606697	CHEMBL3810706	Inhibition of Dyrk2 (unknown origin) by quantitative PCR	B	CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1N(C)CCN		CHEMBL3103192	=	IC50	nM	40.0	CHEMBL4376	Homo sapiens	IC50	uM	0.04
	16606705	CHEMBL3810698	Inhibition of Dyrk2 (unknown origin) 0.1 uM by quantitative PCR	B	CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1N(C)CCN		CHEMBL3103192	>	Inhibition	%	50.0	CHEMBL4376	Homo sapiens	INH	%	50.0
	16614453	CHEMBL3817319	Inhibition of human DYRK2 at 1 uM using [RRRFRPASPLRGPPK] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	1.0	CHEMBL4376	Homo sapiens	INH	%	1.0
	16654123	CHEMBL3829291	Inhibition of human DYRK2 (3 to 528 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	84.0	CHEMBL4376	Homo sapiens	Activity	%	84.0
Not Active	18006242	CHEMBL4003313	Inhibition of human recombinant GST-fused DYRK2 expressed in Escherichia coli at 0.003 to 10 uM using RS peptide as substrate after 30 mins in presence of [gamma-33P]ATP by scintillation counting method	B	ClC[N@@+]12CCCC/C=C\CC[C@@H]3C=C4CN(CCCC/C=C\CC[C@H](C1)[C@H]4CC2)C3		CHEMBL4064546		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
Active	18021263	CHEMBL4005961	Inhibition of full-length human DYRK2 (1 to 528 amino acid residues) expressed in mammalian expression system at 1 uM in presence of [gamma-33P]-ATP by KINOMEscan assay	B	Cc1nc(NC2CCCC2)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cn2)n1		CHEMBL4081497		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
	18037117	CHEMBL4008939	Inhibition of full-length recombinant human GST-tagged DYRK2 expressed in Escherichia coli using woodtide as substrate after 30 mins in presence of [gamma-33P]ATP	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	IC50	nM	2000.0	CHEMBL4376	Homo sapiens	IC50	uM	2.0
Active	18037180	CHEMBL4008911	Stabilization of DYRK2 in human U251 cell lysate at 10 uM preincubated for 1 hr followed by incubation at 40 to 70 degreeC for 3 mins by cellular thermal shift assay	B	Nc1ccc(-c2cnc3[nH]cc(-c4ccc(O)cc4)c3c2)cc1		CHEMBL4096575		Activity			CHEMBL4376	Homo sapiens	Activity		
	18037262	CHEMBL4008894	Inhibition of DYRK2 (unknown origin) using woodtide as substrate after 40 mins in presence of [gamma-33P]ATP by microbeta scintillation counting	B	O=C(Nc1cccc(O)c1)c1c[nH]c2ncc(-c3ccc(O)cc3)cc12		CHEMBL4097535	>	IC50	nM	1000.0	CHEMBL4376	Homo sapiens	IC50	nM	1000.0
	18037263	CHEMBL4008894	Inhibition of DYRK2 (unknown origin) using woodtide as substrate after 40 mins in presence of [gamma-33P]ATP by microbeta scintillation counting	B	O=C(Nc1ccc(O)cc1)c1c[nH]c2ncc(-c3ccc(O)cc3)cc12		CHEMBL4070354	>	IC50	nM	1000.0	CHEMBL4376	Homo sapiens	IC50	nM	1000.0
	18037264	CHEMBL4008894	Inhibition of DYRK2 (unknown origin) using woodtide as substrate after 40 mins in presence of [gamma-33P]ATP by microbeta scintillation counting	B	O=C(Nc1cccc(O)c1)c1cnc2[nH]cc(-c3ccc(O)cc3)c2c1		CHEMBL4105239	=	IC50	nM	847.0	CHEMBL4376	Homo sapiens	IC50	nM	847.0
	18037265	CHEMBL4008894	Inhibition of DYRK2 (unknown origin) using woodtide as substrate after 40 mins in presence of [gamma-33P]ATP by microbeta scintillation counting	B	O=C(Nc1ccc(O)cc1)c1cnc2[nH]cc(-c3ccc(O)cc3)c2c1		CHEMBL4080994	>	IC50	nM	1000.0	CHEMBL4376	Homo sapiens	IC50	nM	1000.0
	18037266	CHEMBL4008894	Inhibition of DYRK2 (unknown origin) using woodtide as substrate after 40 mins in presence of [gamma-33P]ATP by microbeta scintillation counting	B	NC(=O)Nc1ccc(-c2cnc3[nH]cc(-c4ccc(O)cc4)c3c2)cc1		CHEMBL4067661	=	IC50	nM	476.0	CHEMBL4376	Homo sapiens	IC50	nM	476.0
	18037267	CHEMBL4008894	Inhibition of DYRK2 (unknown origin) using woodtide as substrate after 40 mins in presence of [gamma-33P]ATP by microbeta scintillation counting	B	CS(=O)(=O)Nc1ccc(-c2cnc3[nH]cc(-c4ccc(O)cc4)c3c2)cc1		CHEMBL4088888	=	IC50	nM	724.0	CHEMBL4376	Homo sapiens	IC50	nM	724.0
	18037268	CHEMBL4008894	Inhibition of DYRK2 (unknown origin) using woodtide as substrate after 40 mins in presence of [gamma-33P]ATP by microbeta scintillation counting	B	CC(=O)Nc1ccc(-c2cnc3[nH]cc(-c4ccc(O)cc4)c3c2)cc1		CHEMBL4078550	=	IC50	nM	536.0	CHEMBL4376	Homo sapiens	IC50	nM	536.0
	18037269	CHEMBL4008894	Inhibition of DYRK2 (unknown origin) using woodtide as substrate after 40 mins in presence of [gamma-33P]ATP by microbeta scintillation counting	B	Nc1ccc(-c2cnc3[nH]cc(-c4ccc(O)cc4)c3c2)cc1		CHEMBL4096575	=	IC50	nM	567.0	CHEMBL4376	Homo sapiens	IC50	nM	567.0
	18037270	CHEMBL4008894	Inhibition of DYRK2 (unknown origin) using woodtide as substrate after 40 mins in presence of [gamma-33P]ATP by microbeta scintillation counting	B	Oc1ccc(-c2c[nH]c3ncc(-c4ccc(-c5nnn[nH]5)cc4)cc23)cc1		CHEMBL4087125	=	IC50	nM	408.0	CHEMBL4376	Homo sapiens	IC50	nM	408.0
	18037271	CHEMBL4008894	Inhibition of DYRK2 (unknown origin) using woodtide as substrate after 40 mins in presence of [gamma-33P]ATP by microbeta scintillation counting	B	Oc1ccc(-c2c[nH]c3ncc(-c4ccc5[nH]ccc5c4)cc23)cc1		CHEMBL4065701	=	IC50	nM	644.0	CHEMBL4376	Homo sapiens	IC50	nM	644.0
	18037272	CHEMBL4008894	Inhibition of DYRK2 (unknown origin) using woodtide as substrate after 40 mins in presence of [gamma-33P]ATP by microbeta scintillation counting	B	O=[N+]([O-])c1ccc(-c2cnc3[nH]cc(-c4ccc(O)cc4)c3c2)cc1		CHEMBL4075959	>	IC50	nM	1000.0	CHEMBL4376	Homo sapiens	IC50	nM	1000.0
	18037273	CHEMBL4008894	Inhibition of DYRK2 (unknown origin) using woodtide as substrate after 40 mins in presence of [gamma-33P]ATP by microbeta scintillation counting	B	Nc1ccc(-c2c[nH]c3ncc(-c4ccc(O)cc4)cc23)cc1		CHEMBL4092345	>	IC50	nM	1000.0	CHEMBL4376	Homo sapiens	IC50	nM	1000.0
	18037274	CHEMBL4008894	Inhibition of DYRK2 (unknown origin) using woodtide as substrate after 40 mins in presence of [gamma-33P]ATP by microbeta scintillation counting	B	Oc1ccc(-c2cnc3[nH]cc(-c4ccc(-c5nnn[nH]5)cc4)c3c2)cc1		CHEMBL4102553	=	IC50	nM	416.0	CHEMBL4376	Homo sapiens	IC50	nM	416.0
	18037275	CHEMBL4008894	Inhibition of DYRK2 (unknown origin) using woodtide as substrate after 40 mins in presence of [gamma-33P]ATP by microbeta scintillation counting	B	Oc1ccc(-c2cnc3[nH]cc(-c4ccc5[nH]ccc5c4)c3c2)cc1		CHEMBL4084605	=	IC50	nM	571.0	CHEMBL4376	Homo sapiens	IC50	nM	571.0
	18037276	CHEMBL4008894	Inhibition of DYRK2 (unknown origin) using woodtide as substrate after 40 mins in presence of [gamma-33P]ATP by microbeta scintillation counting	B	Oc1ccc(-c2ccc3[nH]nc(-c4ccc(O)cc4)c3c2)cc1		CHEMBL4083661	>	IC50	nM	1000.0	CHEMBL4376	Homo sapiens	IC50	nM	1000.0
	18037277	CHEMBL4008894	Inhibition of DYRK2 (unknown origin) using woodtide as substrate after 40 mins in presence of [gamma-33P]ATP by microbeta scintillation counting	B	Oc1ccc(-c2ccc3[nH]cc(-c4ccc(O)cc4)c3c2)cc1		CHEMBL4073972	>	IC50	nM	1000.0	CHEMBL4376	Homo sapiens	IC50	nM	1000.0
	18037278	CHEMBL4008894	Inhibition of DYRK2 (unknown origin) using woodtide as substrate after 40 mins in presence of [gamma-33P]ATP by microbeta scintillation counting	B	Oc1ccc(-c2cnc3[nH]cc(-c4ccc(O)cc4)c3c2)cc1		CHEMBL3102950	=	IC50	nM	166.0	CHEMBL4376	Homo sapiens	IC50	nM	166.0
	18064941	CHEMBL4014119	Inhibition of human DYRK2	B	C[C@@H](c1ccc(F)cc1)n1nnc2cnc3ccc(-c4ccc5ocnc5c4)cc3c21		CHEMBL4083249	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	nM	10000.0
	18114395	CHEMBL4025099	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	97.0	CHEMBL4376	Homo sapiens	Activity	%	97.0
	18135435	CHEMBL4029688	Inhibition of full length wild type human DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	O=C1NC(=S)S/C1=C\c1cscn1		CHEMBL4061891	=	Activity	%	15.0	CHEMBL4376	Homo sapiens	Activity	%	15.0
	18135452	CHEMBL4029688	Inhibition of full length wild type human DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	O=C1NC(=S)S/C1=C\c1csc(-c2ccc(C(F)(F)F)cc2)n1		CHEMBL4075290	=	Activity	%	95.0	CHEMBL4376	Homo sapiens	Activity	%	95.0
	18135469	CHEMBL4029688	Inhibition of full length wild type human DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	O=C1NC(=S)N2C(=O)C3Nc4cc(Cl)cc(Cl)c4C3C=C12		CHEMBL4096175	=	Activity	%	117.0	CHEMBL4376	Homo sapiens	Activity	%	117.0
	18135486	CHEMBL4029688	Inhibition of full length wild type human DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	N=C1NC(=O)/C(=C/c2csc(-c3ccc(C(F)(F)F)cc3)n2)S1		CHEMBL4064860	=	Activity	%	87.0	CHEMBL4376	Homo sapiens	Activity	%	87.0
	18193239	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	Fc1ccc2ncc(-c3cccc(C(F)(F)F)c3)n2n1		CHEMBL4099677	=	IC50	nM	6300.0	CHEMBL4376	Homo sapiens	IC50	uM	6.3
	18193240	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	O=Cc1cccc(-c2cnc3ccc(F)nn23)c1		CHEMBL4081668	=	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	uM	3.0
	18193241	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	Clc1ccc2ncc(-c3ccc4[nH]ccc4c3)n2n1		CHEMBL4091942	=	IC50	nM	610.0	CHEMBL4376	Homo sapiens	IC50	uM	0.61
	18193242	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	Clc1ccc2ncc(-c3cccnc3)n2n1		CHEMBL4076906	=	IC50	nM	11000.0	CHEMBL4376	Homo sapiens	IC50	uM	11.0
	18193243	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	FC(F)(F)c1cccc(-c2cnc3ccc(Cl)nn23)c1		CHEMBL4070065	=	IC50	nM	480.0	CHEMBL4376	Homo sapiens	IC50	uM	0.48
	18193244	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	FC(F)(F)c1cccc(/C=C/c2cnc3ccc(Cl)nn23)c1		CHEMBL4097256	=	IC50	nM	7100.0	CHEMBL4376	Homo sapiens	IC50	uM	7.1
	18193245	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	Clc1cccc(-c2cnc3ccc(Cl)nn23)c1		CHEMBL4061394	=	IC50	nM	1300.0	CHEMBL4376	Homo sapiens	IC50	uM	1.3
	18193246	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	Nc1cccc(-c2cnc3ccc(Cl)nn23)c1		CHEMBL4089542	=	IC50	nM	7000.0	CHEMBL4376	Homo sapiens	IC50	uM	7.0
	18193247	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	Nc1ccc(Cl)cc1-c1cnc2ccc(Cl)nn12		CHEMBL4087260	=	IC50	nM	19000.0	CHEMBL4376	Homo sapiens	IC50	uM	19.0
	18193248	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	O=Cc1cccc(-c2cnc3ccc(Cl)nn23)c1		CHEMBL4076448	=	IC50	nM	820.0	CHEMBL4376	Homo sapiens	IC50	uM	0.82
	18193249	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	O/N=C/c1cccc(-c2cnc3ccc(Cl)nn23)c1		CHEMBL4077159	=	IC50	nM	730.0	CHEMBL4376	Homo sapiens	IC50	uM	0.73
	18193250	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)NC(=O)c1cccc(-c2cnc3ccc(Cl)nn23)c1		CHEMBL4093231	=	IC50	nM	3100.0	CHEMBL4376	Homo sapiens	IC50	uM	3.1
	18193251	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@H](CO)NC(=O)c1cccc(-c2cnc3ccc(Cl)nn23)c1		CHEMBL4075820	=	IC50	nM	8200.0	CHEMBL4376	Homo sapiens	IC50	uM	8.2
	18193252	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	FC(F)(F)c1ccc(-c2cnc3ccc(Cl)nn23)cc1		CHEMBL4085467	=	IC50	nM	8600.0	CHEMBL4376	Homo sapiens	IC50	uM	8.6
	18193253	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3ccc4[nH]ccc4c3)n2n1		CHEMBL4090770	=	IC50	nM	380.0	CHEMBL4376	Homo sapiens	IC50	uM	0.38
	18193254	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3cc4ccccc4[nH]3)n2n1		CHEMBL4062820	=	IC50	nM	210.0	CHEMBL4376	Homo sapiens	IC50	uM	0.21
	18193255	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3cc4cc(Br)ccc4[nH]3)n2n1		CHEMBL4082981	=	IC50	nM	1200.0	CHEMBL4376	Homo sapiens	IC50	uM	1.2
	18193256	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3cccnc3)n2n1		CHEMBL4100956	=	IC50	nM	600.0	CHEMBL4376	Homo sapiens	IC50	uM	0.6
	18193257	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(C(F)(F)F)c3)n2n1		CHEMBL4086402	=	IC50	nM	180.0	CHEMBL4376	Homo sapiens	IC50	uM	0.18
	18193258	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3ccc(C(F)(F)F)cc3)n2n1		CHEMBL4104296	=	IC50	nM	780.0	CHEMBL4376	Homo sapiens	IC50	uM	0.78
	18193259	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(/C=C/c3cccc(C(F)(F)F)c3)n2n1		CHEMBL4080844	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	18193260	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(Cl)c3)n2n1		CHEMBL4105084	=	IC50	nM	50.0	CHEMBL4376	Homo sapiens	IC50	uM	0.05
	18193261	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(N)c3)n2n1		CHEMBL4088717	=	IC50	nM	1900.0	CHEMBL4376	Homo sapiens	IC50	uM	1.9
	18193262	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3cc(Cl)ccc3N)n2n1		CHEMBL4067477	=	IC50	nM	21000.0	CHEMBL4376	Homo sapiens	IC50	uM	21.0
	18193263	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(NC(C)=O)c3)n2n1		CHEMBL4061526	=	IC50	nM	43.0	CHEMBL4376	Homo sapiens	IC50	uM	0.043
	18193264	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(SC)c3)n2n1		CHEMBL4089652	=	IC50	nM	120.0	CHEMBL4376	Homo sapiens	IC50	uM	0.12
	18193265	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(S(C)(=O)=O)c3)n2n1		CHEMBL4070189	=	IC50	nM	82.0	CHEMBL4376	Homo sapiens	IC50	uM	0.082
	18193266	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3ccsc3)n2n1		CHEMBL4097368	=	IC50	nM	600.0	CHEMBL4376	Homo sapiens	IC50	uM	0.6
	18193267	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3ccnc(SC)n3)n2n1		CHEMBL4092047	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	18193268	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3ccnc([S+](C)[O-])n3)n2n1		CHEMBL4071234	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	18193269	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3ccnc(S(C)(=O)=O)n3)n2n1		CHEMBL4062683	=	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	18193270	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3ccnc(N)n3)n2n1		CHEMBL4084364	=	IC50	nM	400.0	CHEMBL4376	Homo sapiens	IC50	uM	0.4
	18193271	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CCOC(=O)c1cccc(-c2cnc3ccc(N[C@@H](CC)CO)nn23)c1		CHEMBL4071322	=	IC50	nM	48.0	CHEMBL4376	Homo sapiens	IC50	uM	0.048
	18193272	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(C(=O)O)c3)n2n1		CHEMBL4092117	=	IC50	nM	1600.0	CHEMBL4376	Homo sapiens	IC50	uM	1.6
	18193273	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(C=O)c3)n2n1		CHEMBL4093104	=	IC50	nM	63.0	CHEMBL4376	Homo sapiens	IC50	uM	0.063
	18193274	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(/C=N/O)c3)n2n1		CHEMBL4065432	=	IC50	nM	390.0	CHEMBL4376	Homo sapiens	IC50	uM	0.39
	18193275	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)/N=C/c1cccc(-c2cnc3ccc(N[C@@H](CC)CO)nn23)c1		CHEMBL4070227	=	IC50	nM	500.0	CHEMBL4376	Homo sapiens	IC50	uM	0.5
	18193276	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)NC(=O)c1cccc(-c2cnc3ccc(N[C@@H](CC)CO)nn23)c1		CHEMBL4071413	=	IC50	nM	2500.0	CHEMBL4376	Homo sapiens	IC50	uM	2.5
	18193277	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)Nc1ccc2ncc(-c3cccc(C(=O)N[C@H](CC)CO)c3)n2n1		CHEMBL4098237	=	IC50	nM	4500.0	CHEMBL4376	Homo sapiens	IC50	uM	4.5
	18193278	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC(C)[C@@H](CO)Nc1ccc2ncc(-c3cccnc3)n2n1		CHEMBL4074132	=	IC50	nM	190.0	CHEMBL4376	Homo sapiens	IC50	uM	0.19
	18193279	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CCOC(=O)Nc1ccc2ncc(-c3cccnc3)n2n1		CHEMBL4083948	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	18193280	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CCOC(=O)Nc1ccc2ncc(-c3cccc(Cl)c3)n2n1		CHEMBL4075509	=	IC50	nM	1600.0	CHEMBL4376	Homo sapiens	IC50	uM	1.6
	18193281	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC(=O)Nc1cccc(Nc2ccc3ncc(-c4cccc(Cl)c4)n3n2)c1		CHEMBL4074499	=	IC50	nM	110.0	CHEMBL4376	Homo sapiens	IC50	uM	0.11
	18193282	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	OCCN1CCN(c2ccc3ncc(-c4cccc(Cl)c4)n3n2)CC1		CHEMBL4071013	=	IC50	nM	440.0	CHEMBL4376	Homo sapiens	IC50	uM	0.44
	18193283	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	Clc1cccc(-c2cnc3ccc(N4CCC(N5CCCCC5)CC4)nn23)c1		CHEMBL4064988	=	IC50	nM	3200.0	CHEMBL4376	Homo sapiens	IC50	uM	3.2
	18193284	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)N(C(C)=O)c1ccc2ncc(-c3cccc(NC(C)=O)c3)n2n1		CHEMBL4092673	=	IC50	nM	120.0	CHEMBL4376	Homo sapiens	IC50	uM	0.12
	18193285	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC(=O)Nc1cccc(Nc2ccc3ncc(-c4cccc(NC(C)=O)c4)n3n2)c1		CHEMBL4102871	=	IC50	nM	40.0	CHEMBL4376	Homo sapiens	IC50	uM	0.04
	18193286	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@H](CO)/N=C/c1cccc(-c2cnc3ccc(N[C@H](CC)CO)nn23)c1		CHEMBL4084919	=	IC50	nM	380.0	CHEMBL4376	Homo sapiens	IC50	uM	0.38
	18193287	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@H](CO)NC(=O)c1cccc(-c2cnc3ccc(N[C@H](CC)CO)nn23)c1		CHEMBL4076663	=	IC50	nM	7200.0	CHEMBL4376	Homo sapiens	IC50	uM	7.2
	18193288	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CC[C@@H](CO)NC(=O)c1cccc(-c2cnc3ccc(N[C@H](CC)CO)nn23)c1		CHEMBL4079343	=	IC50	nM	3900.0	CHEMBL4376	Homo sapiens	IC50	uM	3.9
	18193289	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	COc1ccc2ncc(-c3ccc4[nH]ccc4c3)n2n1		CHEMBL4079347	=	IC50	nM	320.0	CHEMBL4376	Homo sapiens	IC50	uM	0.32
	18193290	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	COc1ccc2ncc(-c3cccc(C(F)(F)F)c3)n2n1		CHEMBL4098107	=	IC50	nM	1200.0	CHEMBL4376	Homo sapiens	IC50	uM	1.2
	18193291	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	COc1ccc2ncc(-c3ccc(C(F)(F)F)cc3)n2n1		CHEMBL4063254	=	IC50	nM	2500.0	CHEMBL4376	Homo sapiens	IC50	uM	2.5
	18193292	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	COc1ccc2ncc(/C=C/c3cccc(C(F)(F)F)c3)n2n1		CHEMBL4091127	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	18193293	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	COc1ccc2ncc(-c3ccnc(SC)n3)n2n1		CHEMBL4067420	=	IC50	nM	1200.0	CHEMBL4376	Homo sapiens	IC50	uM	1.2
	18193294	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	COc1ccc2ncc(-c3ccnc([S+](C)[O-])n3)n2n1		CHEMBL4062568	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	18193295	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	COc1ccc2ncc(-c3ccnc(N)n3)n2n1		CHEMBL4077125	=	IC50	nM	1400.0	CHEMBL4376	Homo sapiens	IC50	uM	1.4
	18193296	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	COc1ccc2ncc(-c3cccc(/C=N/O)c3)n2n1		CHEMBL4072506	=	IC50	nM	170.0	CHEMBL4376	Homo sapiens	IC50	uM	0.17
	18193297	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CSc1ccc2ncc(-c3ccc4[nH]ccc4c3)n2n1		CHEMBL4090223	=	IC50	nM	440.0	CHEMBL4376	Homo sapiens	IC50	uM	0.44
	18193298	CHEMBL4041965	Inhibition of GST tagged recombinant human DYRK2 expressed in Escherichia coli using using woodtide as substrate after 30 mins by [gamma-33P]ATP based scintillation counting analysis	B	CSc1ccc2ncc(-c3cccc(C(F)(F)F)c3)n2n1		CHEMBL4069158	=	IC50	nM	1800.0	CHEMBL4376	Homo sapiens	IC50	uM	1.8
	18203623	CHEMBL4043910	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL4376	Homo sapiens	Activity	%	100.0
	18225353	CHEMBL4048702	Inhibition of DYRK2 (unknown origin) at 1 uM relative to control	B	CC1(C)NC(=O)c2c(Cl)cc(Nc3cc(N)ncn3)c(=O)n21		CHEMBL4067557	=	Inhibition	%	67.0	CHEMBL4376	Homo sapiens	INH	%	67.0
	18225377	CHEMBL4048702	Inhibition of DYRK2 (unknown origin) at 1 uM relative to control	B	Nc1cc(Nc2cc(Cl)c3n(c2=O)C2(CCCC2)NC3=O)ncn1		CHEMBL4094975	=	Inhibition	%	81.0	CHEMBL4376	Homo sapiens	INH	%	81.0
	18232216	CHEMBL4050290	Inhibition of human DYRK2 assessed as residual activity at 1 uM in presence of 33P-ATP by filter-binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	5.0	CHEMBL4376	Homo sapiens	Activity	%	5.0
	18253789	CHEMBL4055179	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL4376	Homo sapiens	Activity	%	100.0
	18253790	CHEMBL4055179	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL4376	Homo sapiens	Activity	%	100.0
	18265830	CHEMBL4057280	Inhibition of DYRK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	8.0	CHEMBL4376	Homo sapiens	INH	%	8.0
	18266026	CHEMBL4057476	Inhibition of DYRK2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	3.3	CHEMBL4376	Homo sapiens	INH	%	3.3
	18282868	CHEMBL4120453	Inhibition of DYRK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	8.0	CHEMBL4376	Homo sapiens	INH	%	8.0
	18283082	CHEMBL4120667	Inhibition of DYRK2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-0.7	CHEMBL4376	Homo sapiens	INH	%	-0.7
	18283297	CHEMBL4120882	Inhibition of DYRK2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	4.7	CHEMBL4376	Homo sapiens	INH	%	4.7
	18407907	CHEMBL4151463	Inhibition of human DYRK2 expressed in mammalian expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(CO)nccc12		CHEMBL4066450	=	Activity	%	6.5	CHEMBL4376	Homo sapiens	Activity	%	6.5
	18407948	CHEMBL4151463	Inhibition of human DYRK2 expressed in mammalian expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(C)nc(CO)cc12		CHEMBL4173266	=	Activity	%	4.1	CHEMBL4376	Homo sapiens	Activity	%	4.1
	18407993	CHEMBL4151463	Inhibition of human DYRK2 expressed in mammalian expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	3.2	CHEMBL4376	Homo sapiens	Activity	%	3.2
	18408143	CHEMBL4151507	Inhibition of N-terminal GST tagged recombinant full-length human DYRK2 expressed in Escherichia coli at 1 uM	B	Cn1cc(-c2ccc(N(C(=O)NCc3ccccc3)[C@H]3CC[C@H](Nc4ccc(C#N)cn4)CC3)cc2)ccc1=O		CHEMBL4160662	>=	Inhibition	%	80.0	CHEMBL4376	Homo sapiens	INH	%	80.0
	18440165	CHEMBL4156989	Binding affinity to wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	97.0	CHEMBL4376	Homo sapiens	Activity	%	97.0
	18449835	CHEMBL4178072	Inhibition of human DYRK2 (3 to 528 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	116.0	CHEMBL4376	Homo sapiens	Activity	%	116.0
	18463743	CHEMBL4181159	Inhibition of recombinant human His6-tagged DYRK2 expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	1.0	CHEMBL4376	Homo sapiens	INH	%	1.0
	18484605	CHEMBL4185768	Binding affinity to wild-type human full length DYRK2 (M1 to S528 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL4376	Homo sapiens	Activity	%	100.0
	18485016	CHEMBL4185768	Binding affinity to wild-type human full length DYRK2 (M1 to S528 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	92.0	CHEMBL4376	Homo sapiens	Activity	%	92.0
	18507816	CHEMBL4190946	Inhibition of recombinant full-length human DYRK2 at 1 uM using casein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-10.0	CHEMBL4376	Homo sapiens	INH	%	-10.0
	18653675	CHEMBL4230066	Inhibition of DYRK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	11.0	CHEMBL4376	Homo sapiens	INH	%	11.0
	18653676	CHEMBL4230066	Inhibition of DYRK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	-3.0	CHEMBL4376	Homo sapiens	INH	%	-3.0
	18655567	CHEMBL4230668	Binding affinity to wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL4376	Homo sapiens	Activity	%	100.0
	18674634	CHEMBL4235345	Inhibition of DYRK2 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL4376	Homo sapiens	Ki	nM	2000.0
	18674635	CHEMBL4235345	Inhibition of DYRK2 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL4376	Homo sapiens	Ki	nM	2000.0
Not Determined	18674636	CHEMBL4235345	Inhibition of DYRK2 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL4376	Homo sapiens	Ki		
	18728152	CHEMBL4259476	Inhibition of recombinant GST-tagged Dyrk2 (unknown origin) expressed in Escherichia coli BL21 (DE3) at 0.5 uM using KKISGRLSPIMTEQ-NH2 peptide as substrate in presence of [gamma-32P]-ATP relative to control	B	O=C(Nc1ccccc1)Nc1nc2ccc(O)cc2s1		CHEMBL4285513	=	Inhibition	%	40.4	CHEMBL4376	Homo sapiens	INH	%	40.4
	18728153	CHEMBL4259476	Inhibition of recombinant GST-tagged Dyrk2 (unknown origin) expressed in Escherichia coli BL21 (DE3) at 0.5 uM using KKISGRLSPIMTEQ-NH2 peptide as substrate in presence of [gamma-32P]-ATP relative to control	B	O=C(Nc1nc2ccc(O)cc2s1)Oc1ccccc1		CHEMBL4278195	=	Inhibition	%	18.6	CHEMBL4376	Homo sapiens	INH	%	18.6
	18728154	CHEMBL4259476	Inhibition of recombinant GST-tagged Dyrk2 (unknown origin) expressed in Escherichia coli BL21 (DE3) at 0.5 uM using KKISGRLSPIMTEQ-NH2 peptide as substrate in presence of [gamma-32P]-ATP relative to control	B	O=C(Cc1cccc(O)c1)Nc1nc2ccc(O)cc2s1		CHEMBL4288885	=	Inhibition	%	50.1	CHEMBL4376	Homo sapiens	INH	%	50.1
	18728155	CHEMBL4259476	Inhibition of recombinant GST-tagged Dyrk2 (unknown origin) expressed in Escherichia coli BL21 (DE3) at 0.5 uM using KKISGRLSPIMTEQ-NH2 peptide as substrate in presence of [gamma-32P]-ATP relative to control	B	O=C(Nc1ccc(C(=O)NCc2ccccc2)cc1)Nc1nc2ccc(O)cc2s1		CHEMBL4277134	=	Inhibition	%	38.1	CHEMBL4376	Homo sapiens	INH	%	38.1
	18728156	CHEMBL4259476	Inhibition of recombinant GST-tagged Dyrk2 (unknown origin) expressed in Escherichia coli BL21 (DE3) at 0.5 uM using KKISGRLSPIMTEQ-NH2 peptide as substrate in presence of [gamma-32P]-ATP relative to control	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3nc4ccc(O)cc4s3)cc2)CC1		CHEMBL4287375	=	Inhibition	%	34.5	CHEMBL4376	Homo sapiens	INH	%	34.5
	18728157	CHEMBL4259476	Inhibition of recombinant GST-tagged Dyrk2 (unknown origin) expressed in Escherichia coli BL21 (DE3) at 0.5 uM using KKISGRLSPIMTEQ-NH2 peptide as substrate in presence of [gamma-32P]-ATP relative to control	B	O=C(Nc1cccc(O)c1)Nc1nc2ccc(O)cc2s1		CHEMBL4283894	=	Inhibition	%	64.7	CHEMBL4376	Homo sapiens	INH	%	64.7
	18728172	CHEMBL4259477	Inhibition of recombinant GST-tagged Dyrk2 (unknown origin) expressed in Escherichia coli BL21 (DE3) using KKISGRLSPIMTEQ-NH2 peptide as substrate in presence of [gamma-32P]-ATP	B	O=C(Cc1cccc(O)c1)Nc1nc2ccc(O)cc2s1		CHEMBL4288885	=	IC50	nM	5000.0	CHEMBL4376	Homo sapiens	IC50	uM	5.0
	18749714	CHEMBL4263576	Binding affinity to full length wild type human DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 10 uM by Kinomescan method relative to control	B	O=c1[nH]c2ccc(C3=NN=C(NCc4ccc(F)cc4)SC3)cc2[nH]1		CHEMBL4280328	=	Activity	%	55.0	CHEMBL4376	Homo sapiens	Activity	%	55.0
	18749715	CHEMBL4263576	Binding affinity to full length wild type human DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 10 uM by Kinomescan method relative to control	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	3.2	CHEMBL4376	Homo sapiens	Activity	%	3.2
	18750328	CHEMBL4263639	Inhibition of recombinant human Dyrk2 (unknown origin) at 2 uM by Lantha-screen assay	A	O=C(Cc1ccc(F)cc1)Nc1cncc(-c2cc(-c3cccnc3)cs2)c1		CHEMBL4290247	=	Inhibition	%	40.0	CHEMBL4376	Homo sapiens	INH	%	40.0
	18751130	CHEMBL4263784	Inhibition of DYRK2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	7.0	CHEMBL4376	Homo sapiens	INH	%	7.0
	18751646	CHEMBL4264257	Binding affinity to wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	5.2	CHEMBL4376	Homo sapiens	Activity	%	5.2
	18761472	CHEMBL4266550	Inhibition of recombinant human N-terminal 6His-tagged full length DYRK2 expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	11.0	CHEMBL4376	Homo sapiens	INH	%	11.0
	18761768	CHEMBL4266550	Inhibition of recombinant human N-terminal 6His-tagged full length DYRK2 expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	2.0	CHEMBL4376	Homo sapiens	INH	%	2.0
	18761931	CHEMBL4266550	Inhibition of recombinant human N-terminal 6His-tagged full length DYRK2 expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1	Outside typical range	CHEMBL4290222	=	Inhibition	%	-29.0	CHEMBL4376	Homo sapiens	INH	%	-29.0
	18762092	CHEMBL4266649	Inhibition of human full length DYRK2 using KKISGRLSPIMTEQ as substrate after 30 mins in presence of [gamma33P-ATP]	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	IC50	nM	900.0	CHEMBL4376	Homo sapiens	IC50	uM	0.9
	18762112	CHEMBL4266656	Inhibition of DYRK2 (unknown origin)	B	CN1C(=O)/C(=C\c2ccc3c(c2)OCO3)N=C1N		CHEMBL4291088	=	IC50	nM	490.0	CHEMBL4376	Homo sapiens	IC50	uM	0.49
	18810504	CHEMBL4275865	Inhibition of recombinant GST-tagged human DYRK2 expressed in Escherichia coli using woodtide as substrate after 30 mins in presence of [gamma-33P] by scintillation counting method	B	CC(C)c1cnn2c(NCc3ccc(-c4ccccn4)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc12		CHEMBL4284209	=	IC50	nM	120.0	CHEMBL4376	Homo sapiens	IC50	uM	0.12
	18810531	CHEMBL4275865	Inhibition of recombinant GST-tagged human DYRK2 expressed in Escherichia coli using woodtide as substrate after 30 mins in presence of [gamma-33P] by scintillation counting method	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	IC50	nM	1700.0	CHEMBL4376	Homo sapiens	IC50	uM	1.7
	18857926	CHEMBL4307772	Binding affinity to wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	87.0	CHEMBL4376	Homo sapiens	Activity	%	87.0
	18892856	CHEMBL4314822	Inhibition of recombinant full-length human DYRK2 assessed as residual activity at 10 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	113.0	CHEMBL4376	Homo sapiens	Activity	%	113.0
	18937875	CHEMBL4327668	Inhibition of human DYRK2 assessed as residual activity at 1 uM using RRRFRPASPLRGPPK as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	99.33	CHEMBL4376	Homo sapiens	Activity	%	99.33
	18937876	CHEMBL4327668	Inhibition of human DYRK2 assessed as residual activity at 1 uM using RRRFRPASPLRGPPK as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	101.63	CHEMBL4376	Homo sapiens	Activity	%	101.63
	18938508	CHEMBL4328028	Inhibition of human DYRK2 assessed as residual activity at 100 uM using RRRFRPASPLRGPPK as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4376	Homo sapiens	Activity	%	65.0
	18938885	CHEMBL4328392	Inhibition of human DYRK2 using RRRFRPASPLRGPPK as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	248.0	CHEMBL4376	Homo sapiens	IC50	10'-7M	2.48
	18958843	CHEMBL4333362	Binding affinity to wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL4376	Homo sapiens	Activity	%	100.0
	18964241	CHEMBL4335058	Inhibition of recombinant human DYRK2 assessed as residual activity at 1 uM using casein as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	82.0	CHEMBL4376	Homo sapiens	Activity	%	82.0
	18964242	CHEMBL4335058	Inhibition of recombinant human DYRK2 assessed as residual activity at 1 uM using casein as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	91.0	CHEMBL4376	Homo sapiens	Activity	%	91.0
	18971875	CHEMBL4336885	Inhibition of recombinant human DYRK2 assessed as residual activity at 10 uM using casein as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	94.0	CHEMBL4376	Homo sapiens	Activity	%	94.0
	19005813	CHEMBL4344402	Binding affinity to wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual bound protein level at 10 uM by Kinomescan method relative to control	B	COc1ccc2c3ccnc(C)c3n(CCCC(N)=O)c2c1		CHEMBL4474836	=	Activity	%	10.0	CHEMBL4376	Homo sapiens	Activity	%	10.0
	19005814	CHEMBL4344402	Binding affinity to wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual bound protein level at 10 uM by Kinomescan method relative to control	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	3.2	CHEMBL4376	Homo sapiens	Activity	%	3.2
	19005815	CHEMBL4344402	Binding affinity to wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual bound protein level at 10 uM by Kinomescan method relative to control	B	COc1ccc2c(c1)[nH]c1c(CO)nccc12		CHEMBL4066450	=	Activity	%	6.5	CHEMBL4376	Homo sapiens	Activity	%	6.5
Not Active	19039806	CHEMBL4351836	Inhibition of recombinant full-length human DYRK2 at 10 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
Active	19041086	CHEMBL4352347	Inhibition of human DYRK2 at 10 uM using RRRFRPASPLRGPPK as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
	19042440	CHEMBL4352753	ATP competitive inhibition of human DYRK2	B	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1		CHEMBL3989870	=	Ki	nM	26.0	CHEMBL4376	Homo sapiens	Ki	nM	26.0
	19059545	CHEMBL4357846	Binding affinity to wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	89.0	CHEMBL4376	Homo sapiens	Activity	%	89.0
	19090116	CHEMBL4365690	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	96.0	CHEMBL4376	Homo sapiens	Activity	%	96.0
	19091901	CHEMBL4366375	Inhibition of human DYRK2 at 100 nM using RRRFRPASPLRGPPK as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	3.05	CHEMBL4376	Homo sapiens	INH	%	3.05
	19092267	CHEMBL4366687	Inhibition of DYRK2 (unknown origin) at 1 uM relative to control	B	Nc1nccc(Oc2ccc(Nc3nccc4ccn(-c5ccc(F)cc5)c(=O)c34)cc2F)c1Cl		CHEMBL4474232	=	Inhibition	%	-9.0	CHEMBL4376	Homo sapiens	INH	%	-9.0
	19144778	CHEMBL4377794	Inhibition of recombinant full-length human DYRK2 at 1 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	-1.0	CHEMBL4376	Homo sapiens	INH	%	-1.0
	19147826	CHEMBL4379222	Inhibition of recombinant full length human DYRK2 using casein as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4376	Homo sapiens	IC50	uM	10.0
	19159373	CHEMBL4382477	Binding affinity to wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	100.0	CHEMBL4376	Homo sapiens	Activity	%	100.0
	19191634	CHEMBL4389196	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	78.0	CHEMBL4376	Homo sapiens	INH	%	78.0
	19191859	CHEMBL4389673	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL4376	Homo sapiens	INH	%	100.0
	19199923	CHEMBL4391299	Binding affinity to wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	53.0	CHEMBL4376	Homo sapiens	Activity	%	53.0
	19251841	CHEMBL4401825	Inhibition of recombinant human GST-tagged DYRK2 at 1 uM by kinomescan assay relative to control	B	O=C(CN1CCOCC1)N[C@H]1CC[C@H](Nc2cc(Cl)nn3c(-c4ccc5[nH]ncc5c4)cnc23)CC1		CHEMBL4565193	>	Inhibition	%	90.0	CHEMBL4376	Homo sapiens	INH	%	90.0
	19266397	CHEMBL4405347	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4376	Homo sapiens	INH	%	50.0
	19303765	CHEMBL4414217	Inhibition of DYRK2 (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1		CHEMBL4462082	=	Activity	%	78.0	CHEMBL4376	Homo sapiens	Activity	%	78.0
	20680063	CHEMBL4622611	Inhibition of recombinant human full length DYRK2 (1 to 528 residues) expressed in mammalian expression system at 1 uM by DiscoverX competition binding assay relative to control	B	Cc1cccc(N(C)c2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL4637319	=	Inhibition	%	19.0	CHEMBL4376	Homo sapiens	INH	%	19.0
	22423671	CHEMBL4674411	Inhibition of human DYRK2 using RRRFRPASPLRGPPK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	104.94	CHEMBL4376	Homo sapiens	Activity	%	104.94
	22423672	CHEMBL4674411	Inhibition of human DYRK2 using RRRFRPASPLRGPPK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	48.58	CHEMBL4376	Homo sapiens	Activity	%	48.58
	22441940	CHEMBL4678874	Inhibition of human recombinant full length N-terminal GST-tagged DYRK2 expressed in Escherichia coli at 0.1 uM incubated for 60 mins by TR-FRET based LanthaScreen Eu kinase binding assay relative to control	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1		CHEMBL4462530	=	Inhibition	%	85.0	CHEMBL4376	Homo sapiens	INH	%	85.0
	22441946	CHEMBL4678880	Inhibition of human recombinant full-length DYRK2 using casein as substrate at 1 uM incubated for 40 mins in presence of [gamma32P]-ATP by scintillation counting method relative to control	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CCCC4)c(Cl)cn2)C1		CHEMBL4754399	=	Inhibition	%	87.0	CHEMBL4376	Homo sapiens	INH	%	87.0
	22441947	CHEMBL4678880	Inhibition of human recombinant full-length DYRK2 using casein as substrate at 1 uM incubated for 40 mins in presence of [gamma32P]-ATP by scintillation counting method relative to control	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1		CHEMBL4462530	=	Inhibition	%	100.0	CHEMBL4376	Homo sapiens	INH	%	100.0
	22441948	CHEMBL4678880	Inhibition of human recombinant full-length DYRK2 using casein as substrate at 1 uM incubated for 40 mins in presence of [gamma32P]-ATP by scintillation counting method relative to control	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(F)cn2)C1		CHEMBL4754081	=	Inhibition	%	89.0	CHEMBL4376	Homo sapiens	INH	%	89.0
	22442114	CHEMBL4678911	Inhibition of DYRK2 (unknown origin) in presence of 5 mM ATP	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1		CHEMBL4462530	=	IC50	nM	8620.0	CHEMBL4376	Homo sapiens	IC50	uM	8.62
	22482650	CHEMBL4687856	Inhibition of human DYRK2 assessed as residual activity at 10 uM relative to control	A	CN1CCC(CNC2=NC(=O)/C(=C/c3csc(-c4ccc(OC(F)(F)F)cc4)n3)S2)CC1		CHEMBL4757567	=	Activity	%	81.0	CHEMBL4376	Homo sapiens	Activity	%	81.0
Not Active	22488209	CHEMBL4689213	Inhibition of human DYRK2 at 100 uM by ADP-Glo assay	A	Cc1ccc(-n2cc(COc3cccc4cnc(Nc5cccc(Cl)c5)nc34)nn2)c([N+](=O)[O-])c1		CHEMBL4783398		Inhibition	%		CHEMBL4376	Homo sapiens	INH		
	22840038	CHEMBL4719510	Binding affinity to DYRK2 (unknown origin) assessed as change in melting temperature of protein at 10 uM by Sypro-orange dye based DSF assay	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(Cl)cc4Cl)c3c2s1		CHEMBL2386747	=	Delta Tm	degrees C	5.0	CHEMBL4376	Homo sapiens	deltaTm	degrees C	5.0
	22840039	CHEMBL4719510	Binding affinity to DYRK2 (unknown origin) assessed as change in melting temperature of protein at 10 uM by Sypro-orange dye based DSF assay	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(OC)cc4F)c3c2s1		CHEMBL3894571	=	Delta Tm	degrees C	5.0	CHEMBL4376	Homo sapiens	deltaTm	degrees C	5.0
	22840044	CHEMBL4719513	Inhibition of DYRK2 (unknown origin)	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(Cl)cc4Cl)c3c2s1		CHEMBL2386747	=	IC50	nM	10.8	CHEMBL4376	Homo sapiens	IC50	nM	10.8
	22840045	CHEMBL4719513	Inhibition of DYRK2 (unknown origin)	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(OC)cc4F)c3c2s1		CHEMBL3894571	=	IC50	nM	3.16	CHEMBL4376	Homo sapiens	IC50	nM	3.16
	22843772	CHEMBL4720758	Inhibition of human DYRK2 using RRRFRPASPLRGPPK as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	112.0	CHEMBL4376	Homo sapiens	IC50	10^-7M	1.12
	22844124	CHEMBL4721110	Inhibition of human DYRK2 assessed as residual activity using RRRFRPASPLRGPPK as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	85.19	CHEMBL4376	Homo sapiens	Activity	%	85.19
	22844686	CHEMBL4721361	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	81.27	CHEMBL4376	Homo sapiens	Activity	%	81.27
	22886534	CHEMBL4728258	Binding affinity to DYRK2 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CCN1/C(=C\C(C)=O)Sc2ccc(OC)cc21		CHEMBL1349996	>	Delta Tm	degrees C	6.0	CHEMBL4376	Homo sapiens	deltaTm	degrees C	6.0
	22886535	CHEMBL4728258	Binding affinity to DYRK2 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CC(=O)c1cccc(-c2cnc3ccc(NCC4CC4)nn23)c1		CHEMBL200528	>	Delta Tm	degrees C	4.0	CHEMBL4376	Homo sapiens	deltaTm	degrees C	4.0
	22886536	CHEMBL4728258	Binding affinity to DYRK2 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	Nc1nccc(-c2ccc3noc(-c4ccc(Cl)cc4)c3c2)n1		CHEMBL409038	>	Delta Tm	degrees C	6.0	CHEMBL4376	Homo sapiens	deltaTm	degrees C	6.0
	22886605	CHEMBL4728308	Inhibition of human DYRK2 by radiometric assay	B	Cn1cc(-c2ccc3occ(-c4cccc(-c5ccncc5)c4)c3n2)cn1		CHEMBL4754195	=	IC50	nM	1309.0	CHEMBL4376	Homo sapiens	IC50	nM	1309.0
	22933064	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4cccc(-c5ccncc5)c4)c3n2)cn1		CHEMBL4754195	=	IC50	nM	1309.0	CHEMBL4376	Homo sapiens	IC50	nM	1309.0
	22933065	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4cccc(C5CCNCC5)c4)c3n2)cn1		CHEMBL4791451	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933066	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	CN1CCC(c2cccc(-c3coc4ccc(-c5cnn(C)c5)nc34)c2)CC1		CHEMBL4741919	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933067	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4cccc(-c5cn[nH]c5)c4)c3n2)cn1		CHEMBL4789951	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933068	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	Cn1cc(-c2cccc(-c3coc4ccc(-c5cnn(C)c5)nc34)c2)cn1		CHEMBL4797457	=	IC50	nM	771.0	CHEMBL4376	Homo sapiens	IC50	nM	771.0
	22933069	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4cccc(-c5cc[nH]n5)c4)c3n2)cn1		CHEMBL4762964	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933070	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	c1ccc(-c2coc3ccc(-c4cn[nH]c4)nc23)cc1		CHEMBL4790030	=	IC50	nM	1151.0	CHEMBL4376	Homo sapiens	IC50	nM	1151.0
	22933071	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	c1ccc2cc(-c3coc4ccc(-c5cn[nH]c5)nc34)ccc2c1		CHEMBL4750420	=	IC50	nM	1433.0	CHEMBL4376	Homo sapiens	IC50	nM	1433.0
	22933072	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	COc1ccc(-c2coc3ccc(-c4cn[nH]c4)nc23)cc1		CHEMBL4743939	=	IC50	nM	1001.0	CHEMBL4376	Homo sapiens	IC50	nM	1001.0
	22933073	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	Cn1cc(-c2coc3ccc(-c4cn[nH]c4)nc23)cn1		CHEMBL4790791	=	IC50	nM	1214.0	CHEMBL4376	Homo sapiens	IC50	nM	1214.0
	22933074	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cn[nH]c4)nc23)cc1		CHEMBL4777288	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933075	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	CC1(c2ccc(-c3coc4ccc(-c5cn[nH]c5)nc34)cc2)CC1		CHEMBL4740998	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933076	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	C=C(C)c1ccc(-c2coc3ccc(-c4cn[nH]c4)nc23)cc1		CHEMBL4743730	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933077	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	c1ccc(Cc2ccc(-c3coc4ccc(-c5cn[nH]c5)nc34)cc2)cc1		CHEMBL4789373	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933078	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	CC(C)Cc1ccc(-c2coc3ccc(-c4cn[nH]c4)nc23)cc1		CHEMBL4794825	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933079	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	c1ccc(-c2ccc(-c3coc4ccc(-c5cn[nH]c5)nc34)cc2)cc1		CHEMBL4778370	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933080	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	c1n[nH]cc1-c1ccc2occ(-c3ccc(C4CCCCC4)cc3)c2n1		CHEMBL4777540	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933081	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	c1n[nH]cc1-c1ccc2occ(-c3ccc(C45CC6CC(CC(C6)C4)C5)cc3)c2n1		CHEMBL4758047	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933082	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4ccc(C(C)(C)C)cc4)c3n2)cn1		CHEMBL4747210	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933083	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4ccc(C(C)(C)C)cc4)c3n2)nn1		CHEMBL4790254	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933084	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cc[nH]n4)nc23)cc1		CHEMBL4800422	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933085	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	Cn1ccc(-c2ccc3occ(-c4ccc(C(C)(C)C)cc4)c3n2)n1		CHEMBL4793177	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933086	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4nn[nH]n4)nc23)cc1		CHEMBL4777533	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933087	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cnsc4)nc23)cc1		CHEMBL4747520	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933088	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cnn(CCN5CCOCC5)c4)nc23)cc1		CHEMBL4795812	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933089	CHEMBL4739021	Inhibition of human full length recombinant DYRK2 using casein substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cn[nH]n4)nc23)cc1		CHEMBL4778153	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933185	CHEMBL4739031	Inhibition of DYRK2 (unknown origin) by NanoBRET cellular target engagement assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cn[nH]c4)nc23)cc1		CHEMBL4777288	>	IC50	nM	50000.0	CHEMBL4376	Homo sapiens	IC50	nM	50000.0
	22933186	CHEMBL4739031	Inhibition of DYRK2 (unknown origin) by NanoBRET cellular target engagement assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cn[nH]n4)nc23)cc1		CHEMBL4778153	>	IC50	nM	50000.0	CHEMBL4376	Homo sapiens	IC50	nM	50000.0
	22933187	CHEMBL4739031	Inhibition of DYRK2 (unknown origin) by NanoBRET cellular target engagement assay	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(OC)cc4F)c3c2s1		CHEMBL3894571	>	IC50	nM	3000.0	CHEMBL4376	Homo sapiens	IC50	nM	3000.0
	22933188	CHEMBL4739031	Inhibition of DYRK2 (unknown origin) by NanoBRET cellular target engagement assay	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	570.0	CHEMBL4376	Homo sapiens	IC50	nM	570.0
	22943996	CHEMBL4742516	Inhibition of DYRK2 (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	B	COCc1cc(C)nc2sc(C(N)=O)c(N)c12		CHEMBL4780986	=	Activity	%	46.0	CHEMBL4376	Homo sapiens	Activity	%	46.0
	22952818	CHEMBL4766755	Inhibition of recombinant human DYRK2 assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	30.0	CHEMBL4376	Homo sapiens	Activity	%	30.0
	23120126	CHEMBL4804325	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	Nc1ncc(-c2cc([N+](=O)[O-])ccc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4874241	=	Activity	%	3.0	CHEMBL4376	Homo sapiens	Activity	%	3.0
	23122531	CHEMBL4804882	Inhibition of human DYRK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	68.0	CHEMBL4376	Homo sapiens	Activity	%	68.0
	23123226	CHEMBL4805470	Inhibition of human DYRK2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	84.0	CHEMBL4376	Homo sapiens	Activity	%	84.0
	23123665	CHEMBL4805909	Inhibition of DNA-tagged human DYRK2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	84.0	CHEMBL4376	Homo sapiens	Activity	%	84.0
	23124542	CHEMBL4806487	Inhibition of human DYRK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4376	Homo sapiens	Activity	%	100.0
	23124543	CHEMBL4806487	Inhibition of human DYRK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	97.0	CHEMBL4376	Homo sapiens	Activity	%	97.0
	23128023	CHEMBL4807816	Inhibition of DYRK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL4376	Homo sapiens	Activity	%	75.0
	23128024	CHEMBL4807816	Inhibition of DYRK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4376	Homo sapiens	Activity	%	75.0
	23128025	CHEMBL4807816	Inhibition of DYRK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL4376	Homo sapiens	Activity	%	75.0
	23152001	CHEMBL4810635	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(C)c1nccc(-c2cnn3ncccc23)n1		CHEMBL4848254	=	Activity	%	19.0	CHEMBL4376	Homo sapiens	Activity	%	19.0
	23152002	CHEMBL4810635	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(c1nccc(-c2cnn3ncccc23)n1)C1CC1		CHEMBL4848696	=	Activity	%	100.0	CHEMBL4376	Homo sapiens	Activity	%	100.0
	23152003	CHEMBL4810635	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	c1cnn2ncc(-c3ccnc(N4CCC45COC5)n3)c2c1		CHEMBL4845809	=	Activity	%	11.0	CHEMBL4376	Homo sapiens	Activity	%	11.0
	23152004	CHEMBL4810635	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CC1CCCN1c1nccc(-c2cnn3ncccc23)n1		CHEMBL4859912	=	Activity	%	66.0	CHEMBL4376	Homo sapiens	Activity	%	66.0
	23152005	CHEMBL4810635	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	C[C@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4853444	=	Activity	%	15.0	CHEMBL4376	Homo sapiens	Activity	%	15.0
	23152006	CHEMBL4810635	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	C[C@@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4870121	=	Activity	%	25.0	CHEMBL4376	Homo sapiens	Activity	%	25.0
	23152007	CHEMBL4810635	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	F[C@@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4852944	=	Activity	%	39.0	CHEMBL4376	Homo sapiens	Activity	%	39.0
	23152008	CHEMBL4810635	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	N[C@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4877372	=	Activity	%	29.0	CHEMBL4376	Homo sapiens	Activity	%	29.0
	23152009	CHEMBL4810635	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	N[C@@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4876980	=	Activity	%	28.0	CHEMBL4376	Homo sapiens	Activity	%	28.0
	23152010	CHEMBL4810635	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	Cc1cnn2ncc(-c3ccnc(N(C)C)n3)c2c1		CHEMBL4851717	=	Activity	%	25.0	CHEMBL4376	Homo sapiens	Activity	%	25.0
	23152011	CHEMBL4810635	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	COc1ccnn2ncc(-c3ccnc(N(C)C)n3)c12		CHEMBL4874923	=	Activity	%	24.0	CHEMBL4376	Homo sapiens	Activity	%	24.0
	23152012	CHEMBL4810635	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(C)c1nccc(-c2cnc3ncccn23)n1		CHEMBL4872408	=	Activity	%	35.0	CHEMBL4376	Homo sapiens	Activity	%	35.0
	23152013	CHEMBL4810635	Inhibition of wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(C)c1ncc(F)c(-c2cnn3ncccc23)n1		CHEMBL4861396	=	Activity	%	55.0	CHEMBL4376	Homo sapiens	Activity	%	55.0
	23152085	CHEMBL4810647	Binding affinity to wild-type human full length DYRK2 (M1 to S528 residues) expressed in mammalian expression system measured after 1 hr by competitive binding assay	B	CN(C)c1nccc(-c2cnn3ncccc23)n1		CHEMBL4848254	=	Kd	nM	360.0	CHEMBL4376	Homo sapiens	Kd	nM	360.0
Not Active	23317366	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	94.0	CHEMBL4376	Homo sapiens	% Control	%	94.0
Not Active	23317834	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	87.0	CHEMBL4376	Homo sapiens	% Control	%	87.0
Not Active	23318504	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	52.0	CHEMBL4376	Homo sapiens	% Control	%	52.0
Not Active	23318984	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	89.0	CHEMBL4376	Homo sapiens	% Control	%	89.0
Not Active	23319621	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	71.4	CHEMBL4376	Homo sapiens	% Control	%	71.4
Not Active	23320096	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	82.9	CHEMBL4376	Homo sapiens	% Control	%	82.9
Not Active	23320774	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23321242	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	81.0	CHEMBL4376	Homo sapiens	% Control	%	81.0
Not Active	23321872	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	74.0	CHEMBL4376	Homo sapiens	% Control	%	74.0
Not Active	23322340	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	92.0	CHEMBL4376	Homo sapiens	% Control	%	92.0
Not Active	23323029	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	75.0	CHEMBL4376	Homo sapiens	% Control	%	75.0
Not Active	23323497	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23324351	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23324986	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	93.0	CHEMBL4376	Homo sapiens	% Control	%	93.0
Not Active	23325454	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	90.0	CHEMBL4376	Homo sapiens	% Control	%	90.0
Not Active	23326101	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23326569	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	81.0	CHEMBL4376	Homo sapiens	% Control	%	81.0
Not Active	23327269	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	95.0	CHEMBL4376	Homo sapiens	% Control	%	95.0
Not Active	23327737	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	90.0	CHEMBL4376	Homo sapiens	% Control	%	90.0
Not Active	23328324	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	88.0	CHEMBL4376	Homo sapiens	% Control	%	88.0
Not Active	23328792	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	88.0	CHEMBL4376	Homo sapiens	% Control	%	88.0
Not Active	23329323	CHEMBL4881030	DYRK2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	105.0	CHEMBL4376	Homo sapiens	% residual kinase activity	%	105.0
Not Active	23329738	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23330206	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23330962	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23331430	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23332017	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	82.5	CHEMBL4376	Homo sapiens	% Control	%	82.5
Not Active	23332483	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23333201	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23333840	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	92.0	CHEMBL4376	Homo sapiens	% Control	%	92.0
Not Active	23334308	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	96.0	CHEMBL4376	Homo sapiens	% Control	%	96.0
Not Active	23335287	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23335755	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23336382	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	77.0	CHEMBL4376	Homo sapiens	% Control	%	77.0
Not Active	23336850	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	94.0	CHEMBL4376	Homo sapiens	% Control	%	94.0
Not Active	23337931	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	89.0	CHEMBL4376	Homo sapiens	% Control	%	89.0
Not Active	23338399	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	81.0	CHEMBL4376	Homo sapiens	% Control	%	81.0
Not Active	23339011	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	92.0	CHEMBL4376	Homo sapiens	% Control	%	92.0
Not Active	23339479	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	83.0	CHEMBL4376	Homo sapiens	% Control	%	83.0
Not Active	23340116	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	95.0	CHEMBL4376	Homo sapiens	% Control	%	95.0
Not Active	23340584	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	91.0	CHEMBL4376	Homo sapiens	% Control	%	91.0
Not Active	23341241	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	89.0	CHEMBL4376	Homo sapiens	% Control	%	89.0
Not Active	23341709	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	93.0	CHEMBL4376	Homo sapiens	% Control	%	93.0
Not Active	23342325	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	87.0	CHEMBL4376	Homo sapiens	% Control	%	87.0
Not Active	23342793	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23343423	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	76.0	CHEMBL4376	Homo sapiens	% Control	%	76.0
Not Active	23343891	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23344529	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23345102	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	77.0	CHEMBL4376	Homo sapiens	% Control	%	77.0
Not Active	23345570	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	66.0	CHEMBL4376	Homo sapiens	% Control	%	66.0
Not Active	23346147	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23346616	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	82.4	CHEMBL4376	Homo sapiens	% Control	%	82.4
Not Active	23347224	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	59.3	CHEMBL4376	Homo sapiens	% Control	%	59.3
Not Active	23347707	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23348286	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23348754	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	93.0	CHEMBL4376	Homo sapiens	% Control	%	93.0
Not Active	23349341	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23349959	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23350427	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	94.0	CHEMBL4376	Homo sapiens	% Control	%	94.0
Not Active	23351032	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	95.0	CHEMBL4376	Homo sapiens	% Control	%	95.0
Not Active	23351500	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	94.0	CHEMBL4376	Homo sapiens	% Control	%	94.0
Not Active	23352524	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	98.0	CHEMBL4376	Homo sapiens	% Control	%	98.0
Not Active	23352992	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	83.0	CHEMBL4376	Homo sapiens	% Control	%	83.0
Not Active	23353874	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23354342	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23355074	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23355542	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	84.0	CHEMBL4376	Homo sapiens	% Control	%	84.0
Not Active	23356178	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23356646	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23357255	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	85.0	CHEMBL4376	Homo sapiens	% Control	%	85.0
Not Active	23357902	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	81.0	CHEMBL4376	Homo sapiens	% Control	%	81.0
Not Active	23358370	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	81.0	CHEMBL4376	Homo sapiens	% Control	%	81.0
Not Active	23358956	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23359554	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	84.0	CHEMBL4376	Homo sapiens	% Control	%	84.0
Not Active	23360022	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	98.0	CHEMBL4376	Homo sapiens	% Control	%	98.0
Not Active	23360607	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	87.0	CHEMBL4376	Homo sapiens	% Control	%	87.0
Not Active	23361075	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	89.0	CHEMBL4376	Homo sapiens	% Control	%	89.0
Not Active	23361648	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	79.0	CHEMBL4376	Homo sapiens	% Control	%	79.0
Not Active	23362184	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	91.0	CHEMBL4376	Homo sapiens	% Control	%	91.0
Not Active	23362652	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	90.0	CHEMBL4376	Homo sapiens	% Control	%	90.0
Not Active	23364294	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23364762	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23365501	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23366044	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23366634	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	97.0	CHEMBL4376	Homo sapiens	% Control	%	97.0
Not Active	23367102	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23367980	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	81.0	CHEMBL4376	Homo sapiens	% Control	%	81.0
Not Active	23368448	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	84.0	CHEMBL4376	Homo sapiens	% Control	%	84.0
Not Active	23369047	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	87.0	CHEMBL4376	Homo sapiens	% Control	%	87.0
Not Active	23369515	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	81.0	CHEMBL4376	Homo sapiens	% Control	%	81.0
Not Active	23370045	CHEMBL4884289	DYRK2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	100.0	CHEMBL4376	Homo sapiens	% residual kinase activity	%	100.0
Not Active	23370483	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	82.0	CHEMBL4376	Homo sapiens	% Control	%	82.0
Not Active	23370951	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23371760	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23372228	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
	23372723	CHEMBL4884688	DYRK2(DYR2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4376	Homo sapiens	pIC50		6.0
	23373132	CHEMBL4884979	DYRK2(DYR2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4376	Homo sapiens	pIC50		6.0
	23373493	CHEMBL4885270	DYRK2(DYR2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4376	Homo sapiens	pIC50		6.0
Not Active	23375655	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	97.0	CHEMBL4376	Homo sapiens	% Control	%	97.0
Not Active	23376123	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	85.0	CHEMBL4376	Homo sapiens	% Control	%	85.0
Not Active	23376700	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23377169	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	99.0	CHEMBL4376	Homo sapiens	% Control	%	99.0
Not Active	23378028	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	88.0	CHEMBL4376	Homo sapiens	% Control	%	88.0
Not Active	23378496	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	92.0	CHEMBL4376	Homo sapiens	% Control	%	92.0
Not Active	23379663	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	95.0	CHEMBL4376	Homo sapiens	% Control	%	95.0
Not Active	23380131	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL4376	Homo sapiens	% Control	%	100.0
Not Active	23380825	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	84.0	CHEMBL4376	Homo sapiens	% Control	%	84.0
Not Active	23381473	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	98.0	CHEMBL4376	Homo sapiens	% Control	%	98.0
Not Active	23381941	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	93.0	CHEMBL4376	Homo sapiens	% Control	%	93.0
Not Active	23382565	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	76.0	CHEMBL4376	Homo sapiens	% Control	%	76.0
Slightly Active	23383033	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	37.0	CHEMBL4376	Homo sapiens	% Control	%	37.0
Not Active	23383609	CHEMBL4887269	DYRK2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	62.0	CHEMBL4376	Homo sapiens	% Ctrl	%	62.0
Not Active	23384254	CHEMBL4887849	DYRK2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	19.11	CHEMBL4376	Homo sapiens	% inhibition	%	19.11
Not Active	23384948	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	89.0	CHEMBL4376	Homo sapiens	% Control	%	89.0
Not Active	23385415	CHEMBL4879672	KinomeScan assay: inhibition of DYRK2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	95.0	CHEMBL4376	Homo sapiens	% Control	%	95.0
